RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: multiple sclerosis
Accession: DOID:2377
browse the term
Definition: A demyelinating disease that involves damage to the fatty myelin sheaths around the axons of the brain and spinal cord resulting in demyelination and scarring. (DO)
Synonyms: exact_synonym: MS; MS (Multiple Sclerosis); acute fulminating multiple sclerosis; disseminated sclerosis; generalized multiple sclerosis; insular sclerosis
related_synonym: MS1; MS2; MS3; MS4; MS5; multiple sclerosis modifier of disease progression; multiple sclerosis, susceptibility to; multiple sclerosis, susceptibility to, 1; multiple sclerosis, susceptibility to, 2; multiple sclerosis, susceptibility to, 3; multiple sclerosis, susceptibility to, 4; multiple sclerosis, susceptibility to, 5
primary_id: MESH:D009103
alt_id: OMIM:126200 ; OMIM:612594 ; OMIM:612595 ; OMIM:612596 ; OMIM:614810
xref: EFO:0003885 ; GARD:10255 ; ICD10CM:G35 ; ICD9CM:340 ; MONDO:0005301 ; NCI:C3243 ; OMIM:PS126200
For additional species annotation, visit the
Alliance of Genome Resources .
Please select species to view GViewer data.
G
P
A2M
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chr 5:62,406,928...62,483,690
Ensembl chr 5:62,440,810...62,483,678
G
D
A2M
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chr27:36,654,328...36,695,775
G
R
A2m
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
M
A2m
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
H
A2M
alpha-2-macroglobulin
IAGP
RGD
PMID:11498265
RGD:1549857
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
N
Acan
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chrNW_004624768:16,093,552...16,156,655
G
G
ACAN
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr29:7,345,350...7,416,951
G
P
ACAN
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr 7:54,449,830...54,520,606
Ensembl chr 7:54,449,816...54,519,194
G
S
Acan
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chrNW_004936483:14,811,152...14,846,305
Ensembl chrNW_004936483:14,811,152...14,846,305
G
D
ACAN
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr 3:51,995,100...52,031,812
Ensembl chr 3:51,969,779...52,031,544
G
B
ACAN
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr15:67,492,494...67,563,265
Ensembl chr15:86,733,853...86,771,420
G
C
Acan
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chrNW_004955416:16,125,536...16,186,046
G
R
Acan
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
G
M
Acan
aggrecan
ISO
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr 7:78,702,974...78,764,847
Ensembl chr 7:78,703,231...78,764,847
G
H
ACAN
aggrecan
IEP
protein:altered expression:central nervous system, plaque (human)
RGD
PMID:11764092
RGD:2315836
NCBI chr15:88,803,436...88,875,353
Ensembl chr15:88,803,436...88,875,353
G
N
Ache
acetylcholinesterase (Cartwright blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chrNW_004624740:16,275,108...16,280,639
Ensembl chrNW_004624740:16,275,117...16,281,793
G
G
ACHE
acetylcholinesterase (Cartwright blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
G
P
ACHE
acetylcholinesterase
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 3:8,732,451...8,738,274
Ensembl chr 3:8,732,441...8,738,605
G
S
Ache
acetylcholinesterase (Cartwright blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chrNW_004936543:856,678...862,080
Ensembl chrNW_004936543:856,676...862,109
G
D
ACHE
acetylcholinesterase
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
G
B
ACHE
acetylcholinesterase (Yt blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 7:92,915,065...92,922,079
Ensembl chr 7:106,311,944...106,318,184
G
C
Ache
acetylcholinesterase (Cartwright blood group)
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chrNW_004955573:79,606...85,799
Ensembl chrNW_004955573:80,298...85,799
G
R
Ache
acetylcholinesterase
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
M
Ache
acetylcholinesterase
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
H
ACHE
acetylcholinesterase (Yt blood group)
IEP
protein:decreased expression:cerebrospinal fluid
RGD
PMID:2953866
RGD:5688127
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
N
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chrNW_004624730:69,941,963...69,959,266
Ensembl chrNW_004624730:69,941,001...69,957,012
G
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
G
P
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
S
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
G
D
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr34:19,398,310...19,410,519
Ensembl chr34:19,354,825...19,409,844
G
B
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr 3:183,876,051...183,889,723
Ensembl chr 3:192,341,320...192,354,885
G
C
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
R
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
M
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
H
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP
protein:increased expression:serum
RGD
PMID:20714168
RGD:5686885
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
N
Ager
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chrNW_004624754:24,138,086...24,140,900
G
G
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr17:39,847,343...39,851,288
Ensembl chr17:39,847,759...39,851,127
G
P
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr 7:24,218,116...24,221,162
Ensembl chr 7:24,218,120...24,221,162
G
S
Ager
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chrNW_004936727:1,418,342...1,422,005
Ensembl chrNW_004936727:1,418,799...1,422,147
G
D
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr12:1,574,251...1,577,410
Ensembl chr12:1,574,251...1,577,129
G
B
AGER
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
C
Ager
advanced glycosylation end-product specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chrNW_004955437:645,482...648,607
Ensembl chrNW_004955437:645,897...648,479
G
R
Ager
advanced glycosylation end product-specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
M
Ager
advanced glycosylation end product-specific receptor
susceptibility
ISO
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
H
AGER
advanced glycosylation end-product specific receptor
susceptibility
IAGP
DNA:polymorphism:cds:p.G82S rs2070600 (human)
RGD
PMID:21511691
RGD:6767562
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
N
Agt
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chrNW_004624775:18,846,222...18,856,093
Ensembl chrNW_004624775:18,849,118...18,855,577
G
G
AGT
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
G
P
AGT
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
G
S
Agt
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chrNW_004936484:19,713,299...19,721,144
Ensembl chrNW_004936484:19,716,165...19,721,261
G
D
AGT
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
B
AGT
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr 1:206,252,141...206,263,830
Ensembl chr 1:211,279,015...211,291,044
G
C
Agt
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
G
R
Agt
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
M
Agt
angiotensinogen
ISO
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
H
AGT
angiotensinogen
IEP
protein:decreased expression:brain,astrocyte:
RGD
PMID:17715340
RGD:13432361
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
G
AIM2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:4,759,746...4,884,460
Ensembl chr20:4,873,008...4,884,764
G
S
Aim2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936740:1,447,869...1,460,836
Ensembl chrNW_004936740:1,451,001...1,460,836
G
B
AIM2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:134,413,232...134,540,344
Ensembl chr 1:138,210,946...138,221,753
G
R
Aim2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:85,865,206...85,906,996
Ensembl chr13:85,866,284...85,906,975
G
M
Aim2
absent in melanoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:173,177,105...173,293,606
Ensembl chr 1:173,178,445...173,293,606
G
H
AIM2
absent in melanoma 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:159,055,051...159,147,132
Ensembl chr 1:159,061,599...159,187,843
G
N
Apoa1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chrNW_004624784:12,249,283...12,251,215
Ensembl chrNW_004624784:12,249,283...12,251,136
G
G
APOA1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
P
APOA1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 9:44,216,481...44,218,360
Ensembl chr 9:44,216,392...44,218,713
G
S
Apoa1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chrNW_004936542:2,111,055...2,112,626
Ensembl chrNW_004936542:2,111,052...2,112,854
G
D
APOA1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 5:16,740,071...16,742,081
Ensembl chr 5:16,740,130...16,741,943
G
B
APOA1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr11:111,673,539...111,675,428
Ensembl chr11:115,606,136...115,608,122
G
C
Apoa1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
G
R
Apoa1
apolipoprotein A1
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
M
Apoa1
apolipoprotein A-I
ISO
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
H
APOA1
apolipoprotein A1
IEP
protein:increased expression: serum
RGD
PMID:20350318
RGD:5508215
NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
G
N
Apoc2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chrNW_004624907:1,765,467...1,769,786
Ensembl chrNW_004624907:1,765,481...1,769,781
G
G
APOC2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
G
P
APOC2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 6:51,404,219...51,406,302
G
S
Apoc2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chrNW_004936706:1,531,219...1,531,921
G
D
APOC2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 1:110,504,806...110,506,986
Ensembl chr 1:110,504,815...110,506,961
G
B
APOC2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr19:41,892,954...41,896,461
G
C
Apoc2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chrNW_004955555:2,019,547...2,021,543
Ensembl chrNW_004955555:2,016,217...2,021,830
G
R
Apoc2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
G
M
Apoc2
apolipoprotein C2
ISO
RGD
PMID:10335523
RGD:1358408
NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
G
H
APOC2
apolipoprotein C2
IAGP
RGD
PMID:10335523
RGD:1358408
NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
G
N
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chrNW_004624907:1,752,322...1,755,308
G
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
P
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
S
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chrNW_004936706:1,512,438...1,516,805
G
D
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
B
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
C
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
R
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896 PMID:15118671
RGD:1331525
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
M
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896 PMID:15118671
RGD:1331525
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
H
APOE
apolipoprotein E
IEA EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15048896 PMID:15118671
RGD:1331525
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
N
B4galt5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004624790:5,770,586...5,792,036
Ensembl chrNW_004624790:5,766,903...5,789,140
G
G
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 2:14,270,945...14,357,052
Ensembl chr 2:14,271,141...14,354,159
G
P
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr17:51,257,273...51,334,566
Ensembl chr17:51,259,813...51,334,020
G
S
B4galt5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004936514:4,719,198...4,736,638
Ensembl chrNW_004936514:4,719,052...4,736,635
G
D
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr24:36,220,973...36,241,482
Ensembl chr24:36,221,189...36,300,804
G
B
B4GALT5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr20:45,977,801...46,058,429
Ensembl chr20:47,041,469...47,123,214
G
C
B4galt5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004955445:8,471,684...8,559,672
Ensembl chrNW_004955445:8,534,220...8,559,672
G
R
B4galt5
beta-1,4-galactosyltransferase 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
G
M
B4galt5
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 2:167,140,364...167,191,155
Ensembl chr 2:167,140,364...167,191,103
G
H
B4GALT5
beta-1,4-galactosyltransferase 5
IEP
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878
G
N
B4galt6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004624770:1,119,202...1,239,127
Ensembl chrNW_004624770:1,160,120...1,240,016
G
G
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:49,037,348...49,101,769
Ensembl chr18:49,037,225...49,102,502
G
P
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 6:115,525,515...115,593,265
Ensembl chr 6:115,524,636...115,593,270
G
S
B4galt6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004936682:1,535,617...1,590,723
Ensembl chrNW_004936682:1,535,586...1,593,827
G
D
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr 7:57,849,872...57,917,289
Ensembl chr 7:57,849,884...57,914,360
G
B
B4GALT6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:24,840,106...24,906,309
Ensembl chr18:28,438,302...28,500,946
G
C
B4galt6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chrNW_004955402:18,945,013...19,024,132
Ensembl chrNW_004955402:18,942,872...19,024,132
G
R
B4galt6
beta-1,4-galactosyltransferase 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:11,958,382...12,015,247
Ensembl chr18:11,958,390...12,015,247
G
M
B4galt6
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6
ISO
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:20,817,656...20,879,461
Ensembl chr18:20,817,656...20,879,461
G
H
B4GALT6
beta-1,4-galactosyltransferase 6
IEP
mRNA:increased expression:white matter
RGD
PMID:25216636
RGD:14390079
NCBI chr18:31,622,246...31,724,641
Ensembl chr18:31,622,246...31,685,836
G
N
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chrNW_004624730:43,793,550...43,849,169
Ensembl chrNW_004624730:43,793,040...43,843,519
G
G
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
P
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr13:104,946,732...105,007,568
G
S
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
G
D
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
G
B
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr 3:162,794,184...162,858,574
Ensembl chr 3:170,845,494...170,911,481
G
C
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chrNW_004955448:15,327,374...15,396,827
Ensembl chrNW_004955448:15,329,273...15,396,970
G
R
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
M
Bche
butyrylcholinesterase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
H
BCHE
butyrylcholinesterase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20122907
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
P
BCL2L2
BCL2 like 2
ISO
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr 7:75,765,603...75,770,743
Ensembl chr 7:75,763,078...75,769,763
G
D
BCL2L2
BCL2 like 2
ISO
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr 8:3,569,335...3,573,922
Ensembl chr 8:3,569,399...3,586,070
G
R
Bcl2l2
Bcl2-like 2
ISO
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
G
M
Bcl2l2
BCL2-like 2
ISO
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr14:55,120,900...55,125,691
Ensembl chr14:55,120,834...55,125,691
G
H
BCL2L2
BCL2 like 2
IEP
mRNA:decreased expression:brain:
RGD
PMID:24270187
RGD:14394512
NCBI chr14:23,306,833...23,311,751
Ensembl chr14:23,298,790...23,311,751
G
N
Bdnf
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chrNW_004624766:17,281,882...17,330,601
Ensembl chrNW_004624766:17,279,630...17,330,490
G
G
BDNF
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
G
P
BDNF
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr 2:32,623,668...32,679,293
Ensembl chr 2:32,624,048...32,679,765
G
S
Bdnf
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
G
D
BDNF
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr21:48,191,580...48,243,699
Ensembl chr21:48,192,670...48,204,480
G
B
BDNF
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr11:27,618,322...27,687,661
Ensembl chr11:27,520,312...27,589,239
G
C
Bdnf
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chrNW_004955476:6,773,244...6,822,201
Ensembl chrNW_004955476:6,772,088...6,822,588
G
R
Bdnf
brain-derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
G
M
Bdnf
brain derived neurotrophic factor
onset
ISO
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
H
BDNF
brain derived neurotrophic factor
onset
IEP
protein:decreased expression:serum
RGD
PMID:20656764
RGD:5684915
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
N
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chrNW_004624760:78,754...257,901
Ensembl chrNW_004624760:81,236...257,787
G
G
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr12:75,441...335,980
Ensembl chr12:78,011...335,820
G
P
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
G
S
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chrNW_004936669:133,488...308,623
Ensembl chrNW_004936669:133,698...308,488
G
D
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr 9:47,813,625...48,009,532
Ensembl chr 9:47,816,393...48,009,406
G
B
CACNA1B
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr 9:108,989,621...109,256,841
G
C
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chrNW_004955513:5,654,915...5,823,094
Ensembl chrNW_004955513:5,654,238...5,824,386
G
R
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
M
Cacna1b
calcium channel, voltage-dependent, N type, alpha 1B subunit
ISO
RGD
PMID:11353727
RGD:1580151
NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164
G
H
CACNA1B
calcium voltage-gated channel subunit alpha1 B
IEP
RGD
PMID:11353727
RGD:1580151
NCBI chr 9:137,877,782...138,124,619
Ensembl chr 9:137,877,782...138,124,624
G
G
CASP1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 1:96,389,697...96,400,610
Ensembl chr 1:96,389,657...96,400,849
G
P
CASP1
caspase 1, apoptosis-related cysteine peptidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 9:35,188,066...35,199,364
Ensembl chr 9:35,186,420...35,200,328
G
B
CASP1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
G
R
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
M
Casp1
caspase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
H
CASP1
caspase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
N
Cav1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chrNW_004624827:2,844,855...2,878,367
Ensembl chrNW_004624827:2,844,115...2,879,179
G
G
CAV1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr21:85,222,724...85,258,562
Ensembl chr21:85,222,879...85,258,627
G
P
CAV1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr18:29,648,120...29,682,451
Ensembl chr18:29,649,992...29,682,465
G
S
Cav1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chrNW_004936589:2,504,235...2,536,778
Ensembl chrNW_004936589:2,504,224...2,537,170
G
D
CAV1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr14:55,458,934...55,494,563
Ensembl chr14:55,461,048...55,492,935
G
B
CAV1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr 7:108,497,125...108,533,090
Ensembl chr 7:121,193,424...121,229,655
G
C
Cav1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chrNW_004955432:22,258,262...22,292,403
Ensembl chrNW_004955432:22,258,250...22,292,403
G
R
Cav1
caveolin 1
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
M
Cav1
caveolin 1, caveolae protein
ISO
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
H
CAV1
caveolin 1
IAGP
DNA:repeats, haplotypes:multiple
RGD
PMID:19828204
RGD:8661778
NCBI chr 7:116,525,009...116,561,185
Ensembl chr 7:116,524,994...116,561,179
G
N
Cblb
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chrNW_004624731:43,803,743...44,018,682
Ensembl chrNW_004624731:43,803,768...44,015,870
G
G
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr22:74,961,831...75,181,307
Ensembl chr22:74,961,859...75,178,548
G
P
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr13:153,480,525...153,700,115
Ensembl chr13:153,395,978...153,700,056
G
S
Cblb
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chrNW_004936701:1,157,790...1,353,375
Ensembl chrNW_004936701:1,157,797...1,353,388
G
D
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr33:11,255,453...11,665,755
Ensembl chr33:11,199,863...11,530,810
G
B
CBLB
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr 3:102,752,406...102,966,414
Ensembl chr 3:109,690,120...109,905,191
G
C
Cblb
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chrNW_004955427:6,601,651...6,812,896
Ensembl chrNW_004955427:6,604,820...6,812,882
G
R
Cblb
Cbl proto-oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
M
Cblb
Casitas B-lineage lymphoma b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr16:51,851,593...52,028,410
Ensembl chr16:51,851,588...52,028,411
G
H
CBLB
Cbl proto-oncogene B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453840
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
N
Ccl1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chrNW_004624875:2,224,784...2,229,465
G
G
CCL1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,868,925...27,890,143
G
P
CCL1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr12:40,728,014...40,731,411
Ensembl chr12:40,728,014...40,731,411
G
S
Ccl1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chrNW_004936538:781,687...784,199
Ensembl chrNW_004936538:781,687...784,199
G
D
CCL1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr 9:38,931,895...38,936,969
Ensembl chr 9:38,933,514...38,961,187
G
B
CCL1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:22,425,022...22,430,243
Ensembl chr17:22,719,425...22,722,341
G
C
Ccl1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chrNW_004955481:9,085,943...9,089,147
G
R
Ccl1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
G
M
Ccl1
C-C motif chemokine ligand 1
ISO
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
G
H
CCL1
C-C motif chemokine ligand 1
IAGP
DNA:SNP:3' utr:c.*136G>A (rs3136682) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,360,328...34,363,233
Ensembl chr17:34,360,328...34,363,233
G
R
Ccl12
C-C motif chemokine ligand 12
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
M
Ccl12
C-C motif chemokine ligand 12
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr11:81,992,671...81,994,225
Ensembl chr11:81,992,671...81,994,226
G
G
CCL13
C-C motif chemokine ligand 13
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,864,260...27,867,457
Ensembl chr16:27,865,318...27,867,415
G
D
CCL13
chemokine (C-C motif) ligand 13
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr 9:38,938,944...38,940,231
Ensembl chr 9:38,938,135...38,940,231
G
B
CCL13
C-C motif chemokine ligand 13
ISO
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:22,430,633...22,432,893
Ensembl chr17:22,723,888...22,726,381
G
H
CCL13
C-C motif chemokine ligand 13
IAGP
DNA:SNPs, haplotype:intron, 3' utr:c.77-105T>C, c.*856T>C (rs159313, rs2072070) (human)
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,356,480...34,358,610
Ensembl chr17:34,356,480...34,358,610
G
G
CCL2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
P
CCL2
chemokine (C-C motif) ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr12:40,798,109...40,800,013
Ensembl chr12:40,798,109...40,800,026
G
D
CCL2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr 9:39,008,187...39,009,932
G
B
CCL2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
R
Ccl2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
M
Ccl2
C-C motif chemokine ligand 2
ISO
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
H
CCL2
C-C motif chemokine ligand 2
IAGP
DNA:SNPs, haplotype
RGD
PMID:19865101
RGD:4145472
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
N
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624843:2,017,738...2,021,153
G
G
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:113,815,099...113,836,562
Ensembl chr10:113,832,573...113,835,736
G
P
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:129,172,743...129,176,069
G
S
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
G
D
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr25:40,506,385...40,509,903
Ensembl chr25:40,506,753...40,509,709
G
B
CCL20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
G
C
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955453:6,846,625...6,850,007
Ensembl chrNW_004955453:6,846,549...6,850,031
G
R
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
G
M
Ccl20
C-C motif chemokine ligand 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
G
H
CCL20
C-C motif chemokine ligand 20
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
N
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chrNW_004624875:3,334,136...3,342,085
Ensembl chrNW_004624875:3,334,078...3,341,614
G
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr16:29,351,214...29,361,317
G
P
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr12:39,652,731...39,659,121
Ensembl chr12:39,648,598...39,659,118
G
S
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chrNW_004936490:253,279...259,947
Ensembl chrNW_004936490:253,034...259,965
G
D
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr 9:37,817,409...37,823,852
Ensembl chr 9:37,817,305...37,823,852
G
B
CCL5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
C
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
G
R
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
M
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
H
CCL5
C-C motif chemokine ligand 5
IEP
mRNA:increased expression:brain, frontal cortex (human)
RGD
PMID:11091283
RGD:4890028
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
G
CCL7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 RGD:6483818
NCBI chr16:27,777,795...27,780,413
G
D
CCL7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 RGD:6483818
NCBI chr 9:38,994,638...38,996,103
Ensembl chr 9:38,993,911...39,010,483
G
R
Ccl7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 , RGD:6483818
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
G
M
Ccl7
C-C motif chemokine ligand 7
ISO
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 , RGD:6483818
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
H
CCL7
C-C motif chemokine ligand 7
IEP IAGP
mRNA,protein:increased expression:brain DNA:polymorphism:promoter
RGD
PMID:9655469 PMID:12127674
RGD:6483814 , RGD:6483818
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
P
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr13:29,251,950...29,286,470
Ensembl chr13:29,285,012...29,376,343
G
N
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chrNW_004624730:74,768,668...74,769,749
Ensembl chrNW_004624730:74,768,668...74,769,798
G
G
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
G
S
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chrNW_004936596:223,660...224,739
Ensembl chrNW_004936596:223,660...224,739
G
D
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr20:42,382,380...42,398,449
Ensembl chr20:42,383,135...42,384,217
G
B
CCR3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
C
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chrNW_004955420:25,702,917...25,723,269
Ensembl chrNW_004955420:25,701,407...25,723,353
G
R
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
M
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21427490
RGD:6892919
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
H
CCR3
C-C motif chemokine receptor 3
IEP
RGD
PMID:21427490
RGD:6892919
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
G
CCR5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr22:7,803,794...7,818,112
G
P
CCR5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr13:29,382,383...29,387,902
Ensembl chr13:29,383,303...29,387,895
G
D
CCR5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr20:42,293,288...42,297,952
Ensembl chr20:42,294,996...42,297,952
G
B
CCR5
C-C motif chemokine receptor 5
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
R
Ccr5
C-C motif chemokine receptor 5
ISO
DNA:frameshift mutation:CDS:p.S185_T195del (rs333) (human) ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression protein:increased expression:blood, cerebrospinal fluid
ClinVar RGD
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 PMID:12451219 PMID:12111306 More...
RGD:1358460 , RGD:8551829
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
M
Ccr5
C-C motif chemokine receptor 5
ISO
DNA:frameshift mutation:CDS:p.S185_T195del (rs333) (human) ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression protein:increased expression:blood, cerebrospinal fluid
ClinVar RGD
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 PMID:12451219 PMID:12111306 More...
RGD:1358460 , RGD:8551829
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
H
CCR5
C-C motif chemokine receptor 5
IAGP IEP
DNA:frameshift mutation:CDS:p.S185_T195del (rs333) (human) ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression protein:increased expression:blood, cerebrospinal fluid
ClinVar RGD
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 PMID:12451219 PMID:12111306 More...
RGD:1358460 , RGD:8551829
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
H
CCR5AS
CCR5 antisense RNA
IAGP
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar
PMID:8639485 PMID:8751444 PMID:8756719 PMID:9055842 PMID:9132277 PMID:9140404 PMID:9207783 PMID:9466996 PMID:9511755 PMID:9585595 PMID:9600249 PMID:9768627 PMID:10520641 PMID:10615909 PMID:10803840 PMID:11081537 PMID:11403804 PMID:11403814 PMID:11517319 PMID:11781692 PMID:12874407 PMID:15744032 PMID:15863470 PMID:16216086 PMID:16248677 PMID:16418398 PMID:19017985 PMID:19073967 PMID:25741868 PMID:28492532 More...
NCBI chr 3:46,363,984...46,407,066
Ensembl chr 3:46,364,391...46,407,117
G
N
Cd24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chrNW_004624780:15,287,426...15,292,292
Ensembl chrNW_004624780:15,287,433...15,292,292
G
G
CD24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr13:66,863,164...66,868,951
G
D
CD24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr12:64,239,957...64,245,114
G
C
Cd24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chrNW_004955411:32,270,881...32,275,236
Ensembl chrNW_004955411:32,270,881...32,275,236
G
R
Cd24
CD24 molecule
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
H
CD24
CD24 molecule
IAGP
RGD
PMID:14657362
RGD:1358462
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
M
Cd24a
CD24a antigen
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261
G
N
Cd28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chrNW_004624765:12,650,092...12,667,168
G
G
CD28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr10:89,471,710...89,505,152
Ensembl chr10:89,471,730...89,500,387
G
P
CD28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr15:107,128,103...107,155,431
Ensembl chr15:107,128,203...107,162,935
G
S
Cd28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chrNW_004936631:335,411...363,407
Ensembl chrNW_004936631:335,411...363,407
G
D
CD28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr37:12,503,849...12,536,362
Ensembl chr37:12,503,811...12,532,854
G
B
CD28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr2B:90,938,795...90,971,438
Ensembl chr2B:209,076,388...209,111,213
G
C
Cd28
CD28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chrNW_004955457:11,159,769...11,253,099
Ensembl chrNW_004955457:11,162,282...11,192,991
G
R
Cd28
Cd28 molecule
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685
G
M
Cd28
CD28 antigen
ISO
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
G
H
CD28
CD28 molecule
IAGP
DNA:SNP:promoter:-372G>A (human)
RGD
PMID:14975605
RGD:1358478
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912
G
N
Cd40
CD40 molecule
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human)
CTD RGD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chrNW_004624790:8,475,640...8,485,927
Ensembl chrNW_004624790:8,476,158...8,485,856
G
G
CD40
CD40 molecule
susceptibility
ISO
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chr 2:17,753,713...17,765,134
Ensembl chr 2:17,753,394...17,764,566
G
P
CD40
CD40 molecule
susceptibility
ISO
DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chr17:48,286,116...48,298,188
Ensembl chr17:48,286,029...48,298,528
G
S
Cd40
CD40 molecule
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) DNA:SNP:5' utr:c.-1C>T (rs1883832) (human)
CTD RGD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
G
D
CD40
CD40 molecule
susceptibility
ISO
DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chr24:33,352,992...33,383,488
Ensembl chr24:33,372,930...33,383,301
G
B
CD40
CD40 molecule
susceptibility
ISO
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
C
Cd40
CD40 molecule
susceptibility
ISO
DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:5' utr:c.-1C>T (rs1883832) (human)
RGD CTD
PMID:19525955 PMID:20190274 PMID:20634952
RGD:5490971 RGD:5490975
NCBI chrNW_004955445:11,191,817...11,202,156
Ensembl chrNW_004955445:11,190,603...11,202,093
G
R
Cd40
CD40 molecule
susceptibility
ISO
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human)
CTD RGD
PMID:19525955 PMID:20634952 PMID:20190274
RGD:5490971 , RGD:5490975
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
M
Cd40
CD40 antigen
susceptibility
ISO
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human)
CTD RGD
PMID:19525955 PMID:20634952 PMID:20190274
RGD:5490971 , RGD:5490975
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
H
CD40
CD40 molecule
susceptibility
IAGP EXP
DNA:SNP:5' utr:c.-1C>T (rs1883832) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:enhancer:g.-6787C>T (rs6074022) (human)
CTD RGD
PMID:19525955 PMID:20634952 PMID:20190274
RGD:5490971 , RGD:5490975
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
N
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624767:11,938,452...12,024,970
Ensembl chrNW_004624767:11,938,028...12,025,069
G
G
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:30,039,854...30,132,646
Ensembl chr 1:30,039,749...30,132,416
G
P
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:25,788,699...25,884,209
Ensembl chr 2:25,788,703...25,884,153
G
S
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936533:2,949,026...3,033,166
G
D
CD44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr18:32,735,493...32,826,483
Ensembl chr18:32,737,907...32,827,107
G
B
CD44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:35,110,732...35,258,238
Ensembl chr11:34,985,634...35,079,009
G
C
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955422:11,106,061...11,189,951
G
R
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
M
Cd44
CD44 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
H
CD44
CD44 molecule (IN blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
G
N
Cd46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chrNW_004624807:4,040,639...4,074,631
G
G
CD46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr25:21,650,825...21,693,898
Ensembl chr25:21,655,969...21,693,878
G
P
CD46
CD46 molecule, complement regulatory protein
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr 9:135,025,439...135,078,910
G
S
Cd46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chrNW_004936557:5,136,784...5,175,543
G
B
CD46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr 1:183,330,423...183,373,916
Ensembl chr 1:188,031,758...188,182,046
G
C
Cd46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chrNW_004955406:43,002,817...43,034,555
G
R
Cd46
CD46 molecule
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr13:106,575,586...106,606,325
Ensembl chr13:106,574,858...106,660,445
G
M
Cd46
CD46 antigen, complement regulatory protein
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr 1:194,721,279...194,781,149
Ensembl chr 1:194,719,134...194,774,557
G
H
CD46
CD46 molecule
IDA
RGD
PMID:21177319
RGD:6483460
NCBI chr 1:207,752,038...207,795,516
Ensembl chr 1:207,752,037...207,795,513
G
G
CD58
CD58 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr20:17,152,663...17,208,646
Ensembl chr20:17,152,777...17,208,671
G
P
CD58
CD58 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr 4:104,170,827...104,225,029
Ensembl chr 4:104,169,883...104,227,917
G
D
CD58
CD58 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr17:53,969,207...53,997,306
Ensembl chr17:53,973,029...53,995,672
G
B
CD58
CD58 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr 1:85,992,828...86,049,066
Ensembl chr 1:121,045,460...121,101,636
G
H
CD58
CD58 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955 PMID:24076602
NCBI chr 1:116,514,534...116,571,026
Ensembl chr 1:116,514,534...116,571,039
G
N
Cd6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chrNW_004624926:325,327...333,405
Ensembl chrNW_004624926:324,828...333,246
G
G
CD6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr 1:12,827,238...12,878,304
Ensembl chr 1:12,828,285...12,877,704
G
P
CD6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr 2:10,739,560...10,785,548
Ensembl chr 2:10,738,471...10,785,516
G
S
Cd6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chrNW_004936581:1,932,596...1,943,671
Ensembl chrNW_004936581:1,932,668...1,969,126
G
D
CD6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr18:55,296,116...55,336,014
Ensembl chr18:55,296,986...55,335,880
G
B
CD6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr11:56,269,585...56,283,516
Ensembl chr11:59,675,221...59,722,916
G
C
Cd6
CD6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chrNW_004955511:5,592,176...5,617,421
G
R
Cd6
Cd6 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634
G
M
Cd6
CD6 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr19:10,766,703...10,807,427
Ensembl chr19:10,766,705...10,807,422
G
H
CD6
CD6 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953 PMID:24076602
NCBI chr11:60,971,680...61,020,377
Ensembl chr11:60,971,680...61,020,377
G
N
Cd86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chrNW_004624912:350,201...432,410
Ensembl chrNW_004624912:350,157...426,712
G
G
CD86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr22:58,741,534...58,805,417
Ensembl chr22:58,741,525...58,805,366
G
P
CD86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr13:138,427,573...138,504,307
Ensembl chr13:138,427,533...138,504,310
G
S
Cd86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chrNW_004936536:8,414,491...8,481,712
G
D
CD86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr33:25,256,267...25,318,855
Ensembl chr33:25,256,267...25,318,087
G
B
CD86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr 3:119,151,884...119,217,641
Ensembl chr 3:126,059,008...126,124,339
G
C
Cd86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chrNW_004955427:21,375,820...21,436,767
Ensembl chrNW_004955427:21,375,794...21,435,874
G
R
Cd86
CD86 molecule
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
G
M
Cd86
CD86 antigen
susceptibility
ISO
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
H
CD86
CD86 molecule
susceptibility
IAGP
DNA:snps, haplotypes:exons: G>A, G>C (rs1129055, rs17281995) (human)
RGD
PMID:26531698
RGD:11354964
NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
G
G
CD96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr22:69,141,470...69,245,962
Ensembl chr22:69,140,288...69,244,097
G
P
CD96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:148,103,424...148,192,272
Ensembl chr13:148,090,630...148,192,232
G
S
Cd96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936834:432,538...522,118
Ensembl chrNW_004936834:434,877...522,411
G
D
CD96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr33:16,231,244...16,327,670
Ensembl chr33:16,231,994...16,325,572
G
B
CD96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:108,694,670...108,798,114
Ensembl chr 3:115,619,374...115,720,858
G
C
Cd96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955427:11,971,051...12,057,185
Ensembl chrNW_004955427:11,971,021...12,059,171
G
R
Cd96
CD96 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:54,702,290...54,776,618
Ensembl chr11:54,702,290...54,776,621
G
M
Cd96
CD96 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr16:45,856,015...45,940,611
Ensembl chr16:45,856,020...45,940,614
G
H
CD96
CD96 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:111,542,197...111,665,996
Ensembl chr 3:111,292,719...111,665,750
G
N
Cdk17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624750:10,964,010...11,052,189
G
G
CDK17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:91,641,917...91,757,925
Ensembl chr11:91,640,374...91,757,876
G
P
CDK17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 5:87,180,132...87,282,391
Ensembl chr 5:87,179,615...87,295,167
G
S
Cdk17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936507:12,317,746...12,409,506
Ensembl chrNW_004936507:12,316,510...12,399,116
G
D
CDK17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:36,020,839...36,068,863
Ensembl chr15:36,023,519...36,076,381
G
B
CDK17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr12:93,864,941...93,980,914
G
C
Cdk17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955405:32,565,193...32,608,388
Ensembl chrNW_004955405:32,565,193...32,608,564
G
R
Cdk17
cyclin-dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 7:27,683,890...27,765,814
Ensembl chr 7:27,683,890...27,764,910
G
M
Cdk17
cyclin dependent kinase 17
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:92,996,492...93,086,956
Ensembl chr10:92,996,737...93,102,933
G
H
CDK17
cyclin dependent kinase 17
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr12:96,278,225...96,400,439
Ensembl chr12:96,278,261...96,400,480
G
N
Cfh
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chrNW_004624798:3,332,549...3,414,435
G
G
CFH
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr25:32,557,697...32,744,763
G
P
CFH
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
G
D
CFH
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr38:2,878,677...2,956,226
G
B
CFH
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr 1:172,155,882...172,251,632
Ensembl chr 1:176,455,247...176,525,521
G
R
Cfh
complement factor H
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
M
Cfh
complement component factor h
no_association
ISO
RGD
PMID:21618592
RGD:5684555
NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
G
H
CFH
complement factor H
no_association
IEP
RGD
PMID:21618592
RGD:5684555
NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
G
N
Ciita
class II major histocompatibility complex transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort DNA:polymorphism:exon:c.1632G>C, rs4774
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chrNW_004624824:8,099,877...8,156,661
Ensembl chrNW_004624824:8,116,537...8,153,482
G
G
CIITA
class II major histocompatibility complex transactivator
no_association susceptibility
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chr 5:10,341,690...10,401,988
Ensembl chr 5:10,372,344...10,400,451
G
P
CIITA
class II major histocompatibility complex transactivator
no_association susceptibility
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort DNA:polymorphism:promoter:-168A>G
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chr 3:32,171,706...32,230,775
Ensembl chr 3:32,172,214...32,230,780
G
S
Ciita
class II major histocompatibility complex transactivator
susceptibility no_association
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chrNW_004936530:9,033,510...9,073,341
G
D
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chr 6:31,774,486...31,837,025
Ensembl chr 6:31,774,609...31,836,820
G
B
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chr16:9,819,440...9,885,379
Ensembl chr16:11,041,434...11,090,485
G
C
Ciita
class II major histocompatibility complex transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:15821736 PMID:16426246 PMID:21653641
RGD:1358146 RGD:5491175 RGD:5491189
NCBI chrNW_004955442:7,600,903...7,647,619
Ensembl chrNW_004955442:7,603,893...7,647,624
G
R
Ciita
class II, major histocompatibility complex, transactivator
susceptibility no_association
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 (human) DNA:polymorphism:promoter:-168A>G (human) DNA:polymorphism:promoter:rs3087456, no association in a German cohort (Human)
RGD
PMID:21653641 PMID:15821736 PMID:16426246
RGD:5491175 , RGD:1358146 , RGD:5491189
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
M
Ciita
class II transactivator
susceptibility no_association
ISO
DNA:polymorphism:exon:c.1632G>C, rs4774 (human) DNA:polymorphism:promoter:-168A>G (human) DNA:polymorphism:promoter:rs3087456, no association in a German cohort (Human)
RGD
PMID:21653641 PMID:15821736 PMID:16426246
RGD:5491175 , RGD:1358146 , RGD:5491189
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
H
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP
DNA:polymorphism:exon:c.1632G>C, rs4774 DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:21653641 PMID:15821736 PMID:16426246
RGD:5491175 , RGD:1358146 , RGD:5491189
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
N
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chrNW_004624730:48,458,593...48,473,463
Ensembl chrNW_004624730:48,458,512...48,474,734
G
G
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr15:18,991,734...19,006,902
Ensembl chr15:18,991,042...19,006,866
G
P
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr13:109,075,672...109,089,097
Ensembl chr13:109,075,452...109,090,111
G
S
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chrNW_004936593:2,072,368...2,087,820
Ensembl chrNW_004936593:2,071,882...2,087,877
G
D
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr34:34,912,903...34,929,441
Ensembl chr34:34,912,449...34,928,433
G
B
CLDN11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 3:167,432,856...167,448,053
Ensembl chr 3:175,621,472...175,908,350
G
C
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chrNW_004955420:580,588...595,052
Ensembl chrNW_004955420:580,588...595,116
G
R
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
M
Cldn11
claudin 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473
G
H
CLDN11
claudin 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25911099
NCBI chr 3:170,418,868...170,434,691
Ensembl chr 3:170,418,868...170,454,733
G
N
Clec16a
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chrNW_004624824:8,174,653...8,400,760
Ensembl chrNW_004624824:8,174,610...8,400,723
G
G
CLEC16A
C-type lectin domain containing 16A
ISO
DNA:polymorphism:intron:g.194570G>A, rs7184083 CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr 5:10,420,866...10,658,370
Ensembl chr 5:10,420,931...10,658,507
G
P
CLEC16A
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr 3:31,938,133...32,158,343
Ensembl chr 3:31,938,135...32,158,320
G
S
Clec16a
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chrNW_004936530:9,089,478...9,264,563
Ensembl chrNW_004936530:9,089,476...9,264,592
G
D
CLEC16A
C-type lectin domain containing 16A
ISO
DNA:polymorphism:intron:g.194570G>A, rs7184083 CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr 6:31,560,940...31,757,100
Ensembl chr 6:31,562,834...31,757,678
G
B
CLEC16A
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr16:9,887,877...10,124,500
Ensembl chr16:11,109,869...11,343,512
G
C
Clec16a
C-type lectin domain containing 16A
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:g.194570G>A, rs7184083
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chrNW_004955442:7,369,616...7,584,052
Ensembl chrNW_004955442:7,368,952...7,584,703
G
R
Clec16a
C-type lectin domain containing 16A
ISO
DNA:polymorphism:intron:g.194570G>A, rs7184083 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578
G
M
Clec16a
C-type lectin domain family 16, member A
ISO
DNA:polymorphism:intron:g.194570G>A, rs7184083 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr16:10,363,173...10,562,742
Ensembl chr16:10,363,203...10,562,742
G
H
CLEC16A
C-type lectin domain containing 16A
IAGP EXP
DNA:polymorphism:intron:g.194570G>A, rs7184083 CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18946483 PMID:19525955 PMID:21653641
RGD:5491175
NCBI chr16:10,944,564...11,182,186
Ensembl chr16:10,944,539...11,182,186
G
P
CMAH
cytidine monophospho-N-acetylneuraminic acid hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 7:19,879,367...19,917,761
Ensembl chr 7:19,870,966...19,955,759
G
M
Cmah
cytidine monophospho-N-acetylneuraminic acid hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:24,511,387...24,661,272
Ensembl chr13:24,511,387...24,661,360
G
R
Cmahp
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:40,557,161...40,642,350
Ensembl chr17:40,583,667...40,642,275
G
H
CMAHP
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:25,081,067...25,138,392
Ensembl chr 6:25,081,862...25,138,081
G
N
Cmpk2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chrNW_004624846:3,417,672...3,432,207
Ensembl chrNW_004624846:3,417,626...3,430,516
G
G
CMPK2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr14:100,804,295...100,820,565
Ensembl chr14:100,804,400...100,819,027
G
P
CMPK2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr 3:128,903,395...128,917,873
Ensembl chr 3:128,903,616...128,917,871
G
S
Cmpk2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chrNW_004936532:3,896,654...3,908,184
Ensembl chrNW_004936532:3,895,755...3,908,367
G
D
CMPK2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr17:4,466,615...4,478,546
G
B
CMPK2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr2A:6,856,242...6,874,567
G
C
Cmpk2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chrNW_004955487:2,010,126...2,024,804
Ensembl chrNW_004955487:2,010,228...2,029,175
G
R
Cmpk2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr 6:43,073,706...43,085,183
Ensembl chr 6:43,073,796...43,085,183
G
M
Cmpk2
cytidine/uridine monophosphate kinase 2
ISO
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr12:26,519,121...26,529,836
Ensembl chr12:26,519,203...26,529,836
G
H
CMPK2
cytidine/uridine monophosphate kinase 2
IEP
mRNA:altered expression:PMN cell (human)
RGD
PMID:20136355
RGD:5133255
NCBI chr 2:6,840,553...6,866,635
Ensembl chr 2:6,840,570...6,866,635
G
N
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chrNW_004624795:1,856,455...1,861,142
Ensembl chrNW_004624795:1,855,992...1,861,053
G
G
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chr16:64,288,583...64,296,940
Ensembl chr16:64,289,828...64,296,922
G
P
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chr12:20,758,081...20,765,655
Ensembl chr12:20,758,083...20,765,553
G
S
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chrNW_004936490:16,834,570...16,841,734
Ensembl chrNW_004936490:16,834,540...16,841,810
G
D
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chr 9:20,888,350...20,896,139
Ensembl chr 9:20,886,574...20,896,079
G
B
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chr17:15,338,085...15,349,089
Ensembl chr17:15,560,056...15,568,916
G
C
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:18676363 PMID:19473295
RGD:6483339 RGD:6483346
NCBI chrNW_004955451:16,115,137...16,119,261
Ensembl chrNW_004955451:16,114,454...16,118,622
G
R
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:19473295 PMID:18676363
RGD:6483339 , RGD:6483346
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
M
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
ISO
RGD
PMID:19473295 PMID:18676363
RGD:6483339 , RGD:6483346
NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555
G
H
CNP
2',3'-cyclic nucleotide 3' phosphodiesterase
IEP IDA
RGD
PMID:19473295 PMID:18676363
RGD:6483339 , RGD:6483346
NCBI chr17:41,966,795...41,977,740
Ensembl chr17:41,966,763...41,977,740
G
N
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chrNW_004624799:6,100,709...6,126,530
Ensembl chrNW_004624799:6,101,728...6,126,520
G
G
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr13:12,626,259...12,653,253
Ensembl chr13:12,630,270...12,631,688
G
P
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 1:56,466,022...56,493,275
Ensembl chr 1:56,467,835...56,492,602
G
S
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chrNW_004936510:3,779,930...3,806,615
Ensembl chrNW_004936510:3,781,210...3,802,693
G
D
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr12:47,537,240...47,560,723
Ensembl chr12:47,509,583...47,560,983
G
B
CNR1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 6:86,017,141...86,044,889
G
C
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chrNW_004955411:15,052,151...15,077,320
Ensembl chrNW_004955411:15,052,163...15,077,320
G
R
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
G
M
Cnr1
cannabinoid receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
H
CNR1
cannabinoid receptor 1
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:12876144
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
N
Cntf
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chrNW_004624864:1,785,215...1,788,608
Ensembl chrNW_004624864:1,782,139...1,792,879
G
G
CNTF
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr 1:14,724,562...14,730,698
Ensembl chr 1:14,728,383...14,730,150
G
P
CNTF
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr 2:12,492,777...12,495,401
Ensembl chr 2:12,493,169...12,496,159
G
S
Cntf
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chrNW_004936581:3,710,171...3,715,753
Ensembl chrNW_004936581:3,710,160...3,715,638
G
D
CNTF
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr18:37,758,148...37,765,698
G
B
CNTF
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr11:53,876,081...53,882,870
Ensembl chr11:57,336,792...57,341,121
G
C
Cntf
ciliary neurotrophic factor
onset
ISO
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chrNW_004955511:3,527,552...3,531,275
Ensembl chrNW_004955511:3,527,552...3,534,348
G
R
Cntf
ciliary neurotrophic factor
onset
ISO
RGD
PMID:11890844
RGD:1626112
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
G
M
Cntf
ciliary neurotrophic factor
onset
ISO
RGD
PMID:11890844
RGD:1626112
NCBI chr19:12,740,892...12,742,996
Ensembl chr19:12,741,024...12,742,996
G
H
CNTF
ciliary neurotrophic factor
onset
IAGP
DNA:point mutation:intron:G-to-A transition at -6 from the start of exon 2, leads to aberrant splicing, frameshift and a truncated protein
RGD
PMID:11890844
RGD:1626112
NCBI chr11:58,622,665...58,625,733
Ensembl chr11:58,622,665...58,625,733
G
N
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chrNW_004624795:6,167,504...6,183,208
Ensembl chrNW_004624795:6,168,797...6,183,071
G
G
COL1A1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr16:43,134,648...43,152,313
Ensembl chr16:43,134,779...43,150,930
G
P
COL1A1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004
G
S
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chrNW_004936490:11,448,552...11,465,836
Ensembl chrNW_004936490:11,448,654...11,464,444
G
D
COL1A1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr 9:26,183,852...26,199,927
Ensembl chr 9:26,183,852...26,199,927
G
B
COL1A1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr17:44,274,349...44,291,764
Ensembl chr17:49,150,677...49,166,677
G
C
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
G
R
Col1a1
collagen type I alpha 1 chain
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
M
Col1a1
collagen, type I, alpha 1
ISO
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
H
COL1A1
collagen type I alpha 1 chain
IEP
mRNA:increased expression:brain
RGD
PMID:20456365
RGD:5688302
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
G
CST3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chr 2:52,834,497...52,838,785
Ensembl chr 2:52,832,181...52,838,865
G
P
CST3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chr17:30,471,056...30,474,486
Ensembl chr17:30,470,855...30,474,590
G
B
CST3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chr20:23,583,043...23,587,399
Ensembl chr20:23,935,942...23,940,425
G
C
Cst3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chrNW_004955415:30,507,972...30,512,109
G
R
Cst3
cystatin C
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:12589965
RGD:5686392 , RGD:5686394
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
M
Cst3
cystatin C
IEP ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:12589965
RGD:5686392 , RGD:5686394
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
H
CST3
cystatin C
ISO IEP
protein:decreased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:12589965
RGD:5686392 , RGD:5686394
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
N
Ctla4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chrNW_004624765:12,449,205...12,454,324
Ensembl chrNW_004624765:12,449,205...12,454,324
G
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chr10:89,637,176...89,644,436
Ensembl chr10:89,638,314...89,642,344
G
P
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chr15:107,283,081...107,288,041
Ensembl chr15:107,282,927...107,289,103
G
S
Ctla4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNPs: :rs3087243,rs11571302(human) DNA:SNP:CDS:49A>G (human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
G
D
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNPs: :rs3087243,rs11571302(human) DNA:SNP:CDS:49A>G (human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chr37:12,647,712...12,653,874
Ensembl chr37:12,634,563...12,653,874
G
B
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNPs: :rs3087243,rs11571302(human) DNA:SNP:CDS:49A>G (human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
C
Ctla4
cytotoxic T-lymphocyte associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:10082437 PMID:17942509 PMID:19740340
RGD:1358538 RGD:2301975 RGD:7411672
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
G
R
Ctla4
cytotoxic T-lymphocyte-associated protein 4
no_association
ISO
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:17942509 PMID:19740340 PMID:10082437
RGD:2301975 , RGD:7411672 , RGD:1358538
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
M
Ctla4
cytotoxic T-lymphocyte-associated protein 4
no_association
ISO
DNA:SNPs: :rs3087243,rs11571302(human) DNA:SNP:CDS:49A>G (human)
RGD
PMID:10082437 PMID:19740340 PMID:17942509
RGD:1358538 , RGD:7411672 , RGD:2301975
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
H
CTLA4
cytotoxic T-lymphocyte associated protein 4
no_association
IAGP
DNA:SNP:CDS:49A>G (human) DNA:SNPs: :rs3087243,rs11571302(human)
RGD
PMID:17942509 PMID:19740340 PMID:10082437
RGD:2301975 , RGD:7411672 , RGD:1358538
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
N
Ctsb
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chrNW_004624758:25,366,120...25,384,554
Ensembl chrNW_004624758:25,366,840...25,373,954
G
G
CTSB
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chr 8:7,246,076...7,269,655
Ensembl chr 8:7,246,013...7,268,854
G
P
CTSB
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
G
D
CTSB
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chr25:26,048,237...26,056,570
Ensembl chr25:26,048,253...26,055,801
G
B
CTSB
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chr 8:7,333,498...7,359,264
G
C
Ctsb
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:11134381 PMID:17086443
RGD:5686392 RGD:5686395
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
G
R
Ctsb
cathepsin B
ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:11134381
RGD:5686392 , RGD:5686395
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
G
M
Ctsb
cathepsin B
IEP ISO
protein:increased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:11134381
RGD:5686392 , RGD:5686395
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
H
CTSB
cathepsin B
ISO IEP
protein:increased expression:cerebrospinal fluid
RGD
PMID:17086443 PMID:11134381
RGD:5686392 , RGD:5686395
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
N
Ctsh
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chrNW_004624941:82,209...98,156
Ensembl chrNW_004624941:82,209...98,182
G
G
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr26:4,451,731...4,473,220
Ensembl chr26:4,451,774...4,472,855
G
P
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 7:48,084,882...48,106,072
Ensembl chr 7:48,083,572...48,106,072
G
S
Ctsh
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chrNW_004936471:37,135,200...37,156,081
Ensembl chrNW_004936471:37,131,817...37,156,476
G
D
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 3:58,103,284...58,113,958
Ensembl chr 3:58,103,291...58,113,718
G
B
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr15:57,893,379...57,917,194
Ensembl chr15:76,852,668...76,876,976
G
C
Ctsh
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chrNW_004955533:39,237...54,881
Ensembl chrNW_004955533:39,284...54,837
G
R
Ctsh
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 8:90,608,941...90,627,824
Ensembl chr 8:90,608,941...90,627,824
G
M
Ctsh
cathepsin H
IEP
RGD
PMID:17086443
RGD:5686392
NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142
G
H
CTSH
cathepsin H
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr15:78,921,058...78,945,046
Ensembl chr15:78,921,058...78,949,574
G
G
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr12:98,347,770...98,353,426
Ensembl chr12:98,347,800...98,353,467
G
P
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
G
S
Ctsl
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chrNW_004936680:3,047,355...3,050,640
G
B
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 9:58,851,899...58,857,170
Ensembl chr 9:86,903,006...86,908,303
G
R
Ctsl
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
M
Ctsl
cathepsin L
IEP
RGD
PMID:17086443
RGD:5686392
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
G
H
CTSL
cathepsin L
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
D
CTSL3
cathepsin L family member 3
ISO
RGD
PMID:17086443
RGD:5686392
NCBI chr 1:72,215,774...72,219,093
G
M
Cxcl15
C-X-C motif chemokine ligand 15
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
N
Cxcl8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chrNW_004624730:1,744,097...1,747,206
Ensembl chrNW_004624730:1,743,916...1,747,293
G
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
G
P
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
G
D
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
B
CXCL8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
C
Cxcl8
C-X-C motif chemokine ligand 8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
G
H
CXCL8
C-X-C motif chemokine ligand 8
IEP
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr11:53,675,704...53,681,372
Ensembl chr11:53,675,226...53,680,443
G
P
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr 5:23,053,129...23,058,865
Ensembl chr 5:23,053,892...23,058,470
G
D
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr10:1,825,224...1,830,845
Ensembl chr10:1,826,046...1,829,911
G
B
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr12:31,158,814...31,164,462
Ensembl chr12:31,419,773...31,424,822
G
R
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
M
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
G
H
CYP27B1
cytochrome P450 family 27 subfamily B member 1
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
G
D
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0301 (human) DNA:polymorphism:cds:HLA-DQB1*06 (human) DNA:polymorphism (human)
OMIM RGD
PMID:15201511 PMID:20463743 PMID:21741664 PMID:21908482
RGD:40818409 RGD:5147555 RGD:5147658 RGD:7421588
NCBI chr12:2,305,307...2,307,711
G
D
DLA-DRA
MHC class II DR alpha chain
ISO
DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chr12:2,133,026...2,137,825
Ensembl chr12:2,132,499...2,168,975
G
N
Dnaaf11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004624735:23,269,253...23,355,832
Ensembl chrNW_004624735:23,269,414...23,355,968
G
G
DNAAF11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 8:127,010,303...127,103,343
Ensembl chr 8:127,008,619...127,103,300
G
P
DNAAF11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 4:8,531,612...8,605,904
Ensembl chr 4:8,532,739...8,608,582
G
S
Dnaaf11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004936470:16,557,381...16,640,519
Ensembl chrNW_004936470:16,557,371...16,640,553
G
D
DNAAF11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr13:29,128,500...29,199,354
Ensembl chr13:29,128,504...29,199,323
G
B
DNAAF11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 8:129,223,591...129,329,535
Ensembl chr 8:132,199,607...132,305,351
G
C
Dnaaf11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004955461:7,204,165...7,311,524
Ensembl chrNW_004955461:7,204,339...7,312,241
G
R
Dnaaf11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 7:98,141,525...98,245,906
Ensembl chr 7:98,144,763...98,245,837
G
M
Dnaaf11
dynein axonemal assembly factor 11
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr15:66,251,707...66,372,769
Ensembl chr15:66,251,707...66,372,759
G
H
DNAAF11
dynein axonemal assembly factor 11
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 8:132,570,416...132,702,913
Ensembl chr 8:132,570,416...132,675,592
G
N
Dusp28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624847:4,893,146...4,894,593
Ensembl chrNW_004624847:4,893,202...4,893,873
G
G
DUSP28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:126,587,748...126,592,419
Ensembl chr10:126,588,867...126,589,861
G
P
DUSP28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:139,536,828...139,539,448
Ensembl chr15:139,537,326...139,539,438
G
S
Dusp28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936745:1,063,365...1,064,590
Ensembl chrNW_004936745:1,063,359...1,064,826
G
D
DUSP28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr25:50,533,767...50,537,513
G
C
Dusp28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955542:909,239...911,139
Ensembl chrNW_004955542:909,917...910,646
G
R
Dusp28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:93,472,832...93,474,207
G
M
Dusp28
dual specificity phosphatase 28
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:92,834,711...92,836,342
Ensembl chr 1:92,834,703...92,836,157
G
H
DUSP28
dual specificity phosphatase 28
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:240,560,054...240,565,256
Ensembl chr 2:240,560,054...240,565,256
G
N
Edn1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chrNW_004624756:13,842,482...13,849,003
Ensembl chrNW_004624756:13,842,164...13,849,029
G
G
EDN1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr17:59,854,186...59,861,319
Ensembl chr17:59,853,699...59,861,198
G
P
EDN1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
G
S
Edn1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
G
D
EDN1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr35:11,808,892...11,815,383
Ensembl chr35:11,808,892...11,815,383
G
B
EDN1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr 6:12,076,312...12,142,861
Ensembl chr 6:12,462,718...12,503,545
G
C
Edn1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chrNW_004955465:2,287,906...2,314,945
Ensembl chrNW_004955465:2,287,798...2,314,753
G
R
Edn1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
G
M
Edn1
endothelin 1
ISO
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
H
EDN1
endothelin 1
IEP
protein:increased expression:plasma (human)
RGD
PMID:12646761
RGD:8661710
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
N
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004624849:1,521,996...1,625,878
Ensembl chrNW_004624849:1,525,235...1,625,893
G
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr16:57,145,080...57,233,757
Ensembl chr16:57,145,191...57,236,230
G
P
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
G
S
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004936541:4,613,197...4,705,911
Ensembl chrNW_004936541:4,617,555...4,705,866
G
D
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr 9:11,930,614...12,006,724
Ensembl chr 9:11,934,965...12,006,814
G
B
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr17:58,132,889...58,224,012
Ensembl chr17:63,226,949...63,317,825
G
C
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004955478:7,720,664...7,803,662
Ensembl chrNW_004955478:7,751,830...7,799,460
G
R
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
M
Ern1
endoplasmic reticulum to nucleus signalling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
H
ERN1
endoplasmic reticulum to nucleus signaling 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
G
N
Fas
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
G
P
FAS
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
S
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:promoter:-670A>G (human) protein:increased expression:white matter of brain:
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chrNW_004936735:209,369...234,582
G
D
FAS
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
B
FAS
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
C
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:promoter:-670A>G (human) protein:increased expression:white matter of brain:
RGD
PMID:8879222 PMID:12098516
RGD:12903947 RGD:12903986
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
R
Fas
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 , RGD:12903986
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
M
Fas
Fas cell surface death receptor
susceptibility
ISO
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 , RGD:12903986
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
H
FAS
Fas cell surface death receptor
susceptibility
IEP IAGP
protein:increased expression:white matter of brain: DNA:polymorphism:promoter:-670A>G (human)
RGD
PMID:8879222 PMID:12098516
RGD:12903947 , RGD:12903986
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
M
Fasl
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31068361 PMID:11438180
RGD:1358622
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
N
Faslg
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism DNA:repeat:promoter:g.-46(CA)11-15 (human)
CTD RGD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chrNW_004624771:9,031,978...9,038,760
Ensembl chrNW_004624771:9,032,016...9,038,825
G
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism DNA:repeat:promoter:g.-46(CA)11-15 (human)
CTD RGD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
G
P
FASLG
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chr 9:115,068,314...115,075,147
Ensembl chr 9:115,068,090...115,076,464
G
S
Faslg
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chrNW_004936481:14,789,547...14,795,780
G
D
FASLG
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
B
FASLG
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chr 1:148,159,826...148,167,785
Ensembl chr 1:151,868,430...151,876,281
G
C
Faslg
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:11438180 PMID:31068361
RGD:1358622
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
G
R
Faslg
Fas ligand
ISO
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31068361 PMID:11438180
RGD:1358622
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
H
FASLG
Fas ligand
IAGP EXP
DNA:repeat:promoter:g.-46(CA)11-15 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:31068361 PMID:11438180
RGD:1358622
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
N
Fcgr2a
Fc fragment of IgG receptor IIa
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chrNW_004624826:23,930...34,735
G
G
FCGR2A
Fc fragment of IgG receptor IIa
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr20:2,480,710...2,512,429
G
S
Fcgr2a
Fc fragment of IgG receptor IIa
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chrNW_004937131:15,542...22,099
G
R
Fcgr2a
Fc gamma receptor 2A
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967
G
H
FCGR2A
Fc gamma receptor IIa
no_association
IAGP
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
N
Fcgr3a
Fc fragment of IgG receptor IIIa
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chrNW_004624826:51,387...59,117
G
G
FCGR3A
Fc fragment of IgG receptor IIIa
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr20:2,466,492...2,475,579
G
P
FCGR3A
Fc fragment of IgG receptor IIIa
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr 4:88,948,357...88,956,513
G
B
FCGR3A
Fc gamma receptor IIIa
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr 1:137,027,943...137,036,738
G
R
Fcgr3a
Fc gamma receptor 3A
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921
G
H
FCGR3A
Fc gamma receptor IIIa
disease_progression
IEP
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
M
Fcgr4
Fc receptor, IgG, low affinity IV
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
G
N
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chrNW_004624883:3,478,112...3,710,586
Ensembl chrNW_004624883:3,477,833...3,710,237
G
G
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:126,735,146...126,999,990
Ensembl chr X:126,735,288...127,000,017
G
P
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:123,456,952...123,684,814
Ensembl chr X:123,456,947...123,684,790
G
S
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chrNW_004936714:461,050...675,745
Ensembl chrNW_004936714:548,619...677,411
G
D
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:120,152,650...120,460,604
Ensembl chr X:120,153,261...120,460,119
G
B
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:141,739,962...142,001,041
Ensembl chr X:151,697,537...151,878,484
G
C
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chrNW_004955498:7,672,982...7,904,783
Ensembl chrNW_004955498:7,672,943...7,904,369
G
R
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:150,244,745...150,501,566
Ensembl chr X:150,261,607...150,501,559
G
M
Gabra3
gamma-aminobutyric acid type A receptor subunit alpha 3
ISO
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:71,476,282...71,700,525
Ensembl chr X:71,476,287...71,700,454
G
H
GABRA3
gamma-aminobutyric acid type A receptor subunit alpha3
IAGP
DNA:repeat::(CA)11-16 (human)
RGD
PMID:9561979
RGD:1358628
NCBI chr X:152,166,234...152,451,315
Ensembl chr X:152,166,234...152,451,315
G
N
Gc
GC vitamin D binding protein
susceptibility no_association
ISO
protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chrNW_004624890:3,274,239...3,318,281
Ensembl chrNW_004624890:3,226,900...3,318,316
G
G
GC
GC vitamin D binding protein
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human) protein:decreased expression:cerebrospinal fluid
CTD RGD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
P
GC
GC vitamin D binding protein
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human) protein:decreased expression:cerebrospinal fluid
CTD RGD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
S
Gc
GC vitamin D binding protein
no_association susceptibility
ISO
protein:decreased expression:cerebrospinal fluid DNA:SNPs:exon:p.T420K, D416E(human) CTD Direct Evidence: marker/mechanism protein:increased expression:plasma:
RGD CTD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chrNW_004936598:3,220,029...3,256,091
Ensembl chrNW_004936598:3,219,991...3,261,629
G
D
GC
GC vitamin D binding protein
susceptibility no_association
ISO
DNA:SNPs:exon:p.T420K, D416E(human) CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma:
RGD CTD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
G
B
GC
GC vitamin D binding protein
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human)
CTD RGD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chr 4:52,431,196...52,473,762
Ensembl chr 4:58,729,236...58,792,073
G
C
Gc
GC vitamin D binding protein
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:exon:p.T420K, D416E(human) protein:increased expression:plasma: protein:decreased expression:cerebrospinal fluid
CTD RGD
PMID:12044990 PMID:12137326 PMID:18807170 PMID:19324981 PMID:25590278
RGD:5509885 RGD:5509887 RGD:5509922 RGD:5509923
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
G
R
Gc
GC, vitamin D binding protein
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human)
CTD RGD
PMID:25590278 PMID:12137326 PMID:18807170 PMID:19324981 PMID:12044990
RGD:5509885 , RGD:5509923 , RGD:5509922 , RGD:5509887
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
M
Gc
vitamin D binding protein
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human)
CTD RGD
PMID:25590278 PMID:12137326 PMID:18807170 PMID:19324981 PMID:12044990
RGD:5509885 , RGD:5509923 , RGD:5509922 , RGD:5509887
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
H
GC
GC vitamin D binding protein
susceptibility no_association
IAGP EXP IEP
CTD Direct Evidence: marker/mechanism protein:decreased expression:cerebrospinal fluid protein:increased expression:plasma: DNA:SNPs:exon:p.T420K, D416E(human)
CTD RGD
PMID:25590278 PMID:12137326 PMID:18807170 PMID:19324981 PMID:12044990
RGD:5509885 , RGD:5509923 , RGD:5509922 , RGD:5509887
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
N
Gli1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004624802:10,483,279...10,494,539
Ensembl chrNW_004624802:10,483,219...10,498,609
G
G
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr11:53,371,929...53,384,339
Ensembl chr11:53,375,558...53,385,269
G
P
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 5:22,736,325...22,747,421
Ensembl chr 5:22,739,900...22,747,421
G
S
Gli1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004936646:1,622,308...1,629,787
Ensembl chrNW_004936646:1,622,308...1,629,779
G
D
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr10:1,565,306...1,575,971
Ensembl chr10:1,565,244...1,575,982
G
B
GLI1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr12:31,453,759...31,466,194
Ensembl chr12:31,710,057...31,722,473
G
C
Gli1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004955458:5,181,761...5,193,500
Ensembl chrNW_004955458:5,185,225...5,193,196
G
R
Gli1
GLI family zinc finger 1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
G
M
Gli1
GLI-Kruppel family member GLI1
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
G
H
GLI1
GLI family zinc finger 1
IEP
RGD
PMID:18991353
RGD:12801440
NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
G
N
Grm8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chrNW_004624783:8,727,563...9,611,933
Ensembl chrNW_004624783:8,737,463...9,611,475
G
G
GRM8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr21:95,264,905...96,060,822
Ensembl chr21:95,264,765...96,050,554
G
P
GRM8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr18:20,945,049...21,756,952
Ensembl chr18:20,951,003...21,758,568
G
S
Grm8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chrNW_004936479:13,768,014...14,504,387
Ensembl chrNW_004936479:13,770,088...14,494,569
G
D
GRM8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr14:8,982,180...9,719,813
Ensembl chr14:8,983,802...9,719,357
G
B
GRM8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr 7:118,430,086...119,249,147
G
C
Grm8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chrNW_004955479:7,520,537...8,279,942
Ensembl chrNW_004955479:7,520,396...8,279,755
G
R
Grm8
glutamate metabotropic receptor 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831
G
M
Grm8
glutamate receptor, metabotropic 8
ISO
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177
G
H
GRM8
glutamate metabotropic receptor 8
IEP
protein:increased expression:astrocyte, microglia, macrophage
RGD
PMID:15589052
RGD:6771187
NCBI chr 7:126,438,598...127,252,941
Ensembl chr 7:126,438,598...127,253,093
G
N
Grn
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004624795:704,066...708,721
Ensembl chrNW_004624795:704,252...707,165
G
G
GRN
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
P
GRN
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr12:18,893,772...18,900,444
Ensembl chr12:18,893,770...18,900,446
G
S
Grn
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004936541:793,548...800,271
Ensembl chrNW_004936541:793,523...800,217
G
D
GRN
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr 9:19,077,430...19,085,443
Ensembl chr 9:19,077,427...19,082,268
G
B
GRN
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr17:13,046,329...13,054,236
Ensembl chr17:13,211,784...13,219,609
G
C
Grn
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004955451:17,368,600...17,371,981
Ensembl chrNW_004955451:17,368,428...17,372,377
G
R
Grn
granulin precursor
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
M
Grn
granulin
ISO
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
H
GRN
granulin precursor
IEP
protein:increased expression:macrophage, microglia
RGD
PMID:21613335
RGD:5509591
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
B
GSTM1
glutathione S-transferase mu 1
susceptibility onset disease_progression
ISO
DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:12792225 RGD:12792249 RGD:5490267
Ensembl chr 1:127,979,238...128,010,411
G
R
Gstm1
glutathione S-transferase mu 1
disease_progression susceptibility onset
ISO
DNA:deletion: : DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:5490267 , RGD:12792249 , RGD:12792225
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
M
Gstm1
glutathione S-transferase, mu 1
disease_progression susceptibility onset
ISO
DNA:deletion: : DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:5490267 , RGD:12792249 , RGD:12792225
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
H
GSTM1
glutathione S-transferase mu 1
disease_progression susceptibility onset
IAGP
DNA:deletion: : DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:5490267 , RGD:12792249 , RGD:12792225
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
N
Gstm3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chrNW_004624772:5,495,452...5,498,714
Ensembl chrNW_004624772:5,495,452...5,498,652
G
G
GSTM3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr20:23,797,794...23,802,910
Ensembl chr20:23,799,177...23,802,921
G
P
GSTM3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 4:110,330,027...110,332,957
Ensembl chr 4:110,330,028...110,332,962
G
S
Gstm3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chrNW_004936704:1,233,909...1,236,864
Ensembl chrNW_004936704:1,233,780...1,237,329
G
D
GSTM3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 6:42,187,869...42,191,274
Ensembl chr 6:42,187,967...42,191,273
G
B
GSTM3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:112,380,890...112,384,988
Ensembl chr 1:127,957,008...127,960,578
G
C
Gstm3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chrNW_004955435:13,253,947...13,256,965
Ensembl chrNW_004955435:13,253,947...13,256,965
G
R
Gstm3
glutathione S-transferase mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 2:195,590,450...195,612,578
Ensembl chr 2:195,607,289...195,612,475
G
M
Gstm3
glutathione S-transferase, mu 3
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 3:107,871,019...107,876,484
Ensembl chr 3:107,871,012...107,876,599
G
H
GSTM3
glutathione S-transferase mu 3
disease_progression
IAGP
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
R
Gstm5
glutathione S-transferase, mu 5
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
M
Gstm5
glutathione S-transferase, mu 5
disease_progression
ISO
DNA:polymorphism:exon:
RGD
PMID:10680782
RGD:5490267
NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
G
G
GSTP1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:6,676,897...6,679,936
G
S
Gstp1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
G
D
GSTP1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr18:49,905,161...49,908,182
Ensembl chr18:49,905,161...49,908,182
G
B
GSTP1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
C
Gstp1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
R
Gstp1
glutathione S-transferase pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
M
Gstp1
glutathione S-transferase, pi 1
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
H
GSTP1
glutathione S-transferase pi 1
disease_progression
IAGP
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
R
Gstt1
glutathione S-transferase theta 1
no_association
ISO
DNA:deletion:: (human)
RGD
PMID:23932298 PMID:10680782
RGD:12792225 , RGD:5490267
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
M
Gstt1
glutathione S-transferase, theta 1
no_association
ISO
DNA:deletion:: (human)
RGD
PMID:23932298 PMID:10680782
RGD:12792225 , RGD:5490267
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
H
GSTT1
glutathione S-transferase theta 1
no_association
IAGP
DNA:deletion:: (human)
RGD
PMID:23932298 PMID:10680782
RGD:12792225 , RGD:5490267
G
M
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
M
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
susceptibility
ISO
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds:HLA-DQB1*06 (human)
OMIM CTD RGD
PMID:21741664 PMID:21908482 PMID:20463743
RGD:5147555 , RGD:7421588 , RGD:5147658
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
M
H2-Ea
histocompatibility 2, class II antigen E alpha
ISO
DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human)
CTD RGD
PMID:17660530 PMID:19834503 PMID:10527398
RGD:5490202 , RGD:5490204
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
M
H2-Eb1
histocompatibility 2, class II antigen E beta
susceptibility onset
ISO
DNA:polymorphism: :HLA-DRB*1501 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) DNA:polymorphism: :HLA-DRB1*0801 (human) DNA:polymorphisms: :HLA-DRB1*11, HLA-DRB1*15 (human)
OMIM CTD RGD
PMID:25911099 PMID:21741664 PMID:20207784 PMID:20580995 PMID:21440682 PMID:21664963 More...
RGD:5147555 , RGD:5147580 , RGD:5147573 , RGD:5147564 , RGD:5147559
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
N
H6pd
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chrNW_004624818:3,025,323...3,052,486
Ensembl chrNW_004624818:3,025,252...3,051,260
G
G
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr20:122,502,084...122,531,214
Ensembl chr20:122,503,687...122,526,074
G
P
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 6:69,666,348...69,700,303
Ensembl chr 6:69,666,601...69,700,298
G
S
H6pd
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chrNW_004936623:3,359,624...3,376,598
Ensembl chrNW_004936623:3,351,716...3,375,146
G
D
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 5:62,548,136...62,577,346
Ensembl chr 5:62,548,221...62,608,964
G
B
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 1:7,996,315...8,031,987
Ensembl chr 1:9,232,666...9,256,631
G
C
H6pd
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chrNW_004955486:4,088,354...4,115,077
Ensembl chrNW_004955486:4,022,306...4,115,077
G
R
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
M
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
ISO
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 4:150,063,931...150,093,480
Ensembl chr 4:150,063,932...150,093,480
G
H
H6PD
hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase
IAGP
DNA:SNP:exon: rs17368528 (human)
RGD
PMID:19935835
RGD:6784513
NCBI chr 1:9,234,774...9,271,337
Ensembl chr 1:9,234,774...9,271,337
G
N
Hdac1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chrNW_004624764:15,510,655...15,552,020
Ensembl chrNW_004624764:15,510,866...15,552,025
G
G
HDAC1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr20:100,529,782...100,575,953
Ensembl chr20:100,530,369...100,558,556
G
P
HDAC1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 6:88,749,611...88,785,220
Ensembl chr 6:88,749,634...88,785,411
G
S
Hdac1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chrNW_004936474:15,320,635...15,351,418
Ensembl chrNW_004936474:15,320,729...15,350,860
G
D
HDAC1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 2:68,901,339...68,936,473
Ensembl chr 2:68,901,651...68,936,186
G
B
HDAC1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 1:31,578,373...31,619,970
Ensembl chr 1:32,585,791...32,626,410
G
C
Hdac1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chrNW_004955452:10,636,366...10,668,873
Ensembl chrNW_004955452:10,636,366...10,670,864
G
R
Hdac1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
G
M
Hdac1
histone deacetylase 1
ISO
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
G
H
HDAC1
histone deacetylase 1
IEP
protein:increased expression:cytoplasm:
RGD
PMID:20037577
RGD:9590131
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
H
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17956852 PMID:32560041 PMID:17125797
RGD:150429806 , RGD:150429801
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696
G
H
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
H
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP EXP
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds:HLA-DQB1*0301 (human) DNA:polymorphism:cds:HLA-DQB1*06 (human)
OMIM CTD RGD
PMID:21741664 PMID:15201511 PMID:21908482 PMID:20463743
RGD:5147555 , RGD:40818409 , RGD:7421588 , RGD:5147658
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
H
HLA-DRA
major histocompatibility complex, class II, DR alpha
IAGP EXP
DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human)
CTD RGD
PMID:17660530 PMID:17660530 PMID:10527398 PMID:19834503
RGD:5490159 , RGD:5490204 , RGD:5490202
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
D
HLA-DRB1
MHC class II DLA DRB1 beta chain
susceptibility onset
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DRB1*0801 (human)
OMIM CTD RGD
PMID:20580995 PMID:25911099
RGD:5147573
NCBI chr12:2,151,409...2,164,564
G
H
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility onset
IAGP EXP
DNA:polymorphism: :HLA-DRB*1501 (human) DNA:polymorphism:cds:HLA-DRB1*1302 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) DNA:polymorphism: :HLA-DRB1*0801 (human) DNA:polymorphisms: :HLA-DRB1*11, HLA-DRB1*15 (human)
OMIM CTD RGD
PMID:25911099 PMID:21741664 PMID:15201511 PMID:20207784 PMID:20580995 PMID:21440682 PMID:21664963 More...
RGD:5147555 , RGD:40818409 , RGD:5147580 , RGD:5147573 , RGD:5147564 , RGD:5147559
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
H
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DRB3*0202, *0301 (human)
RGD
PMID:15201511
RGD:40818409
G
N
Hsp90ab1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chrNW_004624754:15,609,932...15,615,580
Ensembl chrNW_004624754:15,609,920...15,614,263
G
G
HSP90AB1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr17:27,914,261...27,921,666
Ensembl chr17:27,911,013...27,921,251
G
P
HSP90AB1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr 7:39,237,299...39,250,479
Ensembl chr 7:39,244,458...39,250,481
G
S
Hsp90ab1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chrNW_004936476:15,830,459...15,836,994
Ensembl chrNW_004936476:15,830,459...15,835,535
G
D
HSP90AB1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr12:12,658,415...12,664,945
Ensembl chr12:12,660,008...12,664,940
G
B
HSP90AB1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr 6:43,842,796...43,849,637
Ensembl chr 6:45,125,773...45,133,872
G
C
Hsp90ab1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chrNW_004955437:9,872,649...9,878,459
Ensembl chrNW_004955437:9,873,908...9,878,459
G
R
Hsp90ab1
heat shock protein 90 alpha family class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
G
M
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
ISO
RGD
PMID:14688203
RGD:5686803
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
G
H
HSP90AB1
heat shock protein 90 alpha family class B member 1
IDA
RGD
PMID:14688203
RGD:5686803
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
G
N
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chrNW_004624880:2,070,410...2,075,069
Ensembl chrNW_004624880:2,070,523...2,079,421
G
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
G
P
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 9:49,982,278...49,986,760
Ensembl chr 9:49,982,284...49,990,508
G
S
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
G
D
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
G
B
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr11:117,890,545...117,895,262
Ensembl chr11:121,809,800...121,815,773
G
C
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
G
R
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
M
Hspa8
heat shock protein 8
ISO
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
H
HSPA8
heat shock protein family A (Hsp70) member 8
IEP
protein: increased expression: cerebrospinal fluid
RGD
PMID:16303141
RGD:6480236
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
N
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004624828:2,432,584...2,451,997
Ensembl chrNW_004624828:2,432,550...2,453,071
G
G
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
P
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 2:69,097,136...69,107,722
Ensembl chr 2:69,097,122...69,108,205
G
S
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
G
D
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr20:50,818,715...50,827,914
Ensembl chr20:50,818,715...50,827,914
G
B
ICAM1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
C
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
G
R
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
M
Icam1
intercellular adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
H
ICAM1
intercellular adhesion molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
N
Ifnb1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chrNW_004624736:25,099,061...25,099,746
G
P
IFNB1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chr 1:201,850,935...201,851,495
Ensembl chr 1:201,850,935...201,851,495
G
S
Ifnb1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chrNW_004936652:2,736,270...2,736,833
G
D
IFNB1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chr11:40,668,295...40,668,855
Ensembl chr11:40,668,295...40,668,855
G
B
IFNB1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chr 9:20,884,742...20,886,317
G
C
Ifnb1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:15389896 PMID:23517930 PMID:27806875 More...
RGD:401854232
NCBI chrNW_004955434:23,301,623...23,302,304
G
R
Ifnb1
interferon beta 1
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:23517930 PMID:27806875 PMID:15389896 More...
RGD:401854232
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
G
M
Ifnb1
interferon beta 1, fibroblast
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:23517930 PMID:27806875 PMID:15389896 More...
RGD:401854232
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
G
H
IFNB1
interferon beta 1
treatment
EXP IDA
CTD Direct Evidence: therapeutic
CTD RGD
PMID:10520943 PMID:12424511 PMID:12432978 PMID:23517930 PMID:27806875 PMID:15389896 More...
RGD:401854232
NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
G
N
Ifng
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
G
G
IFNG
interferon gamma
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:repeat:intron: (human)
CTD RGD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
P
IFNG
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chr 5:32,477,906...32,482,670
Ensembl chr 5:32,477,906...32,482,670
G
S
Ifng
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
G
D
IFNG
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chr10:10,406,866...10,411,698
Ensembl chr10:10,406,867...10,411,698
G
B
IFNG
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
C
Ifng
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:9818947 PMID:23517930
RGD:1358738
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
R
Ifng
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:9818947
RGD:1358738
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
M
Ifng
interferon gamma
susceptibility
ISO
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:9818947
RGD:1358738
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
H
IFNG
interferon gamma
susceptibility
IAGP EXP
DNA:repeat:intron: (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:9818947
RGD:1358738
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
N
Igf2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chrNW_004624767:14,969,977...14,997,577
Ensembl chrNW_004624767:14,969,866...14,979,026
G
G
IGF2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr 1:1,937,414...1,951,238
Ensembl chr 1:1,936,830...1,945,388
G
P
IGF2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr 2:1,469,183...1,496,417
G
S
Igf2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chrNW_004936816:972,902...981,232
Ensembl chrNW_004936816:972,282...979,167
G
D
IGF2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr18:46,294,036...46,311,982
Ensembl chr18:46,294,019...46,311,982
G
B
IGF2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr11:2,170,190...2,199,442
Ensembl chr11:2,202,743...2,228,890
G
C
Igf2
insulin like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chrNW_004955422:13,880,525...13,907,963
Ensembl chrNW_004955422:13,880,471...13,888,566
G
R
Igf2
insulin-like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
G
M
Igf2
insulin-like growth factor 2
ISO
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
H
IGF2
insulin like growth factor 2
IEP
protein:increased expression:macrophage
RGD
PMID:10417663
RGD:5510017
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
N
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chrNW_004624807:4,687,249...4,691,658
Ensembl chrNW_004624807:4,687,176...4,691,732
G
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
G
P
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
S
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
D
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 7:5,933,285...5,937,057
Ensembl chr 7:5,933,285...5,937,057
G
B
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
C
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
G
R
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
M
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
H
IL10
interleukin 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23517930
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
N
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004624730:37,787,772...37,794,871
Ensembl chrNW_004624730:37,787,909...37,794,940
G
G
IL12A
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr15:30,887,048...30,896,577
Ensembl chr15:30,887,897...30,894,550
G
P
IL12A
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr13:99,733,394...99,741,078
Ensembl chr13:99,733,394...99,741,078
G
S
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004936519:6,166,060...6,180,652
Ensembl chrNW_004936519:6,175,261...6,180,396
G
D
IL12A
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr34:26,125,529...26,133,546
Ensembl chr34:26,124,770...26,133,550
G
B
IL12A
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 3:157,011,675...157,019,897
Ensembl chr 3:165,061,505...165,068,666
G
C
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004955448:10,611,131...10,617,911
G
R
Il12a
interleukin 12A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
M
Il12a
interleukin 12a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
G
H
IL12A
interleukin 12A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
N
Il13
interleukin 13
severity
ISO
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chrNW_004624733:39,427,189...39,430,019
Ensembl chrNW_004624733:39,428,095...39,429,843
G
G
IL13
interleukin 13
severity
ISO
protein:increased expression:cerebrospinal fluid protein:increased expression:serum
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
G
P
IL13
interleukin 13
severity
ISO
protein:increased expression:cerebrospinal fluid protein:increased expression:serum
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chr 2:134,972,099...134,976,672
Ensembl chr 2:134,972,623...134,975,093
G
S
Il13
interleukin 13
severity
ISO
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
D
IL13
interleukin 13
severity
ISO
protein:increased expression:cerebrospinal fluid protein:increased expression:serum
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chr11:20,957,870...20,961,391
Ensembl chr11:20,958,464...20,961,388
G
B
IL13
interleukin 13
severity
ISO
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
C
Il13
interleukin 13
severity
ISO
protein:increased expression:cerebrospinal fluid protein:increased expression:serum
RGD
PMID:21677024 PMID:22031307
RGD:5684368 RGD:8549589
NCBI chrNW_004955408:4,046,406...4,049,795
G
R
Il13
interleukin 13
severity
ISO
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:22031307 PMID:21677024
RGD:5684368 , RGD:8549589
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
M
Il13
interleukin 13
severity
ISO
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:22031307 PMID:21677024
RGD:5684368 , RGD:8549589
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
H
IL13
interleukin 13
severity
IEP
protein:increased expression:serum protein:increased expression:cerebrospinal fluid
RGD
PMID:22031307 PMID:21677024
RGD:5684368 , RGD:8549589
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
N
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (human)
CTD RGD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chrNW_004624855:3,911,349...3,914,214
Ensembl chrNW_004624855:3,911,349...3,913,136
G
G
IL17A
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
G
P
IL17A
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chr 7:46,013,584...46,017,161
Ensembl chr 7:46,013,584...46,017,153
G
S
Il17a
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
D
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma (human)
CTD RGD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chr12:19,854,129...19,862,521
Ensembl chr12:19,854,129...19,862,513
G
B
IL17A
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
C
Il17a
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21455110 PMID:23517930
RGD:8698672
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
G
R
Il17a
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:21455110
RGD:8698672
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
G
M
Il17a
interleukin 17A
ISO
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:21455110
RGD:8698672
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
H
IL17A
interleukin 17A
IEP EXP
protein:increased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23517930 PMID:21455110
RGD:8698672
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
N
Il1b
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
G
G
IL1B
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
S
Il1b
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
D
IL1B
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
B
IL1B
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
C
Il1b
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
R
Il1b
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15210533 PMID:25458313 PMID:10025794
RGD:1358741
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
M
Il1b
interleukin 1 beta
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15210533 PMID:25458313 PMID:10025794
RGD:1358741
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
H
IL1B
interleukin 1 beta
severity
IAGP EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:15210533 PMID:25458313 PMID:10025794
RGD:1358741
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
N
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
G
G
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
G
P
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
G
S
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
G
D
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr17:37,236,690...37,250,424
Ensembl chr17:37,212,751...37,249,329
G
B
IL1RN
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
C
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004955470:1,145,022...1,159,413
Ensembl chrNW_004955470:1,144,810...1,159,471
G
R
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
M
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
H
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
N
Il21r
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chrNW_004624782:12,037,338...12,070,479
Ensembl chrNW_004624782:12,057,651...12,068,650
G
G
IL21R
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chr 5:25,105,947...25,153,914
Ensembl chr 5:25,106,519...25,153,703
G
P
IL21R
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chr 3:19,447,488...19,489,201
Ensembl chr 3:19,443,359...19,489,152
G
S
Il21r
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chrNW_004936501:11,100,170...11,112,112
Ensembl chrNW_004936501:11,100,170...11,110,744
G
D
IL21R
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chr 6:19,181,846...19,217,915
Ensembl chr 6:19,182,071...19,217,931
G
B
IL21R
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
Ensembl chr16:27,774,864...27,821,769
G
C
Il21r
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 RGD:6892963
NCBI chrNW_004955493:5,613,704...5,646,692
Ensembl chrNW_004955493:5,613,564...5,650,583
G
R
Il21r
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 , RGD:6892963
NCBI chr 1:180,168,028...180,195,690
Ensembl chr 1:180,168,097...180,195,522
G
M
Il21r
interleukin 21 receptor
ISO
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 , RGD:6892963
NCBI chr 7:125,202,424...125,232,742
Ensembl chr 7:125,202,601...125,232,742
G
H
IL21R
interleukin 21 receptor
IAGP IEP
DNA:polymorphisms: :
RGD
PMID:20072140 PMID:21281812
RGD:6892695 , RGD:6892963
NCBI chr16:27,402,174...27,452,042
Ensembl chr16:27,402,174...27,452,042
G
N
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chrNW_004624742:27,899,934...27,954,145
Ensembl chrNW_004624742:27,901,071...27,941,109
G
G
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chr20:65,853,379...65,946,000
Ensembl chr20:65,854,349...65,938,024
G
P
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chr 6:145,337,765...145,401,909
Ensembl chr 6:145,335,741...145,401,510
G
S
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chrNW_004936591:4,365,598...4,425,053
Ensembl chrNW_004936591:4,365,762...4,425,005
G
D
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chr 5:43,307,422...43,369,806
Ensembl chr 5:43,308,982...43,368,474
G
B
IL23R
interleukin 23 receptor
no_association
ISO
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chr 1:66,408,839...66,502,535
Ensembl chr 1:68,293,514...68,386,815
G
C
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs: :rs2201841,rs10889677,s7517847(human) DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 RGD:8549632
NCBI chrNW_004955423:23,841,342...23,885,191
Ensembl chrNW_004955423:23,842,475...23,884,904
G
R
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 , RGD:8549632
NCBI chr 4:96,580,568...96,672,540
Ensembl chr 4:96,580,714...96,674,021
G
M
Il23r
interleukin 23 receptor
no_association
ISO
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 , RGD:8549632
NCBI chr 6:67,399,906...67,468,838
Ensembl chr 6:67,399,916...67,468,839
G
H
IL23R
interleukin 23 receptor
no_association
IAGP
DNA:SNPs:cds:p.R381Q(rs11209026),(rs7517847)(human) DNA:SNPs: :rs2201841,rs10889677,s7517847(human)
RGD
PMID:18368064 PMID:24547735
RGD:8549631 , RGD:8549632
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
N
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chrNW_004624775:927,337...991,062
Ensembl chrNW_004624775:924,648...942,354
G
G
IL2RA
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chr 9:6,134,961...6,187,731
Ensembl chr 9:6,141,430...6,149,447
G
P
IL2RA
interleukin 2 receptor subunit alpha
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chr10:64,948,149...65,001,320
Ensembl chr10:64,948,563...65,001,142
G
S
Il2ra
interleukin 2 receptor subunit alpha
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chrNW_004936484:8,514,333...8,555,392
Ensembl chrNW_004936484:8,544,062...8,555,332
G
D
IL2RA
interleukin 2 receptor subunit alpha
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chr 2:29,892,130...29,948,926
Ensembl chr 2:29,894,125...29,944,643
G
B
IL2RA
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chr10:6,053,549...6,103,863
G
C
Il2ra
interleukin 2 receptor subunit alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:17660530 PMID:19119414 PMID:19125193 PMID:19525955 PMID:24076602
RGD:2311526
NCBI chrNW_004955421:22,642,004...22,694,729
Ensembl chrNW_004955421:22,641,511...22,694,913
G
R
Il2ra
interleukin 2 receptor subunit alpha
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17660530 PMID:19119414 PMID:19525955 PMID:24076602 PMID:19125193
RGD:2311526
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
M
Il2ra
interleukin 2 receptor, alpha chain
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17660530 PMID:19119414 PMID:19525955 PMID:24076602 PMID:19125193
RGD:2311526
NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004
G
H
IL2RA
interleukin 2 receptor subunit alpha
IAGP EXP
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17660530 PMID:19119414 PMID:19525955 PMID:24076602 PMID:19125193
RGD:2311526
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
D
IL32
interleukin 32
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:23180362
RGD:150340728
NCBI chr 6:38,119,287...38,122,979
G
B
IL32
interleukin 32
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:23180362
RGD:150340728
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
H
IL32
interleukin 32
IEP
protein:increased expression:blood plasma (human)
RGD
PMID:23180362
RGD:150340728
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
N
Il4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chrNW_004624733:39,412,800...39,420,079
G
G
IL4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
G
P
IL4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr 2:134,986,817...134,994,365
Ensembl chr 2:134,986,817...134,994,365
G
D
IL4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr11:20,972,693...20,981,539
Ensembl chr11:20,972,690...20,981,534
G
B
IL4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
C
Il4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chrNW_004955408:4,058,052...4,065,999
G
R
Il4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
M
Il4
interleukin 4
onset
ISO
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
H
IL4
interleukin 4
onset
IAGP
DNA:repeat:intron 3:allele B1 (human)
RGD
PMID:9184650
RGD:1358745
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
N
Il4r
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chrNW_004624782:11,981,781...12,008,362
G
G
IL4R
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
G
P
IL4R
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 3:19,526,343...19,576,792
Ensembl chr 3:19,523,564...19,576,544
G
S
Il4r
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
G
D
IL4R
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 6:19,254,183...19,280,973
Ensembl chr 6:19,254,487...19,389,291
G
B
IL4R
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
Ensembl chr16:27,642,702...27,737,445
G
C
Il4r
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
G
R
Il4r
interleukin 4 receptor
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
H
IL4R
interleukin 4 receptor
IAGP
RGD
PMID:14712310
RGD:4890395
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
M
Il4ra
interleukin 4 receptor, alpha
ISO
RGD
PMID:14712310
RGD:4890395
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
N
Il6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
G
G
IL6
interleukin 6
treatment severity
ISO
DNA:polymorphism:promoter:-174G>C(human) DNA:polymorphism:promoter:-572 G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
P
IL6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
G
S
Il6
interleukin 6
treatment severity
ISO
DNA:polymorphism:promoter:-174G>C(human) DNA:polymorphism:promoter:-572 G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chrNW_004936549:7,015,595...7,016,246
G
D
IL6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chr14:36,474,268...36,478,519
Ensembl chr14:36,473,394...36,478,519
G
B
IL6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chr 7:23,415,922...23,420,767
G
C
Il6
interleukin 6
treatment severity
ISO
DNA:polymorphism:promoter:-174G>C(human) DNA:polymorphism:promoter:-572 G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:11079567 RGD:12791288 RGD:12792202
NCBI chrNW_004955410:25,079,835...25,084,390
G
R
Il6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:12791288 , RGD:12792202 , RGD:11079567
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
M
Il6
interleukin 6
severity treatment
ISO
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:12791288 , RGD:12792202 , RGD:11079567
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
H
IL6
interleukin 6
severity treatment
IAGP IDA
DNA:polymorphism:promoter:-572 G>C(human) DNA:polymorphism:promoter:-174G>C(human)
RGD
PMID:23202972 PMID:24155968 PMID:26285213
RGD:12791288 , RGD:12792202 , RGD:11079567
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
N
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chrNW_004624744:12,562,536...12,604,037
Ensembl chrNW_004624744:12,567,661...12,604,074
G
G
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 8:74,230,493...74,292,985
Ensembl chr 8:74,231,809...74,292,384
G
P
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 4:57,677,895...57,744,713
Ensembl chr 4:57,684,796...57,744,709
G
S
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chrNW_004936702:110,625...162,957
Ensembl chrNW_004936702:111,211...162,322
G
D
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr29:26,384,493...26,422,586
Ensembl chr29:26,384,493...26,422,737
G
B
IL7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 8:75,254,166...75,337,373
Ensembl chr 8:76,895,095...76,966,918
G
C
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chrNW_004955444:2,365,077...2,400,953
G
R
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
G
M
Il7
interleukin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820
G
H
IL7
interleukin 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17660816
NCBI chr 8:78,675,044...78,805,463
Ensembl chr 8:78,675,743...78,805,523
G
N
Il7r
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chrNW_004624759:19,067,933...19,103,007
Ensembl chrNW_004624759:19,067,856...19,098,859
G
G
IL7R
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 4:34,701,724...34,724,241
Ensembl chr 4:34,701,531...34,721,361
G
P
IL7R
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr16:21,300,141...21,330,156
Ensembl chr16:21,300,111...21,329,585
G
S
Il7r
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chrNW_004936518:5,815,820...5,842,571
G
D
IL7R
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 4:72,633,528...72,668,242
Ensembl chr 4:72,636,325...72,668,300
G
B
IL7R
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 5:74,489,188...74,516,330
Ensembl chr 5:79,769,859...79,792,612
G
C
Il7r
interleukin 7 receptor
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
ClinVar
PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chrNW_004955426:20,785,896...20,818,512
Ensembl chrNW_004955426:20,787,471...20,818,577
G
R
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
CTD ClinVar
PMID:17660530 PMID:17660816 PMID:17660817 PMID:19525955 PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
G
M
Il7r
interleukin 7 receptor
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
CTD ClinVar
PMID:17660530 PMID:17660816 PMID:17660817 PMID:19525955 PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
G
H
IL7R
interleukin 7 receptor
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 3
CTD ClinVar
PMID:17660530 PMID:17660816 PMID:17660817 PMID:19525955 PMID:21664875 PMID:24759676 PMID:25046553 PMID:25741868 PMID:26123418 PMID:27577878 PMID:28436970 PMID:28492532 PMID:32576985 PMID:32765500 More...
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
G
N
Irf5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chrNW_004624783:7,267,680...7,275,918
Ensembl chrNW_004624783:7,260,005...7,274,433
G
G
IRF5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chr21:97,536,803...97,549,576
Ensembl chr21:97,537,790...97,549,945
G
P
IRF5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chr18:19,678,377...19,691,154
Ensembl chr18:19,678,687...19,691,243
G
S
Irf5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chrNW_004936579:6,138,372...6,149,531
Ensembl chrNW_004936579:6,138,281...6,145,205
G
D
IRF5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chr14:7,724,168...7,734,976
Ensembl chr14:7,724,780...7,742,795
G
B
IRF5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:20861862 PMID:25392335
RGD:11055911 RGD:40924643
NCBI chr 7:120,889,752...120,902,096
Ensembl chr 7:133,415,170...133,426,356
G
R
Irf5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:25392335 PMID:20861862
RGD:11055911 , RGD:40924643
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
G
M
Irf5
interferon regulatory factor 5
susceptibility
ISO
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:25392335 PMID:20861862
RGD:11055911 , RGD:40924643
NCBI chr 6:29,526,129...29,541,874
Ensembl chr 6:29,526,624...29,541,870
G
H
IRF5
interferon regulatory factor 5
susceptibility
IDA IAGP
DNA:SNPs: :rs3807306, rs4728142 (human)
RGD
PMID:25392335 PMID:20861862
RGD:11055911 , RGD:40924643
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
N
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chrNW_004624746:2,272,385...2,290,400
Ensembl chrNW_004624746:2,272,389...2,290,455
G
G
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr 5:71,301,878...71,325,622
Ensembl chr 5:71,302,233...71,325,613
G
P
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr 6:3,041,617...3,060,685
Ensembl chr 6:3,041,645...3,097,406
G
S
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chrNW_004936641:2,608,109...2,622,446
Ensembl chrNW_004936641:2,608,100...2,622,409
G
D
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr 5:66,789,264...66,812,477
Ensembl chr 5:66,791,350...66,842,179
G
B
IRF8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr16:66,568,370...66,591,949
Ensembl chr16:85,905,334...85,929,073
G
C
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chrNW_004955541:973,004...988,493
Ensembl chrNW_004955541:973,022...990,106
G
R
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
M
Irf8
interferon regulatory factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr 8:121,463,097...121,483,433
Ensembl chr 8:121,463,097...121,483,433
G
H
IRF8
interferon regulatory factor 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525953
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
N
Jag1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chrNW_004624741:11,647,723...11,683,137
Ensembl chrNW_004624741:11,647,463...11,683,488
G
G
JAG1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chr 2:27,484,699...27,521,108
Ensembl chr 2:27,484,760...27,522,504
G
P
JAG1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chr17:19,591,248...19,629,659
Ensembl chr17:19,591,259...19,629,641
G
S
Jag1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chrNW_004936485:8,857,688...8,894,270
Ensembl chrNW_004936485:8,857,669...8,895,315
G
D
JAG1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chr24:11,656,926...11,693,146
Ensembl chr24:11,657,416...11,692,199
G
B
JAG1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chr20:10,582,234...10,618,507
Ensembl chr20:10,582,094...10,618,383
G
C
Jag1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:16934875 PMID:20805994
RGD:6482233 RGD:6482240
NCBI chrNW_004955415:20,490,414...20,526,068
Ensembl chrNW_004955415:20,490,414...20,527,917
G
R
Jag1
jagged canonical Notch ligand 1
disease_progression
ISO
RGD
PMID:20805994 PMID:16934875
RGD:6482233 , RGD:6482240
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
G
M
Jag1
jagged 1
disease_progression
ISO
RGD
PMID:20805994 PMID:16934875
RGD:6482233 , RGD:6482240
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
G
H
JAG1
jagged canonical Notch ligand 1
disease_progression
IEP IAGP
RGD
PMID:20805994 PMID:16934875
RGD:6482233 , RGD:6482240
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
N
Jarid2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624756:10,932,148...11,079,609
Ensembl chrNW_004624756:10,933,717...11,199,077
G
G
JARID2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:56,651,752...56,928,650
Ensembl chr17:56,651,596...56,928,126
G
P
JARID2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 7:11,358,243...11,601,715
Ensembl chr 7:11,359,230...11,601,401
G
S
Jarid2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936552:1,566,382...1,786,837
Ensembl chrNW_004936552:1,566,788...1,785,490
G
D
JARID2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr35:14,476,656...14,737,535
Ensembl chr35:14,445,914...14,736,158
G
B
JARID2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:15,100,415...15,376,505
Ensembl chr 6:15,466,050...15,739,170
G
C
Jarid2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955590:383,810...512,854
Ensembl chrNW_004955590:384,817...626,684
G
R
Jarid2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:19,777,487...19,957,696
Ensembl chr17:19,777,266...19,955,690
G
M
Jarid2
jumonji and AT-rich interaction domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:44,881,817...45,075,119
Ensembl chr13:44,882,950...45,075,119
G
H
JARID2
jumonji and AT-rich interaction domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:15,246,069...15,522,042
Ensembl chr 6:15,246,069...15,522,042
G
N
Kcnj10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chrNW_004624794:1,180,822...1,211,781
Ensembl chrNW_004624794:1,180,834...1,212,456
G
G
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr20:3,873,915...3,907,587
Ensembl chr20:3,902,513...3,903,652
G
P
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr 4:90,421,956...90,457,406
Ensembl chr 4:90,422,025...90,457,406
G
S
Kcnj10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chrNW_004936740:555,948...589,219
Ensembl chrNW_004936740:555,998...586,353
G
D
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr38:22,114,718...22,143,625
Ensembl chr38:22,130,508...22,140,813
G
B
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr 1:135,391,321...135,424,100
G
C
Kcnj10
potassium inwardly rectifying channel subfamily J member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chrNW_004955468:11,828,525...11,860,365
Ensembl chrNW_004955468:11,828,525...11,860,365
G
R
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
G
M
Kcnj10
potassium inwardly-rectifying channel, subfamily J, member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr 1:172,168,777...172,201,652
Ensembl chr 1:172,168,777...172,201,652
G
H
KCNJ10
potassium inwardly rectifying channel subfamily J member 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24070676
NCBI chr 1:160,037,467...160,070,160
Ensembl chr 1:159,998,651...160,070,160
G
N
Kif1b
kinesin family member 1B
susceptibility no_association
ISO
DNA:snp:intron:c.1590+932T>C (rs10492972) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chrNW_004624818:2,282,999...2,428,586
Ensembl chrNW_004624818:2,282,999...2,428,563
G
G
KIF1B
kinesin family member 1B
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chr20:121,393,478...121,567,704
Ensembl chr20:121,395,836...121,546,803
G
P
KIF1B
kinesin family member 1B
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chr 6:70,495,143...70,663,464
Ensembl chr 6:70,495,144...70,661,798
G
S
Kif1b
kinesin family member 1B
susceptibility no_association
ISO
DNA:snp:intron:c.1590+932T>C (rs10492972) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chrNW_004936623:4,091,093...4,222,510
Ensembl chrNW_004936623:4,091,190...4,218,251
G
D
KIF1B
kinesin family member 1B
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chr 5:63,367,294...63,516,388
Ensembl chr 5:63,376,820...63,513,476
G
B
KIF1B
kinesin family member 1B
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chr 1:8,969,910...9,141,964
Ensembl chr 1:10,198,997...10,364,577 Ensembl chr 1:10,198,997...10,364,577
G
C
Kif1b
kinesin family member 1B
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484
RGD:12738462 RGD:12738463
NCBI chrNW_004955486:3,366,791...3,503,845
Ensembl chrNW_004955486:3,370,596...3,489,052
G
R
Kif1b
kinesin family member 1B
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484 PMID:18997785
RGD:12738463 , RGD:12738462
NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
G
M
Kif1b
kinesin family member 1B
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:snp:intron:c.1590+932T>C (rs10492972) (human)
CTD RGD
PMID:18997785 PMID:20502484 PMID:18997785
RGD:12738463 , RGD:12738462
NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150
G
H
KIF1B
kinesin family member 1B
susceptibility no_association
IAGP EXP
DNA:snp:intron:c.1590+932T>C (rs10492972) (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18997785 PMID:18997785 PMID:20502484
RGD:12738462 , RGD:12738463
NCBI chr 1:10,210,570...10,381,603
Ensembl chr 1:10,210,570...10,381,603
G
N
Kif5a
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chrNW_004624802:10,375,132...10,409,575
Ensembl chrNW_004624802:10,375,774...10,409,566
G
G
KIF5A
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr11:53,458,795...53,493,801
G
P
KIF5A
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr 5:22,813,617...22,851,976
Ensembl chr 5:22,816,854...22,851,973
G
S
Kif5a
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chrNW_004936646:1,697,531...1,730,376
Ensembl chrNW_004936646:1,697,492...1,732,832
G
D
KIF5A
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr10:1,637,007...1,666,790
Ensembl chr10:1,636,932...1,664,767
G
B
KIF5A
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr12:31,340,201...31,376,849
Ensembl chr12:31,599,376...31,635,327
G
C
Kif5a
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chrNW_004955458:5,264,274...5,310,962
Ensembl chrNW_004955458:5,287,111...5,310,962
G
R
Kif5a
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
G
M
Kif5a
kinesin family member 5A
susceptibility
ISO
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217
G
H
KIF5A
kinesin family member 5A
susceptibility
IAGP
DNA:snp:intron:c.1717-152C>G (rs1678542) (human)
RGD
PMID:20508602
RGD:12793067
NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
G
N
Klhl6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624730:72,916,601...72,972,204
G
G
KLHL6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:5,844,728...5,912,392
Ensembl chr15:5,845,721...5,913,734
G
P
KLHL6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:121,426,618...121,487,260
G
S
Klhl6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936578:6,226,533...6,284,343
Ensembl chrNW_004936578:6,226,495...6,284,293
G
D
KLHL6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr34:16,443,282...16,556,991
Ensembl chr34:16,446,944...16,504,549
G
B
KLHL6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:180,523,141...180,591,218
Ensembl chr 3:188,692,200...188,760,926
G
C
Klhl6
kelch like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955420:23,813,482...23,877,886
G
R
Klhl6
kelch-like family member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:80,970,917...81,010,593
Ensembl chr11:80,970,917...81,009,677
G
M
Klhl6
kelch-like 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr16:19,765,242...19,801,766
Ensembl chr16:19,765,246...19,801,787
G
H
KLHL6
kelch like family member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:183,487,551...183,555,706
Ensembl chr 3:183,487,551...183,555,706
G
N
Klk6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chrNW_004624832:3,785,727...3,793,078
Ensembl chrNW_004624832:3,785,644...3,793,074
G
G
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr 6:43,980,680...43,991,873
Ensembl chr 6:43,980,701...43,990,060
G
P
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr 6:55,629,983...55,639,215
Ensembl chr 6:55,629,991...55,638,080
G
S
Klk6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chrNW_004936889:621,645...628,454
Ensembl chrNW_004936889:621,630...629,678
G
D
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr 1:105,902,147...105,907,585
G
B
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr19:47,925,017...47,936,314
Ensembl chr19:56,815,073...56,826,689
G
C
Klk6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chrNW_004955558:1,501,806...1,509,461
Ensembl chrNW_004955558:1,502,881...1,509,558
G
R
Klk6
kallikrein related-peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
G
M
Klk6
kallikrein related-peptidase 6
IEP
RGD
PMID:11802715
RGD:2314867
NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454
G
H
KLK6
kallikrein related peptidase 6
ISO
RGD
PMID:11802715
RGD:2314867
NCBI chr19:50,958,631...50,969,591
Ensembl chr19:50,958,631...50,969,673
G
P
LOC100519934
uncharacterized LOC100519934
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr 1:73,119,758...73,124,368
G
P
LOC100739508
glutathione S-transferase P-like
disease_progression
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:10680782
RGD:5490267
NCBI chr 2:5,005,498...5,009,247
G
B
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism (human) DNA:polymorphism:cds:HLA-DQB1*0301 (human) DNA:polymorphism:cds:HLA-DQB1*06 (human)
OMIM RGD
PMID:15201511 PMID:20463743 PMID:21741664 PMID:21908482
RGD:40818409 RGD:5147555 RGD:5147658 RGD:7421588
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
B
LOC100979269
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chr12:9,154,457...9,202,833
Ensembl chr12:9,385,359...9,433,979
G
B
LOC100982539
signal transducer CD24
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chr 6:104,783,720...104,789,509
Ensembl chr 6:108,655,624...108,657,847
G
B
LOC100987081
HLA class II histocompatibility antigen, DR alpha chain
ISO
DNA:SNPs: :multiple (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human)
RGD CTD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chr 6:32,105,421...32,110,579
Ensembl chr 6:32,982,228...32,987,417
G
B
LOC100991644
low affinity immunoglobulin gamma Fc region receptor II-a
no_association
ISO
DNA:polymorphism: :p.H131R (human)
RGD
PMID:12864991
RGD:5147977
NCBI chr 1:136,892,311...136,906,450
G
B
LOC100995226
HLA class II histocompatibility antigen, DP beta 1 chain
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chr 6:32,648,780...32,659,613
Ensembl chr 6:33,763,566...33,774,387
G
N
LOC101697345
HLA class II histocompatibility antigen, DP beta 1 chain
susceptibility
ISO
DNA:polymorphism: :HLA-DPB1*0501 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human)
RGD CTD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chrNW_004624754:23,661,031...23,672,549
Ensembl chrNW_004624754:23,658,339...23,672,663
G
N
LOC101700851
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chrNW_004624802:10,176,865...10,181,725
Ensembl chrNW_004624802:10,176,919...10,181,657
G
N
LOC101703821
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*06 (human) DNA:polymorphism (human) DNA:polymorphism:cds:HLA-DQB1*0301 (human)
OMIM RGD
PMID:15201511 PMID:20463743 PMID:21741664 PMID:21908482
RGD:40818409 RGD:5147555 RGD:5147658 RGD:7421588
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
G
N
LOC101706353
HLA class II histocompatibility antigen, DR alpha chain
ISO
DNA:polymorphism:promoter (human) CTD Direct Evidence: marker/mechanism DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:SNPs: :multiple (human)
RGD CTD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chrNW_004624754:24,079,459...24,086,342
Ensembl chrNW_004624754:24,079,366...24,084,512
G
S
LOC101955076
low affinity immunoglobulin gamma Fc region receptor III-A
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chrNW_004937131:42,523...49,533
G
S
LOC101959212
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chrNW_004936870:424,832...468,303
Ensembl chrNW_004936870:424,951...468,167
G
S
LOC101963197
HLA class II histocompatibility antigen, DP beta 1 chain
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: :HLA-DPB1*0501 (human) DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human)
CTD RGD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chrNW_004936476:25,730,800...25,741,089
Ensembl chrNW_004936476:25,730,596...25,741,145
G
S
LOC101964975
interleukin-8
ISO
protein:increased expression:serum
RGD
PMID:20138139
RGD:5134999
NCBI chrNW_004936598:1,779,471...1,781,353
Ensembl chrNW_004936598:1,779,471...1,781,353
G
S
LOC101968601
signal transducer CD24
ISO
RGD
PMID:14657362
RGD:1358462
NCBI chrNW_004936491:16,706,745...16,707,010
G
S
LOC101969065
mamu class II histocompatibility antigen, DR alpha chain
ISO
DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chrNW_004936727:540,225...544,968
Ensembl chrNW_004936727:540,217...545,036
G
S
LOC101978323
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chrNW_004936646:1,899,686...1,904,104
Ensembl chrNW_004936646:1,900,259...1,904,104
G
C
LOC102011841
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
PMID:9837822 PMID:25741868 PMID:25741914
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
G
C
LOC102019320
mamu class II histocompatibility antigen, DR alpha chain
ISO
DNA:SNPs: :multiple (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human) DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human)
RGD CTD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chrNW_004955437:1,109,735...1,114,742
Ensembl chrNW_004955437:1,109,713...1,114,802
G
C
LOC102021956
alpha-2-macroglobulin
ISO
RGD
PMID:11498265
RGD:1549857
NCBI chrNW_004955413:6,019,457...6,062,366
Ensembl chrNW_004955413:6,019,082...6,062,529
G
C
LOC102026469
HLA class II histocompatibility antigen, DP beta 1 chain
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chrNW_004955437:1,655,092...1,666,552
Ensembl chrNW_004955437:1,635,538...1,669,042
G
G
LOC103224275
glutathione S-transferase Mu 1
susceptibility disease_progression onset
ISO
DNA:deletion: : (human) DNA:deletion:: (human)
RGD
PMID:10680782 PMID:17437619 PMID:23932298
RGD:12792225 RGD:12792249 RGD:5490267
NCBI chr20:23,854,969...23,861,634
G
P
LOC110258578
interleukin-1 beta-like
severity
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:10025794 PMID:15210533 PMID:25458313
RGD:1358741
G
D
LOC478984
low affinity immunoglobulin gamma Fc region receptor III
disease_progression
ISO
protein:increased expression:gamma-delta T cell
RGD
PMID:18155780
RGD:5508375
NCBI chr38:21,054,870...21,060,948
G
D
LOC607874
cystatin-C-like
ISO
protein:decreased expression:cerebrospinal fluid
RGD
PMID:12589965 PMID:17086443
RGD:5686392 RGD:5686394
NCBI chr23:49,562...53,618
G
D
LOC609365
CD46 molecule, complement regulatory protein-like
ISO
RGD
PMID:21177319
RGD:6483460
NCBI chr 7:6,602,762...6,646,561
G
N
Lrch1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chrNW_004624748:8,294,112...8,479,933
Ensembl chrNW_004624748:8,305,147...8,480,025
G
G
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr 3:24,545,641...24,748,992
G
P
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr11:20,687,657...20,906,743
Ensembl chr11:20,688,596...20,906,608
G
S
Lrch1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chrNW_004936565:93,791...280,192
Ensembl chrNW_004936565:93,779...277,777
G
D
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr22:4,576,658...4,687,621
Ensembl chr22:4,578,733...4,771,753
G
B
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr13:27,697,684...27,897,762
Ensembl chr13:46,416,017...46,613,065
G
C
Lrch1
leucine rich repeats and calponin homology domain containing 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chrNW_004955431:404,575...501,268
Ensembl chrNW_004955431:404,708...498,470
G
R
Lrch1
leucine rich repeats and calponin homology domain containing 1
ISS
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr15:50,070,605...50,249,724
Ensembl chr15:50,071,947...50,249,657
G
M
Lrch1
leucine-rich repeats and calponin homology (CH) domain containing 1
IAGP
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr14:74,992,113...75,185,447
Ensembl chr14:74,992,115...75,185,316
G
H
LRCH1
leucine rich repeats and calponin homology domain containing 1
ISS
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810
MouseDO
NCBI chr13:46,553,170...46,753,041
Ensembl chr13:46,553,168...46,753,040
G
N
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624742:8,010,849...8,096,567
Ensembl chrNW_004624742:8,009,901...8,096,652
G
G
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:43,752,341...43,842,958
Ensembl chr20:43,752,370...43,842,766
G
P
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 4:126,957,099...127,079,042
Ensembl chr 4:126,957,105...127,037,216
G
S
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936537:9,050,495...9,124,649
Ensembl chrNW_004936537:9,049,944...9,124,619
G
D
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:58,895,769...58,932,729
Ensembl chr 6:58,899,996...58,932,729
G
B
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:92,299,691...92,384,733
Ensembl chr 1:91,105,551...91,138,447
G
C
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955423:4,460,212...4,494,317
Ensembl chrNW_004955423:4,460,212...4,494,317
G
R
Lrrc8c
leucine rich repeat containing 8 VRAC subunit C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr14:4,223,901...4,315,590
Ensembl chr14:4,227,832...4,315,249
G
M
Lrrc8c
leucine rich repeat containing 8 family, member C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 5:105,666,850...105,760,884
Ensembl chr 5:105,667,254...105,760,884
G
H
LRRC8C
leucine rich repeat containing 8 VRAC subunit C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:89,615,824...89,719,533
Ensembl chr 1:89,633,072...89,769,903
G
N
Mag
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chrNW_004624794:8,237,005...8,251,933
Ensembl chrNW_004624794:8,236,223...8,258,361
G
G
MAG
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 6:30,224,873...30,246,277
Ensembl chr 6:30,227,442...30,246,481
G
P
MAG
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 6:44,794,197...44,809,933
Ensembl chr 6:44,794,204...44,809,926
G
S
Mag
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chrNW_004936570:989,743...1,004,820
G
D
MAG
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 1:117,288,306...117,301,975
Ensembl chr 1:117,288,343...117,302,386
G
B
MAG
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr19:32,238,457...32,260,497
Ensembl chr19:40,975,763...40,997,401
G
C
Mag
myelin associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chrNW_004955468:4,584,068...4,598,772
Ensembl chrNW_004955468:4,584,162...4,598,914
G
R
Mag
myelin-associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
G
M
Mag
myelin-associated glycoprotein
ISO
RGD
PMID:2419505
RGD:9685292
NCBI chr 7:30,598,600...30,614,347
Ensembl chr 7:30,598,601...30,614,298
G
H
MAG
myelin associated glycoprotein
IEP
RGD
PMID:2419505
RGD:9685292
NCBI chr19:35,292,161...35,313,807
Ensembl chr19:35,292,125...35,313,807
G
N
Mbp
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chrNW_004624806:3,465,881...3,587,428
Ensembl chrNW_004624806:3,489,681...3,588,335
G
G
MBP
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr18:2,844,154...2,996,640
Ensembl chr18:2,868,795...2,997,046
G
P
MBP
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr 1:147,649,516...147,685,289
Ensembl chr 1:147,590,865...147,685,290
G
S
Mbp
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chrNW_004936616:2,082,154...2,159,028
Ensembl chrNW_004936616:2,082,099...2,159,070
G
D
MBP
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr 1:2,841,801...2,952,553
Ensembl chr 1:2,846,589...2,951,860
G
B
MBP
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr18:70,369,882...70,526,693
Ensembl chr18:73,629,522...73,755,351
G
C
Mbp
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chrNW_004955402:60,324,060...60,448,926
Ensembl chrNW_004955402:60,323,950...60,441,406
G
R
Mbp
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
G
M
Mbp
myelin basic protein
ISO
RGD
PMID:1691612
RGD:1358488
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
H
MBP
myelin basic protein
IAGP
RGD
PMID:1691612
RGD:1358488
NCBI chr18:76,978,833...77,133,708
Ensembl chr18:76,978,827...77,133,683
G
N
Mcam
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chrNW_004624784:14,671,524...14,681,151
Ensembl chrNW_004624784:14,673,060...14,681,423
G
G
MCAM
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 1:110,682,631...110,691,717
Ensembl chr 1:110,684,458...110,691,707
G
P
MCAM
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 9:46,506,375...46,522,091
Ensembl chr 9:46,512,784...46,522,083
G
S
Mcam
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chrNW_004936542:4,235,914...4,244,981
Ensembl chrNW_004936542:4,237,010...4,244,462
G
D
MCAM
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 5:14,590,252...14,598,901
Ensembl chr 5:14,567,238...14,598,149
G
B
MCAM
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr11:114,149,583...114,158,234
Ensembl chr11:118,078,179...118,083,893
G
C
Mcam
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chrNW_004955412:20,396,056...20,404,777
Ensembl chrNW_004955412:20,397,051...20,404,780
G
R
Mcam
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
M
Mcam
melanoma cell adhesion molecule
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr 9:44,045,958...44,054,024
Ensembl chr 9:44,045,766...44,054,024
G
H
MCAM
melanoma cell adhesion molecule
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23595028
NCBI chr11:119,308,529...119,317,130
Ensembl chr11:119,308,529...119,321,521
G
G
MHC-DPB1
major histocompatibility complex, class II, DP beta 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human) DNA:polymorphism: :HLA-DPB1*0501 (human)
CTD RGD
PMID:17125797 PMID:17956852 PMID:32560041
RGD:150429801 RGD:150429806
NCBI chr17:38,996,329...39,007,097
G
G
MHC-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
G
G
MHC-DRA
major histocompatibility complex, class II, DR alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:polymorphism:promoter (human) DNA:SNPs: :multiple (human)
CTD RGD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chr17:39,623,324...39,628,464
Ensembl chr17:39,622,402...39,629,261
G
N
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chrNW_004624878:6,017...17,368
Ensembl chrNW_004624878:6,035...17,445
G
G
MMP12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 1:94,243,061...94,261,035
Ensembl chr 1:94,243,875...94,259,591
G
P
MMP12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 9:33,473,625...33,483,630
Ensembl chr 9:33,473,093...33,483,679
G
S
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chrNW_004936551:5,107,567...5,117,843
Ensembl chrNW_004936551:5,106,285...5,117,843
G
D
MMP12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 5:28,918,626...28,933,404
Ensembl chr 5:28,918,594...28,933,309
G
B
MMP12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr11:97,809,644...97,822,063
Ensembl chr11:101,294,475...101,306,762
G
C
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chrNW_004955412:6,045,146...6,057,112
Ensembl chrNW_004955412:6,045,100...6,057,262
G
R
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
M
Mmp12
matrix metallopeptidase 12
susceptibility
ISO
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499
G
H
MMP12
matrix metallopeptidase 12
susceptibility
IAGP
DNA:SNP:promoter:-82A>G (human)
RGD
PMID:19628284
RGD:13204795
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
N
Mmp9
matrix metallopeptidase 9
no_association susceptibility
ISO
DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human)
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chrNW_004624790:8,584,399...8,591,763
Ensembl chrNW_004624790:8,583,457...8,591,713
G
G
MMP9
matrix metallopeptidase 9
no_association susceptibility
ISO
DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human)
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
P
MMP9
matrix metallopeptidase 9
no_association susceptibility
ISO
DNA:repeat, SNP:promoter DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human) mRNA:increased expression:blood, mononuclear cell
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
S
Mmp9
matrix metallopeptidase 9
no_association susceptibility
ISO
DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human)
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
D
MMP9
matrix metallopeptidase 9
susceptibility no_association
ISO
mRNA:increased expression:blood, mononuclear cell DNA:SNP:promoter:-1562C>T (human) DNA:repeat, SNP:promoter DNA:SNP, repeat:promoter:-1562C>T (human)
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
B
MMP9
matrix metallopeptidase 9
susceptibility no_association
ISO
DNA:SNP:promoter:-1562C>T (human) DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
C
Mmp9
matrix metallopeptidase 9
susceptibility no_association
ISO
DNA:SNP, repeat:promoter:-1562C>T (human) DNA:SNP:promoter:-1562C>T (human) DNA:repeat, SNP:promoter mRNA:increased expression:blood, mononuclear cell
RGD
PMID:10713364 PMID:19628284 PMID:20471697 PMID:23401127
RGD:13204754 RGD:13204795 RGD:13204826 RGD:13204848
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
R
Mmp9
matrix metallopeptidase 9
no_association susceptibility
ISO
mRNA:increased expression:blood, mononuclear cell DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter DNA:SNP:promoter:-1562C>T (human)
RGD
PMID:23401127 PMID:20471697 PMID:10713364 PMID:19628284
RGD:13204754 , RGD:13204848 , RGD:13204826 , RGD:13204795
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
M
Mmp9
matrix metallopeptidase 9
no_association susceptibility
ISO
mRNA:increased expression:blood, mononuclear cell DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter DNA:SNP:promoter:-1562C>T (human)
RGD
PMID:23401127 PMID:20471697 PMID:10713364 PMID:19628284
RGD:13204754 , RGD:13204848 , RGD:13204826 , RGD:13204795
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
H
MMP9
matrix metallopeptidase 9
no_association susceptibility
IEP IAGP
mRNA:increased expression:blood, mononuclear cell DNA:SNP, repeat:promoter:-1562C>T (human) DNA:repeat, SNP:promoter DNA:SNP:promoter:-1562C>T (human)
RGD
PMID:23401127 PMID:20471697 PMID:10713364 PMID:19628284
RGD:13204754 , RGD:13204848 , RGD:13204826 , RGD:13204795
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
N
Mog
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chrNW_004624754:25,397,191...25,412,123
Ensembl chrNW_004624754:25,397,144...25,411,319
G
G
MOG
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr17:42,947,174...42,963,046
Ensembl chr17:42,947,279...42,962,159
G
P
MOG
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr 7:22,595,565...22,606,137
Ensembl chr 7:22,595,510...22,610,817
G
S
Mog
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chrNW_004936723:1,070,071...1,112,487
Ensembl chrNW_004936723:1,070,117...1,081,323
G
D
MOG
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr35:26,256,311...26,267,357
Ensembl chr35:26,256,489...26,266,832
G
B
MOG
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr 6:29,461,174...29,476,362
Ensembl chr 6:30,119,599...30,134,152
G
C
Mog
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chrNW_004955583:136,077...150,597
Ensembl chrNW_004955583:136,077...150,649
G
R
Mog
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr20:1,513,137...1,523,473
Ensembl chr20:1,513,239...1,523,474
G
M
Mog
myelin oligodendrocyte glycoprotein
ISO
RGD
PMID:17142321
RGD:9685374
NCBI chr17:37,321,632...37,334,290
Ensembl chr17:37,321,635...37,334,290
G
H
MOG
myelin oligodendrocyte glycoprotein
IDA
RGD
PMID:17142321
RGD:9685374
NCBI chr 6:29,657,092...29,672,365
Ensembl chr 6:29,657,002...29,672,372
G
N
Mphosph9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chrNW_004624747:23,120,950...23,184,250
Ensembl chrNW_004624747:23,125,413...23,181,151
G
G
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr11:118,496,485...118,576,904
Ensembl chr11:118,495,466...118,574,162
G
P
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr14:29,659,027...29,726,756
Ensembl chr14:29,659,034...29,724,461
G
S
Mphosph9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chrNW_004936558:1,483,112...1,536,804
Ensembl chrNW_004936558:1,485,361...1,535,071
G
D
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr26:6,308,313...6,379,937
Ensembl chr26:6,310,878...6,376,170
G
B
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr12:120,755,760...120,831,536
Ensembl chr12:124,991,210...125,065,203
G
C
Mphosph9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chrNW_004955482:5,606,556...5,666,718
Ensembl chrNW_004955482:5,613,021...5,671,074
G
R
Mphosph9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr12:32,275,449...32,346,097
Ensembl chr12:32,275,558...32,342,392
G
M
Mphosph9
M-phase phosphoprotein 9
susceptibility
ISO
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr 5:124,389,022...124,466,001
Ensembl chr 5:124,389,022...124,466,035
G
H
MPHOSPH9
M-phase phosphoprotein 9
susceptibility
IAGP
DNA:snp:intron:122222678G>T rs1790100 (human)
RGD
PMID:19879194
RGD:2316985
NCBI chr12:123,152,324...123,244,002
Ensembl chr12:123,152,320...123,244,014
G
P
MT-ATP6
mitochondrially encoded ATP synthase membrane subunit 6
ISO
DNA:transition:cds:m.9055A>G (human) DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human)
RGD
PMID:17619138 PMID:18708297
RGD:5490259 RGD:5490263
NCBI chr MT:9,120...9,800
Ensembl chr MT:9,120...9,800
G
D
MT-ATP6
mitochondrially encoded ATP synthase membrane subunit 6
ISO
DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human) DNA:transition:cds:m.9055A>G (human)
RGD
PMID:17619138 PMID:18708297
RGD:5490259 RGD:5490263
NCBI chr MT:7,964...8,644
Ensembl chr MT:7,964...8,644
G
R
Mt-atp6
mitochondrially encoded ATP synthase membrane subunit 6
ISO
DNA:transition:cds:m.9055A>G (human) DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human)
RGD
PMID:18708297 PMID:17619138
RGD:5490259 , RGD:5490263
NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
G
M
mt-Atp6
ATP synthase 6, mitochondrial
ISO
DNA:transition:cds:m.9055A>G (human) DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human)
RGD
PMID:18708297 PMID:17619138
RGD:5490259 , RGD:5490263
NCBI chr MT:7,927...8,607
Ensembl chr MT:7,927...8,607
G
H
MT-ATP6
mitochondrially encoded ATP synthase membrane subunit 6
IAGP
DNA:transition:cds:m.9055A>G (human) DNA:point mutations: :m.8697G>A, m.8684C>T, m.8856G>A (human)
RGD
PMID:18708297 PMID:17619138
RGD:5490259 , RGD:5490263
NCBI chr MT:8,527...9,207
Ensembl chr MT:8,527...9,207
G
P
MT-ATP8
mitochondrially encoded ATP synthase membrane subunit 8
ISO
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:8,959...9,162
Ensembl chr MT:8,959...9,162
G
D
MT-ATP8
mitochondrially encoded ATP synthase membrane subunit 8
ISO
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:7,803...8,006
Ensembl chr MT:7,803...8,006
G
R
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
ISO
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
M
mt-Atp8
ATP synthase 8, mitochondrial
ISO
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969
G
H
MT-ATP8
mitochondrially encoded ATP synthase membrane subunit 8
IAGP
DNA:point mutation: :m.8406C>T (human)
RGD
PMID:17619138
RGD:5490263
NCBI chr MT:8,366...8,572
Ensembl chr MT:8,366...8,572
G
P
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:3,922...4,876
Ensembl chr MT:3,922...4,876
G
D
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:2,747...3,702
Ensembl chr MT:2,747...3,703
G
R
Mt-nd1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
ISO
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
G
M
mt-Nd1
NADH dehydrogenase 1, mitochondrial
ISO
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:2,751...3,707
Ensembl chr MT:2,751...3,707
G
H
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
IEP
DNA:amplification:cds:cerebral gray matter (human)
RGD
PMID:18566918
RGD:5490252
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
G
D
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
ISO
DNA:SNP::m.4917A>G
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:3,914...4,955
Ensembl chr MT:3,914...4,957
G
R
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
ISO
DNA:SNP::m.4917A>G (human)
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
M
mt-Nd2
NADH dehydrogenase 2, mitochondrial
ISO
DNA:SNP::m.4917A>G (human)
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
G
H
MT-ND2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
IAGP
DNA:SNP::m.4917A>G
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:4,470...5,511
Ensembl chr MT:4,470...5,511
G
N
Nabp1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624854:4,512,692...4,520,684
G
G
NABP1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr10:77,210,624...77,222,340
Ensembl chr10:77,210,702...77,218,289
G
P
NABP1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:96,313,884...96,322,108
Ensembl chr15:96,313,903...96,335,191
G
S
Nabp1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936506:6,608,333...6,616,076
G
D
NABP1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr37:2,157,357...2,163,812
Ensembl chr37:2,157,356...2,161,091
G
B
NABP1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr2B:78,980,156...78,989,309
Ensembl chr2B:196,895,166...196,903,977
G
C
Nabp1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955403:7,603,002...7,610,925
Ensembl chrNW_004955403:7,604,144...7,611,042
G
R
Nabp1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:50,098,552...50,133,982
Ensembl chr 9:50,126,726...50,134,107
G
M
Nabp1
nucleic acid binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:51,504,127...51,517,634
Ensembl chr 1:51,505,021...51,517,584
G
H
NABP1
nucleic acid binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:191,678,136...191,686,943
Ensembl chr 2:191,678,068...191,741,097
G
P
ND2
NADH dehydrogenase subunit 2
ISO
DNA:SNP::m.4917A>G
RGD
PMID:18708297
RGD:5490259
NCBI chr MT:5,087...6,128
Ensembl chr MT:5,087...6,128
G
N
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chrNW_004624794:172,543...189,031
Ensembl chrNW_004624794:172,707...185,073
G
G
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr20:2,767,864...2,780,336
Ensembl chr20:2,768,064...2,780,704
G
P
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr 4:89,246,958...89,257,090
Ensembl chr 4:89,246,960...89,257,085
G
S
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chrNW_004936903:503,633...514,235
Ensembl chrNW_004936903:499,300...514,893
G
D
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr38:21,271,603...21,281,140
Ensembl chr38:21,271,675...21,285,279
G
B
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr 1:136,609,822...136,626,851
Ensembl chr 1:140,526,690...140,538,705
G
C
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chrNW_004955468:12,961,873...12,971,278
Ensembl chrNW_004955468:12,961,915...12,971,095
G
R
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr13:83,654,402...83,671,474
Ensembl chr13:83,654,406...83,671,420
G
M
Ndufs2
NADH:ubiquinone oxidoreductase core subunit S2
ISO
RGD
PMID:18682780
RGD:6482255
NCBI chr 1:171,062,426...171,078,956
Ensembl chr 1:171,062,422...171,078,957
G
H
NDUFS2
NADH:ubiquinone oxidoreductase core subunit S2
IAGP
RGD
PMID:18682780
RGD:6482255
NCBI chr 1:161,197,417...161,214,395
Ensembl chr 1:161,197,104...161,214,723
G
N
Nectin2
nectin cell adhesion molecule 2
no_association severity
ISO
DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:c.89-104C>T (rs394221) (human)
RGD CTD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chrNW_004624907:1,713,786...1,739,158
Ensembl chrNW_004624907:1,713,443...1,740,627
G
G
NECTIN2
nectin cell adhesion molecule 2
severity no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chr 6:38,320,791...38,361,419
Ensembl chr 6:38,320,933...38,361,742
G
P
NECTIN2
nectin cell adhesion molecule 2
severity no_association
ISO
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chr 6:51,317,386...51,358,665
G
S
Nectin2
nectin cell adhesion molecule 2
no_association severity
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple DNA:polymorphism:intron:c.89-104C>T (rs394221) (human)
CTD RGD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chrNW_004936706:1,470,910...1,498,986
Ensembl chrNW_004936706:1,470,738...1,498,993
G
D
NECTIN2
nectin cell adhesion molecule 2
severity no_association
ISO
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chr 1:110,543,140...110,569,168
Ensembl chr 1:110,543,247...110,569,143
G
B
NECTIN2
nectin cell adhesion molecule 2
no_association severity
ISO
DNA:SNPs: :multiple DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chr19:41,794,037...41,837,047
Ensembl chr19:50,399,668...50,443,024
G
C
Nectin2
nectin cell adhesion molecule 2
severity no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:17376543
RGD:6767558 RGD:6767565
NCBI chrNW_004955555:1,959,702...1,985,679
G
R
Nectin2
nectin cell adhesion molecule 2
severity no_association
ISO
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:16738668 PMID:17376543
RGD:6767558 , RGD:6767565
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
M
Nectin2
nectin cell adhesion molecule 2
severity no_association
ISO
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:16738668 PMID:17376543
RGD:6767558 , RGD:6767565
NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408
G
H
NECTIN2
nectin cell adhesion molecule 2
severity no_association
IAGP EXP
DNA:polymorphism:intron:c.89-104C>T (rs394221) (human) CTD Direct Evidence: marker/mechanism DNA:SNPs: :multiple
CTD RGD
PMID:16738668 PMID:16738668 PMID:17376543
RGD:6767558 , RGD:6767565
NCBI chr19:44,846,297...44,889,223
Ensembl chr19:44,846,175...44,889,223
G
N
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624756:14,663,114...14,850,132
Ensembl chrNW_004624756:14,737,054...14,850,708
G
G
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:60,759,411...60,959,558
Ensembl chr17:60,911,264...60,959,603
G
P
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 7:7,807,042...8,093,553
Ensembl chr 7:7,807,044...7,914,061
G
S
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936534:1,816,755...1,863,200
Ensembl chrNW_004936534:1,760,142...1,863,565
G
D
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr35:10,852,334...11,033,656
Ensembl chr35:10,854,295...10,964,650
G
B
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:11,022,321...11,071,747
Ensembl chr 6:11,297,701...11,420,186
G
C
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955465:3,101,409...3,281,481
Ensembl chrNW_004955465:3,129,707...3,282,632
G
R
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
M
Nedd9
neural precursor cell expressed, developmentally down-regulated gene 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:41,463,392...41,640,836
Ensembl chr13:41,463,057...41,640,838
G
H
NEDD9
neural precursor cell expressed, developmentally down-regulated 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
G
N
Nefh
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chrNW_004624747:5,806,576...5,816,158
Ensembl chrNW_004624747:5,806,645...5,815,554
G
G
NEFH
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr19:12,357,982...12,375,449
G
P
NEFH
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr14:46,559,698...46,568,686
Ensembl chr14:46,559,860...46,568,088
G
S
Nefh
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chrNW_004936657:3,443,406...3,453,096
Ensembl chrNW_004936657:3,443,485...3,453,133
G
D
NEFH
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr26:22,726,523...22,735,129
Ensembl chr26:22,726,526...22,735,125
G
B
NEFH
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr22:10,525,738...10,536,788
G
C
Nefh
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chrNW_004955455:3,735,330...3,744,714
Ensembl chrNW_004955455:3,735,410...3,744,107
G
R
Nefh
neurofilament heavy chain
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
M
Nefh
neurofilament, heavy polypeptide
severity
ISO
RGD
PMID:16764346
RGD:27226808
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
H
NEFH
neurofilament heavy chain
severity
IEP
RGD
PMID:16764346
RGD:27226808
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
N
Nefl
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chrNW_004624758:20,063,109...20,068,459
Ensembl chrNW_004624758:20,062,685...20,068,609
G
G
NEFL
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chr 8:23,077,085...23,083,213
Ensembl chr 8:23,077,086...23,083,222
G
P
NEFL
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chr14:8,991,321...8,996,900
Ensembl chr14:8,991,331...8,997,112
G
S
Nefl
neurofilament light chain
disease_progression
ISO
protein:increased expression:serum (human) protein:increased expresssion:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chrNW_004936757:1,642,122...1,646,499
Ensembl chrNW_004936757:1,642,222...1,645,697
G
D
NEFL
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chr25:32,463,361...32,468,965
Ensembl chr25:32,463,452...32,467,224
G
B
NEFL
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chr 8:24,218,510...24,224,627
Ensembl chr 8:21,134,533...21,140,694
G
C
Nefl
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 RGD:127285024
NCBI chrNW_004955403:47,946,413...47,951,734
Ensembl chrNW_004955403:47,946,353...47,952,026
G
R
Nefl
neurofilament light chain
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 , RGD:127285024
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
M
Nefl
neurofilament, light polypeptide
disease_progression
ISO
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 , RGD:127285024
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
H
NEFL
neurofilament light chain
disease_progression
IEP
protein:increased expresssion:serum (human) protein:increased expression:serum (human)
RGD
PMID:31383792 PMID:33317883
RGD:127284875 , RGD:127285024
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
N
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chrNW_004624795:5,623,686...5,639,545
Ensembl chrNW_004624795:5,623,700...5,639,655
G
G
NGFR
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr16:69,894,000...69,914,209
Ensembl chr16:69,894,139...69,912,189
G
P
NGFR
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr12:25,699,410...25,720,355
Ensembl chr12:25,699,427...25,720,356
G
S
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chrNW_004936490:12,038,500...12,057,257
Ensembl chrNW_004936490:12,035,769...12,057,263
G
D
NGFR
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr 9:25,598,468...25,621,021
Ensembl chr 9:25,601,074...25,623,274
G
B
NGFR
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr17:8,089,600...8,109,361
Ensembl chr17:8,075,316...8,094,966
G
C
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chrNW_004955451:12,030,303...12,047,305
Ensembl chrNW_004955451:12,030,252...12,047,305
G
R
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages (human)
RGD
PMID:11829348
RGD:5508481
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
M
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
ISO
protein:increased expression:reactive astrocytes, microglia/macrophages (human)
RGD
PMID:11829348
RGD:5508481
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
G
H
NGFR
nerve growth factor receptor
IEP
protein:increased expression:reactive astrocytes, microglia/macrophages
RGD
PMID:11829348
RGD:5508481
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
N
Nlrp3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004624937:564,191...584,470
G
G
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr25:84,431,436...84,463,387
Ensembl chr25:84,434,527...84,463,249
G
P
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
G
S
Nlrp3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004936864:709,693...732,119
Ensembl chrNW_004936864:709,709...731,718
G
D
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 8:251,776...313,290
Ensembl chr 8:253,407...313,059
G
B
NLRP3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 1:223,052,307...223,084,736
Ensembl chr 1:228,505,147...228,537,216
G
C
Nlrp3
NLR family pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chrNW_004955581:597,952...616,903
Ensembl chrNW_004955581:597,667...617,410
G
R
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
M
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
H
NLRP3
NLR family pyrin domain containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25458313
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
G
N
Nono
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chrNW_004624903:1,562,818...1,583,648
Ensembl chrNW_004624903:1,562,743...1,586,985
G
G
NONO
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:61,082,923...61,110,895
G
S
Nono
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chrNW_004936762:322,413...343,126
Ensembl chrNW_004936762:321,280...341,537
G
D
NONO
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:55,618,032...55,632,237
Ensembl chr X:55,618,095...55,631,388
G
B
NONO
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:60,547,277...60,564,845
Ensembl chr X:70,602,456...70,619,956
G
C
Nono
non-POU domain containing octamer binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chrNW_004955475:10,833,514...10,853,460
Ensembl chrNW_004955475:10,833,189...10,853,519
G
R
Nono
non-POU domain containing, octamer-binding
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
G
M
Nono
non-POU-domain-containing, octamer binding protein
ISO
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:100,473,295...100,492,193
Ensembl chr X:100,472,924...100,492,197
G
H
NONO
non-POU domain containing octamer binding
HEP
mRNA:altered expression:peripheral blood mononuclear cell (human)
RGD
PMID:29100048
RGD:156420155
NCBI chr X:71,283,635...71,301,168
Ensembl chr X:71,254,814...71,301,522
G
N
Notch4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chrNW_004624754:24,108,661...24,128,053
G
G
NOTCH4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr17:39,806,864...39,837,101
Ensembl chr17:39,808,035...39,837,365
G
P
NOTCH4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr 7:24,231,293...24,256,281
Ensembl chr 7:24,231,293...24,256,281
G
S
Notch4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chrNW_004936727:1,386,842...1,409,823
G
D
NOTCH4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr12:1,585,249...1,608,721
Ensembl chr12:1,587,918...1,607,760
G
B
NOTCH4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr 6:31,842,233...31,871,412
Ensembl chr 6:32,722,112...32,750,978
G
C
Notch4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chrNW_004955437:658,076...679,338
G
R
Notch4
notch receptor 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
M
Notch4
notch 4
ISO
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
G
H
NOTCH4
notch receptor 4
IAGP
DNA: snps: cds: rs422951
RGD
PMID:21654846
RGD:6480692
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
G
N
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chrNW_004624767:1,459,601...1,473,224
Ensembl chrNW_004624767:1,459,601...1,467,795
G
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr 1:18,041,495...18,061,196
Ensembl chr 1:18,041,830...18,051,501
G
P
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr 2:15,315,283...15,336,785
Ensembl chr 2:15,315,282...15,334,820
G
S
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chrNW_004936562:1,937,665...1,946,680
Ensembl chrNW_004936562:1,937,667...1,946,669
G
D
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr18:42,333,173...42,346,152
Ensembl chr18:42,333,202...42,341,236
G
B
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr11:47,195,122...47,215,277
Ensembl chr11:47,748,353...47,768,672
G
C
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
G
R
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
M
Nr1h3
nuclear receptor subfamily 1, group H, member 3
ISO
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
G
H
NR1H3
nuclear receptor subfamily 1 group H member 3
IAGP
ClinVar Annotator: match by term: Multiple sclerosis
ClinVar
PMID:27253448
NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
G
N
P2rx7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chrNW_004624747:21,725,813...21,768,123
Ensembl chrNW_004624747:21,725,395...21,759,453
G
G
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr11:116,505,975...116,560,151
Ensembl chr11:116,529,346...116,563,059
G
P
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr14:31,415,188...31,476,502
Ensembl chr14:31,415,193...31,476,472
G
S
P2rx7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chrNW_004936558:3,106,819...3,149,689
Ensembl chrNW_004936558:3,108,283...3,149,765
G
D
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr26:7,928,863...7,983,956
Ensembl chr26:7,940,985...7,983,740
G
B
P2RX7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr12:118,731,761...118,786,039
Ensembl chr12:122,102,888...122,154,068
G
C
P2rx7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chrNW_004955482:7,048,674...7,087,525
Ensembl chrNW_004955482:7,048,776...7,086,926
G
R
P2rx7
purinergic receptor P2X 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
M
P2rx7
purinergic receptor P2X, ligand-gated ion channel, 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
G
H
P2RX7
purinergic receptor P2X 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17728465
NCBI chr12:121,132,876...121,188,032
Ensembl chr12:121,132,819...121,188,032
G
N
Pdcd1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chrNW_004624847:5,732,922...5,741,908
Ensembl chrNW_004624847:5,732,767...5,742,269
G
G
PDCD1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chr10:127,877,383...127,886,234
Ensembl chr10:127,878,554...127,886,088
G
P
PDCD1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chr15:140,337,353...140,347,493
Ensembl chr15:140,336,258...140,347,478
G
S
Pdcd1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chrNW_004936745:152,571...163,712
Ensembl chrNW_004936745:152,612...161,587
G
D
PDCD1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chr25:51,606,559...51,618,903
Ensembl chr25:51,608,173...51,618,723
G
B
PDCD1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chr12:130,849,353...130,858,776
G
C
Pdcd1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression
ClinVar OMIM
PMID:12402038 PMID:15912506
NCBI chrNW_004955542:49,290...57,747
Ensembl chrNW_004955542:49,259...58,823
G
R
Pdcd1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12402038 PMID:15912506
NCBI chr 9:94,418,786...94,431,945
Ensembl chr 9:94,418,791...94,431,937
G
M
Pdcd1
programmed cell death 1
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12402038 PMID:15912506
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
H
PDCD1
programmed cell death 1
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Multiple sclerosis modifier of disease progression CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12402038 PMID:15912506
NCBI chr 2:241,849,884...241,858,894
Ensembl chr 2:241,849,884...241,858,894
G
N
Phactr2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chrNW_004624753:10,456,910...10,742,311
G
G
PHACTR2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr13:29,401,562...29,702,719
Ensembl chr13:29,401,382...29,560,452
G
P
PHACTR2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 1:21,438,744...21,723,255
Ensembl chr 1:21,443,970...21,722,922
G
S
Phactr2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chrNW_004936625:2,336,455...2,474,032
Ensembl chrNW_004936625:2,343,821...2,538,326
G
D
PHACTR2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 1:35,158,678...35,348,875
Ensembl chr 1:35,088,248...35,342,584
G
B
PHACTR2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 6:141,312,850...141,602,868
Ensembl chr 6:146,174,399...146,323,625
G
C
Phactr2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chrNW_004955436:16,607,279...16,690,412
Ensembl chrNW_004955436:16,619,552...16,694,053
G
R
Phactr2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
G
M
Phactr2
phosphatase and actin regulator 2
ISO
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr10:13,083,461...13,350,266
Ensembl chr10:13,083,461...13,350,156
G
H
PHACTR2
phosphatase and actin regulator 2
IAGP
DNA: snp: : rs1015340
RGD
PMID:20546594
RGD:6483093
NCBI chr 6:143,536,878...143,831,185
Ensembl chr 6:143,536,845...143,831,185
G
N
Pla2g7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chrNW_004624754:13,905,084...13,932,366
Ensembl chrNW_004624754:13,904,797...13,931,670
G
G
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr17:25,538,645...25,571,230
Ensembl chr17:25,538,438...25,574,269
G
P
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr 7:41,488,152...41,531,383
Ensembl chr 7:41,486,598...41,531,345
G
S
Pla2g7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chrNW_004936476:13,609,847...13,646,174
Ensembl chrNW_004936476:13,609,374...13,649,998
G
D
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr12:14,866,229...14,908,230
Ensembl chr12:14,866,229...14,908,114
G
B
PLA2G7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr 6:46,264,262...46,318,487
Ensembl chr 6:47,558,861...47,590,212
G
C
Pla2g7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chrNW_004955437:11,534,251...11,577,942
Ensembl chrNW_004955437:11,534,173...11,555,996
G
R
Pla2g7
phospholipase A2 group VII
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
M
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
H
PLA2G7
phospholipase A2 group VII
IEP
protein:increased expression:plasma
RGD
PMID:22246459
RGD:6482783
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
N
Pnmt
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chrNW_004624795:3,408,559...3,410,669
Ensembl chrNW_004624795:3,408,627...3,410,304
G
G
PNMT
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr16:66,496,290...66,498,840
Ensembl chr16:66,496,027...66,499,111
G
P
PNMT
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr12:22,648,396...22,651,520
Ensembl chr12:22,648,398...22,649,999
G
S
Pnmt
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chrNW_004936490:14,858,682...14,861,614
Ensembl chrNW_004936490:14,858,603...14,865,321
G
D
PNMT
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr 9:22,808,505...22,810,587
Ensembl chr 9:22,808,601...22,810,551
G
B
PNMT
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr17:17,618,399...17,620,691
Ensembl chr17:17,835,277...17,837,180
G
C
Pnmt
phenylethanolamine N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chrNW_004955451:14,414,836...14,417,972
Ensembl chrNW_004955451:14,416,121...14,417,901
G
R
Pnmt
phenylethanolamine-N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr10:83,383,019...83,386,557
Ensembl chr10:83,384,923...83,386,556
G
M
Pnmt
phenylethanolamine-N-methyltransferase
ISO
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493(human)
RGD
PMID:11958827
RGD:1358561
NCBI chr11:98,277,449...98,279,006
Ensembl chr11:98,277,276...98,279,007
G
H
PNMT
phenylethanolamine N-methyltransferase
IAGP
DNA:snps:5' utr:g.-390G>A, g.-184G>A rs876493 (human)
RGD
PMID:11958827
RGD:1358561
NCBI chr17:39,668,019...39,670,475
Ensembl chr17:39,667,981...39,670,475
G
N
Polg
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chrNW_004624768:16,493,123...16,509,747
Ensembl chrNW_004624768:16,491,555...16,509,900
G
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
P
POLG
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr 7:54,889,150...54,907,167
Ensembl chr 7:54,889,157...54,906,844
G
S
Polg
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chrNW_004936483:15,178,947...15,196,277
Ensembl chrNW_004936483:15,179,342...15,195,258
G
D
POLG
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr 3:52,357,062...52,373,768
Ensembl chr 3:52,357,068...52,421,544
G
B
POLG
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr15:68,008,214...68,028,241
Ensembl chr15:87,214,451...87,234,739
G
C
Polg
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chrNW_004955416:15,773,005...15,788,736
Ensembl chrNW_004955416:15,773,473...15,788,651
G
R
Polg
DNA polymerase gamma, catalytic subunit
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
M
Polg
polymerase (DNA directed), gamma
ISO
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
H
POLG
DNA polymerase gamma, catalytic subunit
IAGP
DNA:missense mutations:cds:
RGD
PMID:20837861
RGD:8694283
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
G
N
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chrNW_004624738:7,442,223...7,448,513
Ensembl chrNW_004624738:7,442,292...7,445,020
G
G
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr14:82,491,296...82,499,289
Ensembl chr14:82,494,323...82,499,447
G
P
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
G
S
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chrNW_004936493:7,060,747...7,065,276
Ensembl chrNW_004936493:7,061,587...7,065,109
G
D
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr17:19,431,396...19,438,247
Ensembl chr17:19,431,585...19,434,440
G
B
POMC
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr2A:25,161,668...25,165,600
Ensembl chr2A:25,258,768...25,262,706
G
C
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
G
R
Pomc
proopiomelanocortin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
M
Pomc
pro-opiomelanocortin-alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
H
POMC
proopiomelanocortin
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:2843795 PMID:9664777
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
N
Prf1
perforin 1
ISO
protein:increased expression:blood, T cell OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human)
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chrNW_004624754:4,679,451...4,681,627
Ensembl chrNW_004624754:4,679,521...4,681,627
G
G
PRF1
perforin 1
ISO
DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 protein:increased expression:blood, T cell
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chr 9:60,692,544...60,698,000
Ensembl chr 9:60,692,600...60,698,465
G
P
PRF1
perforin 1
ISO
DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 protein:increased expression:blood, T cell
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chr14:73,515,306...73,520,256
Ensembl chr14:73,512,769...73,520,202
G
S
Prf1
perforin 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 protein:increased expression:blood, T cell DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human)
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chrNW_004936521:8,057,874...8,060,695
Ensembl chrNW_004936521:8,057,874...8,060,695
G
D
PRF1
perforin 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) protein:increased expression:blood, T cell
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chr 4:21,497,865...21,502,429
Ensembl chr 4:21,498,249...21,500,864
G
B
PRF1
perforin 1
ISO
protein:increased expression:blood, T cell OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human)
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chr10:67,071,141...67,078,057
Ensembl chr10:69,597,574...69,603,070
G
C
Prf1
perforin 1
ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 protein:increased expression:blood, T cell DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human)
RGD MouseDO
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 RGD:6482817 RGD:6482820
NCBI chrNW_004955437:20,700,912...20,705,076
Ensembl chrNW_004955437:20,700,718...20,706,929
G
R
Prf1
perforin 1
ISO ISS
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) protein:increased expression:blood, T cell
MouseDO RGD
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 , RGD:6482820 , RGD:6482817
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
M
Prf1
perforin 1 (pore forming protein)
IMP IAGP ISO
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) protein:increased expression:blood, T cell
MouseDO RGD
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 , RGD:6482820 , RGD:6482817
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
G
H
PRF1
perforin 1
ISO ISS IAGP IEP
OMIM:126200 | OMIM:612594 | OMIM:612595 | OMIM:612596 | OMIM:614810 DNA:SNPs:introns:c.-5+321C>T, c.539+82C>T (rs3758562, rs10999426) (human) protein:increased expression:blood, T cell
MouseDO RGD
PMID:19680139 PMID:20921521 PMID:22001684
RGD:6482805 , RGD:6482820 , RGD:6482817
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
G
N
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chrNW_004624855:430,148...1,992,121
Ensembl chrNW_004624855:430,260...1,989,747
G
G
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr13:88,856,056...90,329,379
G
P
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 1:5,698,508...6,731,132
Ensembl chr 1:5,465,312...6,730,872
G
S
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chrNW_004936489:12,118,538...12,913,664
Ensembl chrNW_004936489:12,120,678...13,327,872
G
D
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 1:49,886,887...51,201,930
Ensembl chr 1:49,889,005...51,201,764
G
B
PRKN
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 6:159,293,016...160,679,106
Ensembl chr 6:164,314,990...165,678,770
G
C
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chrNW_004955439:18,664,230...19,953,358
Ensembl chrNW_004955439:18,664,379...19,951,152
G
R
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
G
M
Prkn
parkin RBR E3 ubiquitin protein ligase
ISO
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
H
PRKN
parkin RBR E3 ubiquitin protein ligase
IEP
protein:increased expression:white matter,astrocyte:
RGD
PMID:19716418
RGD:10412736
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
N
Prnp
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624741:5,785,139...5,802,162
Ensembl chrNW_004624741:5,785,158...5,802,162
G
G
PRNP
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:33,368,020...33,384,556
Ensembl chr 2:33,369,629...33,370,366
G
P
PRNP
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:13,694,195...13,705,126
Ensembl chr17:13,694,190...13,705,124
G
S
Prnp
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936485:14,104,829...14,118,614
Ensembl chrNW_004936485:14,104,831...14,118,629
G
D
PRNP
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr24:16,845,224...16,862,319
Ensembl chr24:16,846,207...16,859,815
G
B
PRNP
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:4,713,616...4,728,847
Ensembl chr20:4,523,155...4,523,916
G
C
Prnp
prion protein (Kanno blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955415:15,442,313...15,454,644
Ensembl chrNW_004955415:15,442,313...15,454,644
G
R
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
G
M
Prnp
prion protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349
G
H
PRNP
prion protein (Kanno blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
G
N
Psmb9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chrNW_004624754:23,811,008...23,815,432
Ensembl chrNW_004624754:23,807,272...23,815,417
G
G
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr17:39,246,356...39,251,852
Ensembl chr17:39,245,854...39,251,842
G
P
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr 7:25,072,133...25,077,508
Ensembl chr 7:25,062,367...25,077,523
G
S
Psmb9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chrNW_004936476:25,894,313...25,899,132
Ensembl chrNW_004936476:25,894,027...25,899,319
G
D
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr12:2,432,287...2,438,920
Ensembl chr12:2,432,505...2,438,069
G
B
PSMB9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr 6:32,423,614...32,429,062
Ensembl chr 6:33,539,060...33,564,402
G
C
Psmb9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chrNW_004955437:1,513,425...1,516,164
Ensembl chrNW_004955437:1,513,418...1,516,164
G
R
Psmb9
proteasome 20S subunit beta 9
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
M
Psmb9
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
ISO
RGD
PMID:20174631
RGD:6483446
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
G
H
PSMB9
proteasome 20S subunit beta 9
IAGP
RGD
PMID:20174631
RGD:6483446
NCBI chr 6:32,854,192...32,859,851
Ensembl chr 6:32,844,136...32,859,851
G
N
Ptpn22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chrNW_004624772:9,472,869...9,552,751
Ensembl chrNW_004624772:9,472,913...9,550,990
G
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr20:19,792,807...19,855,784
Ensembl chr20:19,793,083...19,855,827
G
P
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 4:106,692,102...106,758,101
Ensembl chr 4:106,686,604...106,758,099
G
S
Ptpn22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chrNW_004936690:2,180,804...2,232,869
Ensembl chrNW_004936690:2,181,047...2,232,958
G
D
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr17:51,623,628...51,683,039
Ensembl chr17:51,623,623...51,682,858
G
B
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 1:88,685,736...88,743,164
Ensembl chr 1:123,734,511...123,790,830
G
C
Ptpn22
protein tyrosine phosphatase non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chrNW_004955435:17,082,762...17,139,067
G
R
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
M
Ptpn22
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
no_association
ISO
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563
G
H
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
IAGP
DNA:missense mutation: :R620W (rs2476601) (human)
RGD
PMID:15934099
RGD:6484550
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
N
Ptprc
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chrNW_004624798:1,700,732...1,814,603
Ensembl chrNW_004624798:1,699,541...1,814,656
G
G
PTPRC
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr25:30,655,014...30,777,367
Ensembl chr25:30,653,044...30,777,303
G
P
PTPRC
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr10:21,482,984...21,601,627
Ensembl chr10:21,560,073...21,601,308
G
S
Ptprc
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chrNW_004936567:5,266,653...5,378,464
Ensembl chrNW_004936567:5,267,615...5,378,258
G
D
PTPRC
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr 7:4,155,876...4,282,151
Ensembl chr 7:4,137,728...4,282,124
G
B
PTPRC
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr 1:174,246,389...174,364,893
Ensembl chr 1:178,556,104...178,672,994
G
C
Ptprc
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chrNW_004955406:35,005,577...35,127,395
Ensembl chrNW_004955406:35,005,214...35,129,552
G
R
Ptprc
protein tyrosine phosphatase, receptor type, C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
M
Ptprc
protein tyrosine phosphatase receptor type C
ISO
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
G
H
PTPRC
protein tyrosine phosphatase receptor type C
IAGP
DNA:snp:exon:c.77C>G (human)
RGD
PMID:11101853
RGD:1358566
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,757,476
G
N
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chrNW_004624755:6,176,497...6,298,034
Ensembl chrNW_004624755:6,176,497...6,298,225
G
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr27:23,911,084...24,023,856
G
P
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 8:19,933,035...20,166,746
Ensembl chr 8:19,922,779...20,166,754
G
S
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chrNW_004936477:3,354,336...3,445,248
Ensembl chrNW_004936477:3,349,627...3,461,797
G
D
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 3:84,060,417...84,286,008
Ensembl chr 3:84,064,440...84,286,360
G
B
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 4:20,719,548...20,835,439
Ensembl chr 4:25,995,263...26,107,683
G
C
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chrNW_004955443:18,783,061...19,029,441
Ensembl chrNW_004955443:18,783,061...18,910,228
G
R
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr14:57,338,493...57,523,330
Ensembl chr14:57,338,507...57,523,353
G
M
Rbpj
recombination signal binding protein for immunoglobulin kappa J region
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 5:53,713,121...53,814,787
Ensembl chr 5:53,623,494...53,814,704
G
H
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:25853421
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
G
N
Rgma
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chrNW_004624768:10,739,674...10,778,036
Ensembl chrNW_004624768:10,751,991...10,778,050
G
G
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr29:11,592,929...11,638,955
Ensembl chr29:11,592,604...11,638,860
G
P
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr 7:85,921,524...85,968,887
Ensembl chr 7:85,921,594...85,968,888
G
S
Rgma
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chrNW_004936483:9,753,112...9,792,817
Ensembl chrNW_004936483:9,766,275...9,793,001
G
D
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr 3:47,044,342...47,089,923
Ensembl chr 3:47,061,910...47,089,294
G
B
RGMA
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr15:71,728,669...71,774,447
Ensembl chr15:90,922,199...90,956,179
G
C
Rgma
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chrNW_004955416:21,221,023...21,261,831
Ensembl chrNW_004955416:21,221,023...21,261,831
G
R
Rgma
repulsive guidance molecule BMP co-receptor a
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
G
M
Rgma
repulsive guidance molecule family member A
ISO
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr 7:73,025,268...73,069,647
Ensembl chr 7:73,025,257...73,069,647
G
H
RGMA
repulsive guidance molecule BMP co-receptor a
IAGP
DNA:SNPs:intron: (rs997941, rs34925346) (human)
RGD
PMID:20072140
RGD:6892695
NCBI chr15:93,035,271...93,089,211
Ensembl chr15:93,035,271...93,089,211
G
N
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chrNW_004624730:3,316,122...3,361,820
G
G
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr22:10,757,381...10,809,257
Ensembl chr22:10,757,337...10,772,704
G
P
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr13:31,918,484...31,991,207
Ensembl chr13:31,918,834...31,986,607
G
S
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chrNW_004936529:1,000,050...1,045,655
Ensembl chrNW_004936529:999,935...1,045,681
G
D
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr20:39,824,552...39,888,089
Ensembl chr20:39,824,575...39,887,215
G
B
RHOA
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 3:49,282,009...49,339,887
G
C
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chrNW_004955532:1,300,821...1,347,453
Ensembl chrNW_004955532:1,300,462...1,347,451
G
R
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
M
Rhoa
ras homolog family member A
ISO
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
H
RHOA
ras homolog family member A
IEP
protein:increased expression:microglial cell, brain
RGD
PMID:17983427
RGD:2298887
NCBI chr 3:49,359,145...49,411,976
Ensembl chr 3:49,359,139...49,412,998
G
N
Rnf19a
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624763:7,153,382...7,209,622
Ensembl chrNW_004624763:7,152,396...7,209,652
G
G
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 8:95,107,679...95,161,592
Ensembl chr 8:95,105,016...95,139,012
G
P
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 4:36,654,197...36,727,514
Ensembl chr 4:36,635,285...36,725,638
G
S
Rnf19a
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936470:42,965,790...43,007,487
Ensembl chrNW_004936470:42,965,284...43,007,487
G
D
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:2,142,126...2,170,530
Ensembl chr13:2,142,876...2,169,944
G
B
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 8:96,897,388...96,950,440
Ensembl chr 8:99,070,813...99,123,495
G
C
Rnf19a
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955417:15,492,056...15,543,591
Ensembl chrNW_004955417:15,492,056...15,543,591
G
R
Rnf19a
ring finger protein 19A, RBR E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 7:67,425,833...67,465,214
Ensembl chr 7:67,425,837...67,465,222
G
M
Rnf19a
ring finger protein 19A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr15:36,240,080...36,283,293
Ensembl chr15:36,240,079...36,283,293
G
H
RNF19A
ring finger protein 19A, RBR E3 ubiquitin protein ligase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 8:100,257,067...100,336,204
Ensembl chr 8:100,257,060...100,336,218
G
N
Rnf217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chrNW_004624798:6,390,200...6,499,471
G
G
RNF217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr13:48,612,687...48,743,821
G
P
RNF217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 1:37,784,359...37,912,122
Ensembl chr 1:37,788,472...37,912,122
G
S
Rnf217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chrNW_004936639:4,295,293...4,325,468
G
D
RNF217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 1:63,902,985...64,094,491
Ensembl chr 1:63,962,515...64,085,011
G
B
RNF217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 6:122,747,128...122,875,930
Ensembl chr 6:126,867,604...126,992,867
G
C
Rnf217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chrNW_004955436:6,458,088...6,566,112
G
R
Rnf217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 1:26,016,668...26,108,736
Ensembl chr 1:26,015,728...26,108,736
G
M
Rnf217
ring finger protein 217
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr10:31,377,883...31,485,721
Ensembl chr10:31,369,189...31,485,180
G
H
RNF217
ring finger protein 217
IAGP
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to
ClinVar
NCBI chr 6:124,962,437...125,092,634
Ensembl chr 6:124,962,437...125,092,633
G
R
RT1-Ba
RT1 class II, locus Ba
susceptibility
ISO
DNA:polymorphism (human)
RGD
PMID:21741664
RGD:5147555
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
R
RT1-Bb
RT1 class II, locus Bb
susceptibility
ISO
DNA:polymorphism (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:cds:HLA-DQB1*06 (human)
OMIM CTD RGD
PMID:21741664 PMID:21908482 PMID:20463743
RGD:5147555 , RGD:7421588 , RGD:5147658
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
R
RT1-Da
RT1 class II, locus Da
ISO
DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter (human)
CTD RGD
PMID:17660530 PMID:19834503 PMID:10527398
RGD:5490202 , RGD:5490204
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
R
RT1-Db1
RT1 class II, locus Db1
susceptibility onset
ISO
DNA:polymorphism: :HLA-DRB*1501 (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :multiple (human) DNA:polymorphism: :HLA-DRB1*0801 (human) DNA:polymorphisms: :HLA-DRB1*11, HLA-DRB1*15 (human)
OMIM CTD RGD
PMID:25911099 PMID:21741664 PMID:20207784 PMID:20580995 PMID:21440682 PMID:21664963 More...
RGD:5147555 , RGD:5147580 , RGD:5147573 , RGD:5147564 , RGD:5147559
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
R
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :HLA-DPB1*02, HLA-DPB1*03, HLA-DPB1*04 (human)
CTD RGD
PMID:17956852 PMID:32560041
RGD:150429806
NCBI chr20:4,775,598...4,779,590
Ensembl chr20:4,774,650...4,780,618
G
N
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004624826:7,624,852...7,635,330
Ensembl chrNW_004624826:7,626,380...7,635,309
G
G
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr25:59,305,610...59,333,789
Ensembl chr25:59,322,913...59,330,668
G
P
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 4:81,289,061...81,299,657
G
S
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004936481:16,915,203...16,921,840
Ensembl chrNW_004936481:16,915,182...16,921,840
G
D
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 7:28,888,503...28,898,787
Ensembl chr 7:28,888,197...28,898,786
G
B
SELE
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:145,205,684...145,217,143
Ensembl chr 1:148,930,437...148,938,313
G
C
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004955462:7,564,437...7,575,297
G
R
Sele
selectin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
M
Sele
selectin, endothelial cell
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
H
SELE
selectin E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
G
N
Sh2d2a
SH2 domain containing 2A
susceptibility
ISO
DNA:polymorphism:promoter DNA:repeat:promoter:-341(GA)13-33 (human)
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chrNW_004624885:1,951,442...1,960,292
Ensembl chrNW_004624885:1,952,387...1,960,424
G
G
SH2D2A
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chr20:7,052,170...7,063,262
Ensembl chr20:7,052,797...7,062,324
G
P
SH2D2A
SH2 domain containing 2A
susceptibility
ISO
DNA:polymorphism:promoter DNA:repeat:promoter:-341(GA)13-33 (human)
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chr 4:93,282,383...93,293,214
Ensembl chr 4:93,282,413...93,293,205
G
S
Sh2d2a
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chrNW_004936580:5,959,971...5,967,250
Ensembl chrNW_004936580:5,961,000...5,966,677
G
D
SH2D2A
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chr 7:41,186,721...41,195,987
Ensembl chr 7:41,186,252...41,195,122
G
B
SH2D2A
SH2 domain containing 2A
susceptibility
ISO
DNA:polymorphism:promoter DNA:repeat:promoter:-341(GA)13-33 (human)
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chr 1:132,149,450...132,160,280
Ensembl chr 1:135,972,824...135,981,754
G
C
Sh2d2a
SH2 domain containing 2A
susceptibility
ISO
DNA:polymorphism:promoter DNA:repeat:promoter:-341(GA)13-33 (human)
RGD
PMID:11528519 PMID:18554728
RGD:1358573 RGD:2298871
NCBI chrNW_004955545:2,881,954...2,891,021
Ensembl chrNW_004955545:2,881,563...2,891,509
G
R
Sh2d2a
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:18554728 PMID:11528519
RGD:2298871 , RGD:1358573
NCBI chr 2:173,312,253...173,318,810
Ensembl chr 2:173,312,253...173,318,810
G
M
Sh2d2a
SH2 domain containing 2A
susceptibility
ISO
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:18554728 PMID:11528519
RGD:2298871 , RGD:1358573
NCBI chr 3:87,754,070...87,763,116
Ensembl chr 3:87,754,062...87,763,029
G
H
SH2D2A
SH2 domain containing 2A
susceptibility
IAGP
DNA:repeat:promoter:-341(GA)13-33 (human) DNA:polymorphism:promoter
RGD
PMID:11528519 PMID:18554728
RGD:1358573 , RGD:2298871
NCBI chr 1:156,806,243...156,816,848
Ensembl chr 1:156,806,243...156,816,848
G
N
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004624800:2,202,986...2,215,309
Ensembl chrNW_004624800:2,203,393...2,212,068
G
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr21:123,929,937...123,942,451
Ensembl chr21:123,932,900...123,942,395
G
P
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr18:2,546,202...2,555,484
Ensembl chr18:2,545,994...2,555,484
G
S
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004936527:10,033,095...10,042,713
Ensembl chrNW_004936527:10,033,299...10,042,599
G
D
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr16:18,650,553...18,663,571
Ensembl chr16:18,484,809...18,662,903
G
B
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 7:147,400,112...147,414,036
Ensembl chr 7:159,114,666...159,126,651
G
C
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chrNW_004955491:8,647,133...8,657,381
G
R
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
M
Shh
sonic hedgehog
ISO
RGD
PMID:18991353
RGD:12801440
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
H
SHH
sonic hedgehog signaling molecule
IEP
RGD
PMID:18991353
RGD:12801440
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
P
SLA-DRA
MHC class II DR-alpha
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:3' utr:c.*406+228A>G (rs3135388) (human) DNA:polymorphism:promoter (human) DNA:SNPs: :multiple (human)
CTD RGD
PMID:10527398 PMID:17660530 PMID:19834503
RGD:5490159 RGD:5490202 RGD:5490204
NCBI chr 7:24,825,037...24,830,650
Ensembl chr 7:24,825,054...24,835,158
G
N
Slc11a1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chrNW_004624823:6,612,452...6,625,047
Ensembl chrNW_004624823:6,612,452...6,625,300
G
G
SLC11A1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chr10:104,276,553...104,288,466
G
P
SLC11A1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chr15:120,434,100...120,446,396
Ensembl chr15:120,433,952...120,446,396
G
S
Slc11a1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chrNW_004936569:888,309...895,991
Ensembl chrNW_004936569:887,742...895,977
G
D
SLC11A1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human) DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chr37:25,039,203...25,047,461
Ensembl chr37:25,038,360...25,047,282
G
B
SLC11A1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941
G
C
Slc11a1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
RGD CTD
PMID:15584484 PMID:16597321 PMID:18973068
RGD:5684937 RGD:5684960
NCBI chrNW_004955453:14,980,562...14,995,118
Ensembl chrNW_004955453:14,980,562...14,995,608
G
R
Slc11a1
solute carrier family 11 member 1
no_association
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
CTD RGD
PMID:16597321 PMID:18973068 PMID:15584484
RGD:5684937 , RGD:5684960
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
M
Slc11a1
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1
no_association
ISO
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
CTD RGD
PMID:16597321 PMID:18973068 PMID:15584484
RGD:5684937 , RGD:5684960
NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221
G
H
SLC11A1
solute carrier family 11 member 1
no_association
IAGP EXP
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism DNA:repeat, polymorphism, deletions:promoter, cds:p.D543N (human)
CTD RGD
PMID:16597321 PMID:18973068 PMID:15584484
RGD:5684937 , RGD:5684960
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
N
Spp1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chrNW_004624872:4,505,796...4,513,247
Ensembl chrNW_004624872:4,505,522...4,513,742
G
G
SPP1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
G
P
SPP1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chr 8:131,077,786...131,085,334
Ensembl chr 8:131,077,786...131,085,340
G
S
Spp1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chrNW_004936905:148,956...156,023
Ensembl chrNW_004936905:148,945...156,079
G
D
SPP1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chr32:11,354,070...11,362,325
Ensembl chr32:11,353,953...11,362,069
G
B
SPP1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chr 4:80,263,711...80,271,466
Ensembl chr 4:90,988,200...90,995,935
G
C
Spp1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 RGD:1581472
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
R
Spp1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 , RGD:1581472
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
M
Spp1
secreted phosphoprotein 1
ISO
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:11721059 PMID:15885319
RGD:1581329 , RGD:1581472
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
H
SPP1
secreted phosphoprotein 1
IAGP IDA
DNA, protein:SNPs, haplotypes, increased expression:multiple, serum
RGD
PMID:15885319 PMID:11721059
RGD:1581472 , RGD:1581329
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
N
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004624854:4,975,724...5,056,940
Ensembl chrNW_004624854:4,976,507...5,057,391
G
G
STAT4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr10:76,553,626...76,708,540
Ensembl chr10:76,553,606...76,674,928
G
P
STAT4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr15:95,656,206...95,764,099
Ensembl chr15:95,656,077...95,763,472
G
S
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004936506:7,091,982...7,185,938
Ensembl chrNW_004936506:7,095,009...7,184,689
G
D
STAT4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr37:1,566,563...1,685,378
Ensembl chr37:1,566,585...1,829,894
G
B
STAT4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr2B:78,331,402...78,549,231
Ensembl chr2B:196,247,881...196,366,011
G
C
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004955403:8,061,471...8,144,252
Ensembl chrNW_004955403:8,061,471...8,144,276
G
R
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
G
M
Stat4
signal transducer and activator of transcription 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
H
STAT4
signal transducer and activator of transcription 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
G
N
Sys1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624790:9,121,986...9,127,485
Ensembl chrNW_004624790:9,120,280...9,127,567
G
G
SYS1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:18,471,183...18,475,941
Ensembl chr 2:18,472,155...18,475,801
G
P
SYS1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr17:47,686,184...47,694,045
Ensembl chr17:47,686,258...47,694,034
G
S
Sys1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936514:7,518,048...7,529,024
Ensembl chrNW_004936514:7,524,557...7,529,012
G
D
SYS1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr24:32,661,665...32,666,267
Ensembl chr24:32,661,381...32,665,276
G
B
SYS1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:41,694,152...41,698,874
Ensembl chr20:42,784,190...42,795,119
G
C
Sys1
SYS1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955445:11,934,907...11,975,670
Ensembl chrNW_004955445:11,931,200...11,975,660
G
R
Sys1
Sys1 golgi trafficking protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:153,191,061...153,195,463
Ensembl chr 3:153,191,090...153,220,651
G
M
Sys1
SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:164,297,736...164,322,141
Ensembl chr 2:164,298,884...164,321,558
G
H
SYS1
SYS1 golgi trafficking protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:45,361,949...45,376,798
Ensembl chr20:45,361,937...45,376,798
G
N
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chrNW_004624754:23,827,782...23,845,690
Ensembl chrNW_004624754:23,827,706...23,837,356
G
G
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chr17:39,266,870...39,277,658
G
P
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chr 7:25,045,085...25,056,915
Ensembl chr 7:25,045,685...25,056,300
G
S
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chrNW_004936476:25,913,699...25,923,419
Ensembl chrNW_004936476:25,913,663...25,923,427
G
D
TAP2
transporter 2, ATP binding cassette subfamily B member
no_association susceptibility
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chr12:2,407,512...2,417,469
Ensembl chr12:2,378,126...2,432,303
G
B
TAP2
transporter 2, ATP binding cassette subfamily B member
no_association susceptibility
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chr 6:32,394,586...32,408,297
Ensembl chr 6:33,507,332...33,523,750
G
C
Tap2
transporter 2, ATP binding cassette subfamily B member
no_association susceptibility
ISO
DNA:SNPs:CDs:p.V379I, A565T(human) DNA:synonymous mutation: :
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 RGD:6482280 RGD:6482281
NCBI chrNW_004955437:1,480,217...1,499,032
Ensembl chrNW_004955437:1,477,341...1,498,575
G
R
Tap2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 , RGD:6482281 , RGD:6482280
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
M
Tap2
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
susceptibility no_association
ISO
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 , RGD:6482281 , RGD:6482280
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
G
H
TAP2
transporter 2, ATP binding cassette subfamily B member
susceptibility no_association
IAGP
DNA:synonymous mutation: : DNA:SNPs:CDs:p.V379I, A565T(human)
RGD
PMID:7759306 PMID:7797617 PMID:7928442
RGD:6482279 , RGD:6482281 , RGD:6482280
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
N
Tlr4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
G
TLR4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
P
TLR4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 1:258,044,610...258,054,641
Ensembl chr 1:258,044,610...258,058,970
G
S
Tlr4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
D
TLR4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr11:71,356,390...71,367,166
Ensembl chr11:71,356,390...71,367,165
G
B
TLR4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
C
Tlr4
toll like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
R
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
M
Tlr4
toll-like receptor 4
ISO
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
H
TLR4
toll like receptor 4
IEP
mRNA:increased expression:cerebrospinal fluid, mononuclear cell
RGD
PMID:18644848
RGD:2312575
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
N
Tnf
tumor necrosis factor
no_association disease_progression
ISO
DNA:SNP:promoter:-308G>A (human) OMIM:612594 | OMIM:612595 | OMIM:612596
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
G
TNF
tumor necrosis factor
disease_progression no_association
ISO
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
G
P
TNF
tumor necrosis factor
disease_progression no_association
ISO
DNA:SNP:promoter:-308G>A (human) OMIM:612594 | OMIM:612595 | OMIM:612596
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
S
Tnf
tumor necrosis factor
no_association disease_progression
ISO
DNA:SNP:promoter:-308G>A (human) OMIM:612594 | OMIM:612595 | OMIM:612596
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
D
TNF
tumor necrosis factor
disease_progression no_association
ISO
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
B
TNF
tumor necrosis factor
no_association disease_progression
ISO
DNA:SNP:promoter:-308G>A (human) OMIM:612594 | OMIM:612595 | OMIM:612596
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
C
Tnf
tumor necrosis factor
disease_progression no_association
ISO
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
RGD MouseDO
PMID:8887999 PMID:8964914 PMID:9270614
RGD:12904068 RGD:12904657 RGD:7401237
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
R
Tnf
tumor necrosis factor
disease_progression no_association
ISO ISS
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
MouseDO RGD
PMID:8964914 PMID:9270614 PMID:8887999
RGD:7401237 , RGD:12904657 , RGD:12904068
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
M
Tnf
tumor necrosis factor
disease_progression no_association
ISO IAGP
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
MouseDO RGD
PMID:8964914 PMID:9270614 PMID:8887999
RGD:7401237 , RGD:12904657 , RGD:12904068
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
H
TNF
tumor necrosis factor
disease_progression no_association
IEP ISS IAGP
OMIM:612594 | OMIM:612595 | OMIM:612596 DNA:SNP:promoter:-308G>A (human)
MouseDO RGD
PMID:8964914 PMID:9270614 PMID:8887999
RGD:7401237 , RGD:12904657 , RGD:12904068
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
G
TNFAIP3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr13:35,537,103...35,553,396
Ensembl chr13:35,537,102...35,549,197
G
P
TNFAIP3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 1:26,474,158...26,489,771
Ensembl chr 1:26,473,938...26,489,822
G
S
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004936560:5,124,955...5,138,988
Ensembl chrNW_004936560:5,128,843...5,138,345
G
D
TNFAIP3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 1:30,247,432...30,262,992
Ensembl chr 1:30,251,059...30,261,001
G
B
TNFAIP3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 6:135,617,465...135,634,085
Ensembl chr 6:139,705,255...139,720,819
G
C
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004955436:21,566,591...21,581,551
Ensembl chrNW_004955436:21,566,423...21,578,469
G
R
Tnfaip3
TNF alpha induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
G
M
Tnfaip3
tumor necrosis factor, alpha-induced protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
G
H
TNFAIP3
TNF alpha induced protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
N
Tnfrsf1a
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chrNW_004624860:3,111,244...3,123,041
Ensembl chrNW_004624860:3,111,630...3,122,711
G
G
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr11:6,364,544...6,378,880
Ensembl chr11:6,364,330...6,378,902
G
P
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr 5:64,319,349...64,331,876
Ensembl chr 5:64,319,051...64,331,909
G
S
Tnfrsf1a
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
G
D
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr27:38,641,837...38,654,693
Ensembl chr27:38,638,753...38,700,282
G
B
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chr12:6,457,617...6,470,969
Ensembl chr12:6,374,257...6,387,613
G
C
Tnfrsf1a
TNF receptor superfamily member 1A
susceptibility
ISO
ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5
ClinVar OMIM
PMID:22801493 PMID:24033266 PMID:25741868 PMID:28492532
NCBI chrNW_004955413:3,982,670...3,996,320
Ensembl chrNW_004955413:3,981,400...3,996,021
G
R
Tnfrsf1a
TNF receptor superfamily member 1A
susceptibility
ISO
DNA:SNP:intron: (rs1800693) (human) ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:19525953 PMID:22801493 PMID:24033266 PMID:24076602 PMID:25741868 PMID:28492532 PMID:22801493 More...
RGD:8661741
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
M
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
susceptibility
ISO
DNA:SNP:intron: (rs1800693) (human) ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:19525953 PMID:22801493 PMID:24033266 PMID:24076602 PMID:25741868 PMID:28492532 PMID:22801493 More...
RGD:8661741
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
H
TNFRSF1A
TNF receptor superfamily member 1A
susceptibility
IAGP EXP
DNA:SNP:intron: (rs1800693) (human) ClinVar Annotator: match by term: Multiple sclerosis, susceptibility to, 5 CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:19525953 PMID:22801493 PMID:24033266 PMID:24076602 PMID:25741868 PMID:28492532 PMID:22801493 More...
RGD:8661741
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
N
Tnfsf14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004624828:3,763,849...3,770,500
G
G
TNFSF14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 6:6,235,641...6,241,706
Ensembl chr 6:6,236,193...6,241,311
G
P
TNFSF14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 2:72,478,178...72,483,885
Ensembl chr 2:72,473,477...72,483,989
G
S
Tnfsf14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004936588:3,976,492...3,979,825
Ensembl chrNW_004936588:3,976,492...3,979,825
G
D
TNFSF14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr20:53,604,101...53,607,522
Ensembl chr20:53,603,709...53,607,522
G
B
TNFSF14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr19:5,691,648...5,700,935
Ensembl chr19:6,614,378...6,621,763
G
C
Tnfsf14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chrNW_004955495:2,829,314...2,834,826
Ensembl chrNW_004955495:2,829,402...2,835,335
G
R
Tnfsf14
TNF superfamily member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr 9:2,068,295...2,073,128
Ensembl chr 9:2,069,104...2,073,216
G
M
Tnfsf14
tumor necrosis factor (ligand) superfamily, member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr17:57,496,437...57,501,182
Ensembl chr17:57,496,492...57,501,177
G
H
TNFSF14
TNF superfamily member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24076602
NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,661,253...6,670,588
G
N
Tnfsf9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chrNW_004624828:3,615,860...3,623,377
G
G
TNFSF9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr 6:6,131,157...6,136,345
Ensembl chr 6:6,131,571...6,135,463
G
P
TNFSF9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr 2:72,578,811...72,582,834
Ensembl chr 2:72,578,821...72,582,745
G
S
Tnfsf9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chrNW_004936588:3,844,924...3,847,218
G
D
TNFSF9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr20:53,680,882...53,682,521
Ensembl chr20:53,679,880...53,682,706
G
B
TNFSF9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr19:5,558,021...5,562,901
Ensembl chr19:6,476,941...6,483,352
G
C
Tnfsf9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chrNW_004955495:3,101,965...3,107,552
G
R
Tnfsf9
TNF superfamily member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
M
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
ISO
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
G
H
TNFSF9
TNF superfamily member 9
IEP
protein:increased expression:plasma, monocyte (human)
RGD
PMID:16970683
RGD:2317352
NCBI chr19:6,531,026...6,535,924
Ensembl chr19:6,531,026...6,535,924
G
N
Traf1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624760:14,423,735...14,445,033
Ensembl chrNW_004624760:14,424,157...14,446,084
G
G
TRAF1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr12:18,647,131...18,672,685
Ensembl chr12:18,650,190...18,670,643
G
P
TRAF1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 1:260,948,191...260,973,978
Ensembl chr 1:260,949,111...260,973,709
G
S
Traf1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936487:9,349,883...9,368,946
Ensembl chrNW_004936487:9,349,483...9,367,045
G
D
TRAF1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr11:73,920,729...73,939,644
Ensembl chr11:73,927,007...73,937,655
G
B
TRAF1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:92,030,205...92,056,776
Ensembl chr 9:120,376,592...120,402,948
G
C
Traf1
TNF receptor associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955419:7,117,869...7,145,274
Ensembl chrNW_004955419:7,121,382...7,137,763
G
R
Traf1
TNF receptor-associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:18,222,024...18,242,163
Ensembl chr 3:18,222,054...18,241,807
G
M
Traf1
TNF receptor-associated factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784
G
H
TRAF1
TNF receptor associated factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
N
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chrNW_004624828:2,499,811...2,518,817
Ensembl chrNW_004624828:2,500,339...2,517,694
G
G
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr 6:9,399,945...9,420,054
Ensembl chr 6:9,399,775...9,417,630
G
P
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr 2:69,157,774...69,183,555
Ensembl chr 2:69,157,811...69,183,456
G
S
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chrNW_004936659:681,463...704,484
Ensembl chrNW_004936659:681,310...702,962
G
D
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr20:50,747,145...50,770,008
Ensembl chr20:50,748,329...50,769,216
G
B
TYK2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr19:9,901,612...9,932,623
Ensembl chr19:10,565,490...10,594,541
G
C
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chrNW_004955495:1,618,099...1,637,996
Ensembl chrNW_004955495:1,617,999...1,636,068
G
R
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr 8:19,641,881...19,667,157
Ensembl chr 8:19,641,884...19,667,044
G
M
Tyk2
tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr 9:21,015,364...21,042,689
Ensembl chr 9:21,015,364...21,042,539
G
H
TYK2
tyrosine kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19525955
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,533...10,380,608
G
N
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004624857:3,606,573...3,625,991
Ensembl chrNW_004624857:3,606,431...3,627,063
G
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr20:32,616,425...32,635,903
Ensembl chr20:32,615,333...32,635,862
G
P
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
S
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004936748:785,491...802,791
Ensembl chrNW_004936748:785,455...803,048
G
D
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 6:49,341,669...49,359,841
Ensembl chr 6:49,342,151...49,359,933
G
B
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:103,377,815...103,395,118
Ensembl chr 1:102,091,336...102,107,732
G
C
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
G
R
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
M
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
H
VCAM1
vascular cell adhesion molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20175758
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
N
Vdr
vitamin D receptor
susceptibility no_association
ISO
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:polymorphisms: :rs731236,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chrNW_004624816:4,314,146...4,423,946
Ensembl chrNW_004624816:4,365,961...4,424,514
G
G
VDR
vitamin D receptor
susceptibility no_association
ISO
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human)
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
G
P
VDR
vitamin D receptor
susceptibility no_association
ISO
DNA:polymorphisms: :rs731236,rs7975232(human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
S
Vdr
vitamin D receptor
no_association susceptibility
ISO
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:polymorphisms: :rs731236,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chrNW_004936512:5,741,836...5,800,999
Ensembl chrNW_004936512:5,740,748...5,801,109
G
D
VDR
vitamin D receptor
susceptibility no_association
ISO
DNA:silent mutation, haplotype:cds: (rs731236) (human) DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chr27:6,852,915...6,909,466
Ensembl chr27:6,852,723...6,909,470
G
B
VDR
vitamin D receptor
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
CTD RGD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
G
C
Vdr
vitamin D receptor
susceptibility no_association
ISO
DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human)
RGD CTD
PMID:21664963 PMID:25685788 PMID:25853421 PMID:26540116 PMID:27049563
RGD:11353119 RGD:11530654 RGD:13210790 RGD:5147559
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
G
R
Vdr
vitamin D receptor
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
CTD RGD
PMID:25853421 PMID:15118671 PMID:27049563 PMID:25685788 PMID:26540116 PMID:21664963 More...
RGD:1331525 , RGD:11530654 , RGD:13210790 , RGD:11353119 , RGD:5147559
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
M
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
CTD RGD
PMID:25853421 PMID:15118671 PMID:27049563 PMID:25685788 PMID:26540116 PMID:21664963 More...
RGD:1331525 , RGD:11530654 , RGD:13210790 , RGD:11353119 , RGD:5147559
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
H
VDR
vitamin D receptor
no_association susceptibility
TAS EXP IAGP IEA
CTD Direct Evidence: marker/mechanism DNA:polymorphisms: :rs731236,rs7975232(human) DNA:polymorphisms: :rs731236,rs1544410,rs7975232(human) DNA:silent mutation, haplotype:cds: (rs731236) (human)
CTD RGD
PMID:25853421 PMID:15118671 PMID:27049563 PMID:25685788 PMID:26540116 PMID:21664963 PMID:15118671 More...
RGD:1331525 , RGD:11530654 , RGD:13210790 , RGD:11353119 , RGD:5147559 , RGD:1331525
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
N
Vhl
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004624731:5,350,912...5,359,286
G
G
VHL
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr22:46,184,621...46,203,065
Ensembl chr22:46,184,756...46,204,428
G
P
VHL
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr13:66,334,535...66,342,401
Ensembl chr13:66,334,591...66,342,654
G
S
Vhl
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004936602:3,135,790...3,140,622
G
D
VHL
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr20:8,206,616...8,211,347
Ensembl chr20:8,206,616...8,211,323
G
B
VHL
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:10,077,630...10,089,499
Ensembl chr 3:10,430,143...10,440,234
G
C
Vhl
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chrNW_004955561:1,573,525...1,578,295
Ensembl chrNW_004955561:1,573,525...1,580,511
G
R
Vhl
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 4:146,772,483...146,779,376
Ensembl chr 4:146,772,468...146,779,377
G
M
Vhl
von Hippel-Lindau tumor suppressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 6:113,600,955...113,608,595
Ensembl chr 6:113,600,920...113,608,594
G
H
VHL
von Hippel-Lindau tumor suppressor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,667
G
N
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004624747:5,123,085...5,128,465
G
G
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr19:11,670,605...11,677,168
G
P
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr14:46,011,239...46,016,526
Ensembl chr14:46,008,377...46,016,526
G
S
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004936657:2,891,171...2,895,409
Ensembl chrNW_004936657:2,891,907...2,896,174
G
D
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr26:22,162,675...22,168,149
Ensembl chr26:22,163,222...22,168,105
G
B
XBP1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr22:9,863,479...9,869,491
Ensembl chr22:27,567,041...27,571,943
G
C
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chrNW_004955455:3,037,885...3,041,827
G
R
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
M
Xbp1
X-box binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
G
H
XBP1
X-box binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:30661753
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
R
Zfp267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 2:119,017,280...119,035,885
Ensembl chr 2:119,017,285...119,031,900
G
M
Zfp267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 3:36,205,233...36,224,491
Ensembl chr 3:36,205,166...36,224,491
G
G
ZNF267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr 5:28,517,588...28,561,125
Ensembl chr 5:28,517,720...28,561,117
G
B
ZNF267
zinc finger protein 267
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr16:22,924,355...22,968,670
Ensembl chr16:32,336,675...32,380,262
G
H
ZNF267
zinc finger protein 267
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:31068361
NCBI chr16:31,873,807...31,917,357
Ensembl chr16:31,873,807...31,917,357
G
N
Aqp4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chrNW_004624770:5,581,192...5,593,470
Ensembl chrNW_004624770:5,580,808...5,594,628
G
G
AQP4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr18:53,729,143...53,742,916
Ensembl chr18:53,729,186...53,743,156
G
P
AQP4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr 6:111,407,632...111,422,169
Ensembl chr 6:111,407,639...111,422,109
G
S
Aqp4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chrNW_004936550:5,931,201...5,943,999
Ensembl chrNW_004936550:5,931,194...5,941,354
G
D
AQP4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr 7:61,855,617...61,868,953
Ensembl chr 7:61,855,744...61,865,089
G
B
AQP4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr18:20,108,607...20,122,381
Ensembl chr18:23,713,146...23,726,919
G
C
Aqp4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chrNW_004955772:1,160...10,709
Ensembl chrNW_004955772:1,159...10,709
G
R
Aqp4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
G
M
Aqp4
aquaporin 4
ISO
RGD
PMID:17468440
RGD:8698645
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
H
AQP4
aquaporin 4
IDA
RGD
PMID:17468440
RGD:8698645
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
N
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004624754:4,724,633...4,805,672
Ensembl chrNW_004624754:4,724,591...4,795,127
G
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 9:60,538,718...60,625,903
Ensembl chr 9:60,540,303...60,625,570
G
P
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr14:73,565,158...73,657,257
Ensembl chr14:73,538,090...73,653,560
G
S
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004936521:7,951,176...8,025,666
Ensembl chrNW_004936521:7,952,365...8,025,614
G
D
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 4:21,534,309...21,612,528
Ensembl chr 4:21,534,006...21,611,987
G
B
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:67,145,400...67,232,934
Ensembl chr10:69,671,222...69,758,229
G
C
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004955437:20,592,278...20,664,075
Ensembl chrNW_004955437:20,593,739...20,664,075
G
R
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
G
M
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:61,032,886...61,109,447
Ensembl chr10:61,032,891...61,109,217
G
H
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
IAGP
DNA:SNPs:intron: A>G, C>G (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:70,672,506...70,762,441
Ensembl chr10:70,672,506...70,762,441
G
N
Bche
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chrNW_004624730:43,793,550...43,849,169
Ensembl chrNW_004624730:43,793,040...43,843,519
G
G
BCHE
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
G
P
BCHE
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr13:104,946,732...105,007,568
G
S
Bche
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chrNW_004936707:1,784,338...1,913,401
Ensembl chrNW_004936707:1,854,444...1,913,460
G
D
BCHE
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
G
B
BCHE
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr 3:162,794,184...162,858,574
Ensembl chr 3:170,845,494...170,911,481
G
C
Bche
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chrNW_004955448:15,327,374...15,396,827
Ensembl chrNW_004955448:15,329,273...15,396,970
G
R
Bche
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
M
Bche
butyrylcholinesterase
ISO
RGD
PMID:20122907
RGD:5687690
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
H
BCHE
butyrylcholinesterase
IEP
RGD
PMID:20122907
RGD:5687690
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
N
Cd274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chrNW_004624736:9,991,851...10,017,047
Ensembl chrNW_004624736:9,996,156...10,013,814
G
G
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr12:74,038,844...74,060,662
Ensembl chr12:74,041,767...74,056,806
G
P
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 1:216,646,378...216,792,731
Ensembl chr 1:216,660,041...216,792,724
G
S
Cd274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
G
D
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 1:93,461,735...93,605,772
Ensembl chr 1:93,585,518...93,603,522
G
B
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
G
C
Cd274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chrNW_004955434:9,487,309...9,508,366
Ensembl chrNW_004955434:9,487,315...9,505,904
G
R
Cd274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
M
Cd274
CD274 antigen
severity
IMP
RGD
PMID:21494618
RGD:6893669
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
H
CD274
CD274 molecule
severity
ISO
RGD
PMID:21494618
RGD:6893669
NCBI chr 9:5,450,542...5,470,554
Ensembl chr 9:5,450,503...5,470,566
G
D
DLA-DQB1
major histocompatibility complex, class II, DQ beta 1
severity
ISO
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr12:2,305,307...2,307,711
G
N
Gc
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chrNW_004624890:3,274,239...3,318,281
Ensembl chrNW_004624890:3,226,900...3,318,316
G
G
GC
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
P
GC
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 8:68,326,293...68,360,262
Ensembl chr 8:68,326,299...68,360,262
G
S
Gc
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chrNW_004936598:3,220,029...3,256,091
Ensembl chrNW_004936598:3,219,991...3,261,629
G
D
GC
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr13:60,795,305...60,828,038
Ensembl chr13:60,795,305...60,827,929
G
B
GC
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 4:52,431,196...52,473,762
Ensembl chr 4:58,729,236...58,792,073
G
C
Gc
GC vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
G
R
Gc
GC, vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
G
M
Gc
vitamin D binding protein
ISO
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
H
GC
GC vitamin D binding protein
IEP
protein:increased expression:cerebrospinal fluid:
RGD
PMID:20093204
RGD:5509869
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
N
Grn
granulin precursor
susceptibility
ISO
DNA:SNPs: :rs2879096, rs4792938(human) protein:increased expression:cerebrospinal fluids
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chrNW_004624795:704,066...708,721
Ensembl chrNW_004624795:704,252...707,165
G
G
GRN
granulin precursor
susceptibility
ISO
DNA:SNPs: :rs2879096, rs4792938(human) protein:increased expression:cerebrospinal fluids
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
P
GRN
granulin precursor
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chr12:18,893,772...18,900,444
Ensembl chr12:18,893,770...18,900,446
G
S
Grn
granulin precursor
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chrNW_004936541:793,548...800,271
Ensembl chrNW_004936541:793,523...800,217
G
D
GRN
granulin precursor
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chr 9:19,077,430...19,085,443
Ensembl chr 9:19,077,427...19,082,268
G
B
GRN
granulin precursor
susceptibility
ISO
DNA:SNPs: :rs2879096, rs4792938(human) protein:increased expression:cerebrospinal fluids
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chr17:13,046,329...13,054,236
Ensembl chr17:13,211,784...13,219,609
G
C
Grn
granulin precursor
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:20463744 PMID:21613335
RGD:5509591 RGD:5509596
NCBI chrNW_004955451:17,368,600...17,371,981
Ensembl chrNW_004955451:17,368,428...17,372,377
G
R
Grn
granulin precursor
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:21613335 PMID:20463744
RGD:5509591 , RGD:5509596
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
M
Grn
granulin
susceptibility
ISO
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:21613335 PMID:20463744
RGD:5509591 , RGD:5509596
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
H
GRN
granulin precursor
susceptibility
IEP IAGP
protein:increased expression:cerebrospinal fluids DNA:SNPs: :rs2879096, rs4792938(human)
RGD
PMID:21613335 PMID:20463744
RGD:5509591 , RGD:5509596
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
M
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
severity
ISO
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
M
H2-Eb1
histocompatibility 2, class II antigen E beta
severity
ISO
DNA:polymorphisms, haplotype: :HLA-DR2, HLA-DRB1*1501 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
G
H
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
severity
IAGP
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
D
HLA-DRB1
MHC class II DLA DRB1 beta chain
severity
ISO
DNA:polymorphisms, haplotype: :HLA-DR2, HLA-DRB1*1501 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr12:2,151,409...2,164,564
G
H
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
severity
IAGP
DNA:polymorphisms, haplotype: :HLA-DR2, HLA-DRB1*1501 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
N
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004624904:2,314,197...2,320,900
Ensembl chrNW_004624904:2,314,249...2,318,791
G
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
P
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
S
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004936512:11,481,017...11,487,737
G
D
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr27:1,013,459...1,020,083
Ensembl chr27:1,015,868...1,019,891
G
B
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:34,456,900...34,463,317
Ensembl chr12:35,184,943...35,188,443
G
C
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004955458:1,530,163...1,536,874
G
R
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
M
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
G
H
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
N
Igfbp3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chrNW_004624740:6,878,818...6,886,512
Ensembl chrNW_004624740:6,877,348...6,886,512
G
G
IGFBP3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr21:12,905,309...12,914,199
Ensembl chr21:12,905,280...12,914,205
G
P
IGFBP3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr18:50,002,921...50,009,425
Ensembl chr18:50,003,022...50,010,690
G
S
Igfbp3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chrNW_004936478:20,511,490...20,518,251
Ensembl chrNW_004936478:20,510,137...20,518,306
G
D
IGFBP3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr16:1,021,855...1,027,604
Ensembl chr16:1,021,972...1,026,392
G
B
IGFBP3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr 7:46,564,234...46,573,145
G
C
Igfbp3
insulin like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chrNW_004955456:6,795,560...6,802,147
Ensembl chrNW_004955456:6,795,604...6,800,845
G
R
Igfbp3
insulin-like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
G
M
Igfbp3
insulin-like growth factor binding protein 3
disease_progression
ISO
RGD
PMID:15732261
RGD:1626118
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
H
IGFBP3
insulin like growth factor binding protein 3
disease_progression
IEP
RGD
PMID:15732261
RGD:1626118
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
N
Il4r
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chrNW_004624782:11,981,781...12,008,362
G
G
IL4R
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
G
P
IL4R
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 3:19,526,343...19,576,792
Ensembl chr 3:19,523,564...19,576,544
G
S
Il4r
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
G
D
IL4R
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 6:19,254,183...19,280,973
Ensembl chr 6:19,254,487...19,389,291
G
B
IL4R
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
Ensembl chr16:27,642,702...27,737,445
G
C
Il4r
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
G
R
Il4r
interleukin 4 receptor
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
G
H
IL4R
interleukin 4 receptor
IAGP
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
M
Il4ra
interleukin 4 receptor, alpha
ISO
DNA:missense mutation:cds:p.Q551R (human)
RGD
PMID:11164908
RGD:1358313
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
B
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
severity
ISO
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
N
LOC101703821
HLA class II histocompatibility antigen, DQ beta 1 chain
severity
ISO
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
G
N
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chrNW_004624790:8,584,399...8,591,763
Ensembl chrNW_004624790:8,583,457...8,591,713
G
G
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
P
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
S
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
D
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
B
MMP9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
C
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
R
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
M
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:14504963
RGD:13204808
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
H
MMP9
matrix metallopeptidase 9
IEP
RGD
PMID:14504963
RGD:13204808
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
N
Polg
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chrNW_004624768:16,493,123...16,509,747
Ensembl chrNW_004624768:16,491,555...16,509,900
G
G
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
P
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr 7:54,889,150...54,907,167
Ensembl chr 7:54,889,157...54,906,844
G
S
Polg
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chrNW_004936483:15,178,947...15,196,277
Ensembl chrNW_004936483:15,179,342...15,195,258
G
D
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr 3:52,357,062...52,373,768
Ensembl chr 3:52,357,068...52,421,544
G
B
POLG
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr15:68,008,214...68,028,241
Ensembl chr15:87,214,451...87,234,739
G
C
Polg
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chrNW_004955416:15,773,005...15,788,736
Ensembl chrNW_004955416:15,773,473...15,788,651
G
R
Polg
DNA polymerase gamma, catalytic subunit
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:133,382,766...133,398,567
G
M
Polg
polymerase (DNA directed), gamma
ISO
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
H
POLG
DNA polymerase gamma, catalytic subunit
IAGP
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
G
H
POLGARF
POLG alternative reading frame
IAGP
ClinVar Annotator: match by term: Primary progressive multiple sclerosis
ClinVar
PMID:2504279 PMID:16401742 PMID:21880868 PMID:25741868 PMID:26467025 PMID:28480171 PMID:28492532 PMID:32504279 More...
NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,330,208...89,333,809
G
R
RT1-Bb
RT1 class II, locus Bb
severity
ISO
DNA:polymorphism: :HLA-DQB1*0602 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
R
RT1-Db1
RT1 class II, locus Db1
severity
ISO
DNA:polymorphisms, haplotype: :HLA-DR2, HLA-DRB1*1501 (human)
RGD
PMID:19616314
RGD:5147610
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
N
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chrNW_004624800:2,202,986...2,215,309
Ensembl chrNW_004624800:2,203,393...2,212,068
G
G
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr21:123,929,937...123,942,451
Ensembl chr21:123,932,900...123,942,395
G
P
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr18:2,546,202...2,555,484
Ensembl chr18:2,545,994...2,555,484
G
S
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chrNW_004936527:10,033,095...10,042,713
Ensembl chrNW_004936527:10,033,299...10,042,599
G
D
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr16:18,650,553...18,663,571
Ensembl chr16:18,484,809...18,662,903
G
B
SHH
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr 7:147,400,112...147,414,036
Ensembl chr 7:159,114,666...159,126,651
G
C
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chrNW_004955491:8,647,133...8,657,381
G
R
Shh
sonic hedgehog signaling molecule
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
M
Shh
sonic hedgehog
ISO
RGD
PMID:12926841
RGD:12801414
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
H
SHH
sonic hedgehog signaling molecule
IEP
RGD
PMID:12926841
RGD:12801414
NCBI chr 7:155,799,980...155,812,463
Ensembl chr 7:155,799,980...155,812,463
G
N
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chrNW_004624847:2,189,167...2,200,355
Ensembl chrNW_004624847:2,189,257...2,200,352
G
G
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr10:122,558,998...122,573,747
Ensembl chr10:122,571,853...122,572,941
G
P
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr15:136,370,457...136,382,559
Ensembl chr15:136,370,530...136,382,553
G
S
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chrNW_004936525:1,559,575...1,570,679
G
D
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr25:47,327,921...47,339,632
Ensembl chr25:47,327,963...47,339,622
G
B
ACKR3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr2B:123,795,664...123,810,067
Ensembl chr2B:242,666,173...242,667,261
G
C
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chrNW_004955453:195,346...218,034
Ensembl chrNW_004955453:195,346...218,034
G
R
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237
G
M
Ackr3
atypical chemokine receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr 1:90,131,702...90,143,446
Ensembl chr 1:90,131,702...90,144,473
G
H
ACKR3
atypical chemokine receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624384
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
G
N
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004624754:4,724,633...4,805,672
Ensembl chrNW_004624754:4,724,591...4,795,127
G
G
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 9:60,538,718...60,625,903
Ensembl chr 9:60,540,303...60,625,570
G
P
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr14:73,565,158...73,657,257
Ensembl chr14:73,538,090...73,653,560
G
S
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004936521:7,951,176...8,025,666
Ensembl chrNW_004936521:7,952,365...8,025,614
G
D
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr 4:21,534,309...21,612,528
Ensembl chr 4:21,534,006...21,611,987
G
B
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:67,145,400...67,232,934
Ensembl chr10:69,671,222...69,758,229
G
C
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chrNW_004955437:20,592,278...20,664,075
Ensembl chrNW_004955437:20,593,739...20,664,075
G
R
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif, 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr20:29,143,029...29,219,846
Ensembl chr20:29,144,354...29,219,866
G
M
Adamts14
ADAM metallopeptidase with thrombospondin type 1 motif 14
ISO
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:61,032,886...61,109,447
Ensembl chr10:61,032,891...61,109,217
G
H
ADAMTS14
ADAM metallopeptidase with thrombospondin type 1 motif 14
IAGP
DNA:SNP:intron: C>T (human)
RGD
PMID:15913795
RGD:6771190
NCBI chr10:70,672,506...70,762,441
Ensembl chr10:70,672,506...70,762,441
G
N
Apoa4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chrNW_004624784:12,237,329...12,240,013
Ensembl chrNW_004624784:12,233,593...12,239,763
G
G
APOA4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 1:108,186,627...108,190,508
Ensembl chr 1:108,186,921...108,189,698
G
P
APOA4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 9:44,201,587...44,204,072
Ensembl chr 9:44,201,508...44,204,206
G
S
Apoa4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chrNW_004936542:2,098,683...2,101,127
Ensembl chrNW_004936542:2,098,683...2,101,127
G
D
APOA4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 5:16,751,588...16,754,215
Ensembl chr 5:16,751,799...16,754,837
G
B
APOA4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr11:111,659,186...111,661,790
Ensembl chr11:115,591,788...115,594,382
G
C
Apoa4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chrNW_004955412:18,158,095...18,160,636
Ensembl chrNW_004955412:18,155,801...18,160,701
G
R
Apoa4
apolipoprotein A4
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
G
M
Apoa4
apolipoprotein A-IV
onset
ISO
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
H
APOA4
apolipoprotein A4
onset
IEP
protein:decreased expression:cerebrospinal fluid (human)
RGD
PMID:19383442
RGD:5685649
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
N
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chrNW_004624907:1,752,322...1,755,308
G
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
P
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 6:51,373,113...51,375,333
Ensembl chr 6:51,372,292...51,375,330
G
S
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chrNW_004936706:1,512,438...1,516,805
G
D
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 1:110,525,717...110,528,534
Ensembl chr 1:110,525,722...110,528,440
G
B
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
C
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
R
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
M
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
H
APOE
apolipoprotein E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15096402 PMID:34624384
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
N
Cd36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chrNW_004624739:29,341,620...29,441,232
Ensembl chrNW_004624739:29,407,568...29,441,333
G
G
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr21:68,214,875...68,309,336
Ensembl chr21:68,216,201...68,268,669
G
P
CD36
CD36 molecule
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
S
Cd36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chrNW_004936810:791,823...838,303
Ensembl chrNW_004936810:758,182...838,365
G
D
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr18:20,299,808...20,375,856
Ensembl chr18:20,339,050...20,372,639
G
B
CD36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr 7:72,566,478...72,643,517
Ensembl chr 7:86,265,114...86,305,865
G
C
Cd36
CD36 molecule (CD36 blood group)
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chrNW_004955410:5,003,720...5,120,903
Ensembl chrNW_004955410:5,003,668...5,075,313
G
R
Cd36
CD36 molecule
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
M
Cd36
CD36 molecule
ISO
RGD
PMID:20855355
RGD:6893496
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
H
CD36
CD36 molecule (CD36 blood group)
IEP
RGD
PMID:20855355
RGD:6893496
NCBI chr 7:80,602,207...80,679,274
Ensembl chr 7:80,369,575...80,679,277
G
N
Cd80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chrNW_004624731:28,630,540...28,655,297
Ensembl chrNW_004624731:28,630,446...28,651,994
G
G
CD80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr22:61,258,281...61,294,772
G
P
CD80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr13:140,693,312...140,730,541
Ensembl chr13:140,693,382...140,728,976
G
S
Cd80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chrNW_004936536:6,462,080...6,483,450
G
D
CD80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr33:23,177,136...23,208,421
Ensembl chr33:23,177,138...23,201,380
G
B
CD80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr 3:116,646,590...116,683,725
Ensembl chr 3:123,559,559...123,594,870
G
C
Cd80
CD80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chrNW_004955427:19,237,251...19,274,001
Ensembl chrNW_004955427:19,236,445...19,261,517
G
R
Cd80
Cd80 molecule
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
G
M
Cd80
CD80 antigen
ISO
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
G
H
CD80
CD80 molecule
IEP
protein:increased expression:blood, B cell
RGD
PMID:21310664
RGD:6893670
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
N
Cspg4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chrNW_004624894:564,252...595,048
Ensembl chrNW_004624894:561,683...594,878
G
G
CSPG4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr26:7,735,972...7,761,355
Ensembl chr26:7,694,014...7,761,342
G
P
CSPG4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr 7:57,949,182...57,988,602
Ensembl chr 7:57,949,455...57,988,335
G
S
Cspg4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chrNW_004936471:34,438,676...34,475,005
Ensembl chrNW_004936471:34,438,676...34,475,052
G
D
CSPG4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr30:38,465,486...38,498,365
Ensembl chr30:38,465,241...38,497,971
G
B
CSPG4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr15:54,583,010...54,621,240
Ensembl chr15:74,177,909...74,200,498
G
C
Cspg4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chrNW_004955450:2,631,310...2,663,118
Ensembl chrNW_004955450:2,631,327...2,662,269
G
R
Cspg4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
G
M
Cspg4
chondroitin sulfate proteoglycan 4
ISO
RGD
PMID:10976643
RGD:5686865
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
G
H
CSPG4
chondroitin sulfate proteoglycan 4
IDA
RGD
PMID:10976643
RGD:5686865
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
N
Ctss
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chrNW_004624772:18,421,905...18,446,857
Ensembl chrNW_004624772:18,419,736...18,438,786
G
G
CTSS
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
G
P
CTSS
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 4:98,415,273...98,442,952
Ensembl chr 4:98,417,883...98,442,950
G
S
Ctss
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chrNW_004936580:963,176...991,732
Ensembl chrNW_004936580:963,153...991,442
G
D
CTSS
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr17:59,893,840...59,910,878
Ensembl chr17:59,893,840...59,910,849
G
B
CTSS
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 1:126,084,249...126,118,221
Ensembl chr 1:129,733,996...129,768,318
G
C
Ctss
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chrNW_004955413:99,279...124,793
Ensembl chrNW_004955413:99,159...124,042
G
R
Ctss
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
M
Ctss
cathepsin S
ISO
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
H
CTSS
cathepsin S
IEP
mRNA, protein:increased expression:blood, leukocyte
RGD
PMID:21143385
RGD:5687146
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
N
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chrNW_004624791:15,290,022...15,315,848
Ensembl chrNW_004624791:15,289,348...15,315,848
G
P
FAS
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr14:100,927,305...100,954,781
Ensembl chr14:100,927,089...100,956,716
G
S
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chrNW_004936735:209,369...234,582
G
D
FAS
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
B
FAS
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
C
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
R
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
M
Fas
Fas cell surface death receptor
susceptibility
ISO
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
H
FAS
Fas cell surface death receptor
susceptibility
IAGP
DNA:polymorphism:intron:735T>C(human)
RGD
PMID:15218339
RGD:12903953
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
N
Grn
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004624795:704,066...708,721
Ensembl chrNW_004624795:704,252...707,165
G
G
GRN
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr16:62,037,344...62,045,765
Ensembl chr16:62,036,412...62,045,614
G
P
GRN
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr12:18,893,772...18,900,444
Ensembl chr12:18,893,770...18,900,446
G
S
Grn
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004936541:793,548...800,271
Ensembl chrNW_004936541:793,523...800,217
G
D
GRN
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr 9:19,077,430...19,085,443
Ensembl chr 9:19,077,427...19,082,268
G
B
GRN
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr17:13,046,329...13,054,236
Ensembl chr17:13,211,784...13,219,609
G
C
Grn
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chrNW_004955451:17,368,600...17,371,981
Ensembl chrNW_004955451:17,368,428...17,372,377
G
R
Grn
granulin precursor
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
M
Grn
granulin
disease_progression
ISO
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
H
GRN
granulin precursor
disease_progression
IEP
protein:increased expression:cerebrospinal fluids
RGD
PMID:21613335
RGD:5509591
NCBI chr17:44,345,302...44,353,106
Ensembl chr17:44,345,246...44,353,106
G
N
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chrNW_004624733:32,284,793...32,310,980
G
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
G
P
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr16:66,162,318...66,208,868
G
S
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chrNW_004936515:6,030,402...6,051,161
G
D
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr 4:53,012,223...53,066,611
Ensembl chr 4:53,046,970...53,128,952 Ensembl chr 4:53,046,970...53,128,952
G
B
HAVCR1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr 5:152,429,337...152,459,800
Ensembl chr 5:158,413,073...158,442,481
G
C
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chrNW_004955408:11,047,679...11,070,492
G
R
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
M
Havcr1
hepatitis A virus cellular receptor 1
ISO
RGD
PMID:15153541
RGD:5128853
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
H
HAVCR1
hepatitis A virus cellular receptor 1
IEP
RGD
PMID:15153541
RGD:5128853
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
N
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chrNW_004624904:2,314,197...2,320,900
Ensembl chrNW_004624904:2,314,249...2,318,791
G
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
P
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
S
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chrNW_004936512:11,481,017...11,487,737
G
D
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr27:1,013,459...1,020,083
Ensembl chr27:1,015,868...1,019,891
G
B
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr12:34,456,900...34,463,317
Ensembl chr12:35,184,943...35,188,443
G
C
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chrNW_004955458:1,530,163...1,536,874
G
R
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
M
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
G
H
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Relapsing remitting multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
G
N
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chrNW_004624880:2,070,410...2,075,069
Ensembl chrNW_004624880:2,070,523...2,079,421
G
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
G
P
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 9:49,982,278...49,986,760
Ensembl chr 9:49,982,284...49,990,508
G
S
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chrNW_004936542:7,577,192...7,581,598
Ensembl chrNW_004936542:7,577,149...7,581,923
G
D
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 5:11,292,219...11,296,851
Ensembl chr 5:11,292,262...11,296,797
G
C
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
G
R
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
M
Hspa8
heat shock protein 8
ISO
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
H
HSPA8
heat shock protein family A (Hsp70) member 8
IEP
protein: increased expression
RGD
PMID:21824468
RGD:5688780
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
N
Klc1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chrNW_004624734:1,221,531...1,275,002
Ensembl chrNW_004624734:1,219,270...1,266,754
G
G
KLC1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr24:81,617,049...81,632,845
G
P
KLC1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
G
S
Klc1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chrNW_004936621:1,471,574...1,505,119
Ensembl chrNW_004936621:1,543,444...1,560,076 Ensembl chrNW_004936621:1,543,444...1,560,076
G
D
KLC1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr 8:71,401,795...71,444,056
Ensembl chr 8:71,400,003...71,444,062
G
B
KLC1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr14:84,255,959...84,326,767
Ensembl chr14:104,065,775...104,135,818
G
C
Klc1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chrNW_004955538:2,462,491...2,503,398
Ensembl chrNW_004955538:2,470,473...2,503,398
G
R
Klc1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr 6:130,823,416...130,866,729
Ensembl chr 6:130,823,419...130,867,031
G
M
Klc1
kinesin light chain 1
susceptibility
ISO
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr12:111,724,869...111,774,278
Ensembl chr12:111,725,283...111,774,278
G
H
KLC1
kinesin light chain 1
susceptibility
IAGP
DNA:SNP:intron:56836G>C (rs8702) (human)
RGD
PMID:17999208
RGD:5684008
NCBI chr14:103,629,211...103,701,544
Ensembl chr14:103,561,896...103,714,249
G
N
Mmp19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chrNW_004624802:12,176,406...12,182,128
Ensembl chrNW_004624802:12,175,989...12,181,578
G
G
MMP19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr11:51,786,076...51,794,325
G
P
MMP19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr 5:21,279,514...21,285,943
Ensembl chr 5:21,280,130...21,285,774
G
S
Mmp19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chrNW_004936646:298,854...304,479
Ensembl chrNW_004936646:299,059...304,430
G
D
MMP19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr10:219,193...224,873
Ensembl chr10:219,618...224,778
G
B
MMP19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr12:33,068,282...33,075,324
Ensembl chr12:33,794,249...33,801,658
G
C
Mmp19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chrNW_004955458:3,473,279...3,479,620
Ensembl chrNW_004955458:3,473,279...3,479,620
G
R
Mmp19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
G
M
Mmp19
matrix metallopeptidase 19
ISO
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr10:128,626,779...128,636,696
Ensembl chr10:128,626,779...128,636,693
G
H
MMP19
matrix metallopeptidase 19
IEP
mRNA:increased expression:mononuclear cell
RGD
PMID:11438176
RGD:1642025
NCBI chr12:55,835,433...55,842,936
Ensembl chr12:55,835,433...55,842,966
G
N
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004624790:8,584,399...8,591,763
Ensembl chrNW_004624790:8,583,457...8,591,713
G
G
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
P
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr17:48,179,690...48,186,782
Ensembl chr17:48,179,671...48,186,788
G
S
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
D
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr24:33,274,260...33,281,116
Ensembl chr24:33,274,268...33,281,293
G
B
MMP9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr20:42,346,305...42,354,018
Ensembl chr20:43,432,389...43,440,129
G
C
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
R
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
M
Mmp9
matrix metallopeptidase 9
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
H
MMP9
matrix metallopeptidase 9
treatment
IEP
RGD
PMID:16412833
RGD:13204825
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
N
Nefh
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chrNW_004624747:5,806,576...5,816,158
Ensembl chrNW_004624747:5,806,645...5,815,554
G
G
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr19:12,357,982...12,375,449
G
P
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr14:46,559,698...46,568,686
Ensembl chr14:46,559,860...46,568,088
G
S
Nefh
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chrNW_004936657:3,443,406...3,453,096
Ensembl chrNW_004936657:3,443,485...3,453,133
G
D
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr26:22,726,523...22,735,129
Ensembl chr26:22,726,526...22,735,125
G
B
NEFH
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr22:10,525,738...10,536,788
G
C
Nefh
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chrNW_004955455:3,735,330...3,744,714
Ensembl chrNW_004955455:3,735,410...3,744,107
G
R
Nefh
neurofilament heavy chain
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351
G
M
Nefh
neurofilament, heavy polypeptide
treatment
ISO
RGD
PMID:15222692
RGD:27226879
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
H
NEFH
neurofilament heavy chain
treatment
IEP
RGD
PMID:15222692
RGD:27226879
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
N
Nefl
neurofilament light chain
ISO
protein:increased expression:CSF (human) associated with relapse;protein:increased expression:serum (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chrNW_004624758:20,063,109...20,068,459
Ensembl chrNW_004624758:20,062,685...20,068,609
G
G
NEFL
neurofilament light chain
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chr 8:23,077,085...23,083,213
Ensembl chr 8:23,077,086...23,083,222
G
P
NEFL
neurofilament light chain
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chr14:8,991,321...8,996,900
Ensembl chr14:8,991,331...8,997,112
G
S
Nefl
neurofilament light chain
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chrNW_004936757:1,642,122...1,646,499
Ensembl chrNW_004936757:1,642,222...1,645,697
G
D
NEFL
neurofilament light chain
ISO
protein:increased expression:CSF (human) associated with relapse;protein:increased expression:serum (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chr25:32,463,361...32,468,965
Ensembl chr25:32,463,452...32,467,224
G
B
NEFL
neurofilament light chain
ISO
protein:increased expression:CSF (human) associated with relapse;protein:increased expression:serum (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chr 8:24,218,510...24,224,627
Ensembl chr 8:21,134,533...21,140,694
G
C
Nefl
neurofilament light chain
ISO
protein:increased expression:CSF (human) associated with relapse;protein:increased expression:serum (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 RGD:127285027
NCBI chrNW_004955403:47,946,413...47,951,734
Ensembl chrNW_004955403:47,946,353...47,952,026
G
R
Nefl
neurofilament light chain
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 , RGD:127285027
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
G
M
Nefl
neurofilament, light polypeptide
ISO
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 , RGD:127285027
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
H
NEFL
neurofilament light chain
IEP
associated with relapse;protein:increased expression:serum (human) protein:increased expression:CSF (human)
RGD
PMID:30761586 PMID:33658322
RGD:127285025 , RGD:127285027
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
N
Nod2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chrNW_004624757:5,956,873...6,000,052
Ensembl chrNW_004624757:5,958,486...6,000,103
G
G
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr 5:36,492,158...36,531,766
Ensembl chr 5:36,496,414...36,530,499
G
P
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr 6:34,132,127...34,167,446
Ensembl chr 6:34,130,938...34,177,534
G
S
Nod2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
G
D
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr 2:64,636,850...64,667,232
Ensembl chr 2:64,635,519...64,667,232
G
B
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
C
Nod2
nucleotide binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chrNW_004955433:8,746,213...8,780,119
Ensembl chrNW_004955433:8,746,004...8,782,710
G
R
Nod2
nucleotide-binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr19:18,382,369...18,422,817
Ensembl chr19:18,382,439...18,417,177
G
M
Nod2
nucleotide-binding oligomerization domain containing 2
disease_progression
ISO
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
H
NOD2
nucleotide binding oligomerization domain containing 2
disease_progression
IAGP
DNA:SNPs: :rs3135499,rs2066842(human)
RGD
PMID:20595247
RGD:13204725
NCBI chr16:50,693,606...50,733,075
Ensembl chr16:50,693,588...50,733,077
G
N
Nog
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chrNW_004624795:11,696,102...11,697,367
Ensembl chrNW_004624795:11,696,353...11,697,051
G
G
NOG
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr16:36,816,783...36,818,693
Ensembl chr16:36,817,476...36,818,174
G
P
NOG
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr12:32,891,321...32,892,206
Ensembl chr12:32,891,321...32,892,206
G
S
Nog
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chrNW_004936490:6,262,651...6,264,069
Ensembl chrNW_004936490:6,262,785...6,263,483
G
D
NOG
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr 9:31,453,604...31,456,060
G
B
NOG
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr17:50,669,186...50,671,081
Ensembl chr17:55,532,394...55,533,092
G
C
Nog
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chrNW_004955451:6,192,368...6,193,766
Ensembl chrNW_004955451:6,193,042...6,193,740
G
R
Nog
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
G
M
Nog
noggin
ISO
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr11:89,191,464...89,193,385
Ensembl chr11:89,191,464...89,193,158
G
H
NOG
noggin
IEP
mRNA,protein:decreased expression:mononuclear cell"
RGD
PMID:21111488
RGD:12801480
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
G
N
S100b
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chrNW_004624745:31,645,927...31,652,846
Ensembl chrNW_004624745:31,645,927...31,652,832
G
G
S100B
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
G
P
S100B
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
G
D
S100B
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr31:39,783,990...39,788,289
Ensembl chr31:39,784,506...39,788,183
G
B
S100B
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr21:33,063,845...33,070,073
Ensembl chr21:46,197,750...46,203,953
G
C
S100b
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chrNW_004955407:42,972,584...42,980,510
Ensembl chrNW_004955407:42,972,584...42,980,510
G
R
S100b
S100 calcium binding protein B
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
M
S100b
S100 protein, beta polypeptide, neural
ISO
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
H
S100B
S100 calcium binding protein B
IEP
protein:increased expression:brain, cerebrospinal fluid
RGD
PMID:12076997
RGD:5508822
NCBI chr21:46,598,604...46,605,082
Ensembl chr21:46,598,604...46,605,208
G
N
Serpine1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chrNW_004624740:16,128,145...16,136,696
Ensembl chrNW_004624740:16,128,059...16,137,337
G
G
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
G
P
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
S
Serpine1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
G
D
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 6:8,719,547...8,727,160
Ensembl chr 6:8,720,825...8,726,301
G
B
SERPINE1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 7:93,267,517...93,279,728
Ensembl chr 7:106,510,130...106,518,450
G
C
Serpine1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
G
R
Serpine1
serpin family E member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
M
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
H
SERPINE1
serpin family E member 1
disease_progression
IEP
protein:increased expression:plasma:
RGD
PMID:10739162
RGD:13208510
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
N
Timp1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004624978:120,723...125,006
Ensembl chrNW_004624978:121,803...124,912
G
G
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
G
P
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr X:42,103,251...42,106,289
Ensembl chr X:42,102,172...42,106,296
G
S
Timp1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004936502:13,345,936...13,350,170
Ensembl chrNW_004936502:13,345,832...13,350,248
G
D
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr X:41,201,623...41,205,314
Ensembl chr X:41,201,638...41,205,310
G
B
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr X:40,018,190...40,022,636
Ensembl chr X:47,914,906...47,919,419
G
C
Timp1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chrNW_004955516:507,113...511,360
Ensembl chrNW_004955516:505,789...512,118
G
R
Timp1
TIMP metallopeptidase inhibitor 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
M
Timp1
tissue inhibitor of metalloproteinase 1
treatment
ISO
RGD
PMID:16412833
RGD:13204825
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
H
TIMP1
TIMP metallopeptidase inhibitor 1
treatment
IEP
RGD
PMID:16412833
RGD:13204825
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
N
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004624904:2,314,197...2,320,900
Ensembl chrNW_004624904:2,314,249...2,318,791
G
G
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr11:50,397,173...50,403,192
Ensembl chr11:50,396,888...50,400,802
G
P
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr 5:19,485,033...19,491,418
Ensembl chr 5:19,485,096...19,491,417
G
S
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004936512:11,481,017...11,487,737
G
D
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr27:1,013,459...1,020,083
Ensembl chr27:1,015,868...1,019,891
G
B
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:34,456,900...34,463,317
Ensembl chr12:35,184,943...35,188,443
G
C
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chrNW_004955458:1,530,163...1,536,874
G
R
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
M
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
G
H
HNRNPA1
heterogeneous nuclear ribonucleoprotein A1
IAGP
ClinVar Annotator: match by term: Chronic progressive multiple sclerosis
ClinVar
NCBI chr12:54,280,726...54,287,087
Ensembl chr12:54,280,193...54,287,088
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all